jENS - 2017

Share your experience by using the
hashtag #jenscongress on:
/JENS.CONGRESS /jens_congress
@JENS_Congress /groups/8519337/profile
HOW TO DOWNLOAD THE CONGRESS APP
1. Connect to the Wi-Fi

network: Convention Center
password: venezia2017
2. Enter your store:
3. Search and download the MCA EVENTS app
You can now interact with speakers using Q&A on MCA app. Ask questions to the
speakers directly via app and engage the discussion at the end of the sessions.
22 33
ORGANISING INSTITUTIONS
Dear Colleagues, Dear Friends,
The European Society for Paediatric Research (ESPR), the European Society for Neo-
european foundation for
the care of newborn infants
natology (ESN), the Union of European Neonatal and Perinatal Societies (UENPS) and
www.efcni.org the European Foundation for the Care of Newborn Infants (EFCNI) have combined
The European Foundation for the Care of Newborn Infants (EFCNI) is the first pan-European organisation their efforts for the 2nd Congress of joint European Neonatal Societies (jENS 2017). The
and network to represent the interests of preterm and newborn infants and their families. congress promises yet again to be a unique event in the field of neonatology.
It gathers together parents, healthcare experts from different disciplines, and scientists with the common
goal of improving long-term health of preterm and newborn children. Our vision and activities are to ensu-
re the best start in life for every baby with best possible treatments and care. The congress will highlight best scientific research and clinical care programmes avai-
lable nowadays. You will also have access to sessions where world-leading experts
will cover a wide range of topics in neonatology, ranging from state-of-the-art basic
and clinical research to patient-centred care and clinical guidelines.
A panel of more than 130 leading international experts who have personally contri-
buted to the state of the art will review cutting-edge developments in the areas of
neonatal care and research, which are particularly active today.
Networking and interactivity between renowned experts participants, Key Opinion

www.espr.info
Leaders, industry and the Organising Societies - will be the keywords of this congress.
The European Society for Paediatric Research (ESPR) aims to promote paediatric research and post-gra-
Innovative and interactive tools such as specially designed apps, jENS TV, interacti-
duate training in Europe. The Society aims to encourage collaboration between the various specialized
fields of paediatrics, with the goal of maintaining paediatrics as a unified, scientifically orientated discipli-
ve e-posters, interactive communications between speakers and the audience and
ne. It has involved into a dynamic and vibrant society which takes up wider societal responsabilities and much more will make this congress a truly pioneering experience.
has a succesful Journal in Pediatric Research. Within ESPR, the European Society of Neonatology (ESN) is
responsible for education and training in Neonatology in Europe. In the past year a transition from ESN to The 2nd edition of the congress comes to the most famous Italian city. Venice, with
a new Board of Neonatology (EBN) was realised to improve the representation of all European countries in its combining spectacular buildings, incredible charm, and a true touch of romance
the neonatal educational activities of ESPR. was ranked the most beautiful city in the world. It certainly deserves a visit and will
without a doubt become one of the congress locations that live on in memory.
The Organising Societies and Scientific Committee of jENS warmly welcome all par-
ticipants in this 2nd edition and thanks all presenters and supporters for their great
commitment. We wish you fruitful discussions with leading experts in the field of
neonatology and are convinced that together, we will make the 2nd jENS an unfor-
gettable experience.
www.uenps.eu
Enjoy the Congress!
The mission of UENPS is to improve healthcare in the neonatal and perinatal medicine in the European
countries. Main goals of UENPS are to improve quality in perinatal and neonatal care by integrating, coor-
dinating and adding national and scientific societies efforts, to promote the knowledge of the perinatal
indicators and to develop recommendations, guidelines, training of the healthcare providers and any Professor Luc Zimmermann Professor Manuel Sanchez Luna
other tool to achieve the best healthcare for every newborn and surveillance of neonatal rights wherever President ESPR President UENPS
they are born.
SUPPORTED BY Doctor Morten Breindahl Silke Mader

President ESN Chairwoman EFCNI
44 55
EXECUTIVE COMMITTEE SCIENTIFIC COMMITTEE
MANON BENDERS VIRGILIO P. CARNIELLI PIERRE GRESSENS

Congress President Chair Past Scientific President
LUC ZIMMERMANN MANUEL
President of ESPR SNCHEZ-LUNA
President of UENPS
AGNES PETRA HPPI NEIL MARLOW

VAN DEN HOOGEN
SILKE MADER MORTEN BREINDAHL

Chairwoman of the President of the European
Executive Board and Society for Neonatology
Co-Founder of EFCNI (ESN)

the care of newborn infants
OLA D. SAUGSTAD UMBERTO SIMEONI
66 77
DARSENA VENEZIA ROMA FIRENZE CAPRI COMO NAPOLI
ROOM ROOM ROOM ROOM ROOM ROOM ROOM
GOUND FLOOR GOUND FLOOR GOUND FLOOR GOUND FLOOR PALAZZO DEL CINEMA PALAZZO DEL CINEMA GOUND FLOOR
09:00 09:00
ESN
COURSE 1
NEONATAL
INFECTIONS
12:00 12:00
17:30 17:30
09:00 - 17:30 ESN COURSE 1 | CAPRI ROOM (PALAZZO DEL CINEMA)
NEONATAL INFECTIONS

09:00 - 09:15 Introduction/welcome
Sinno Simons (The Netherlands)
09:15 - 10:15 Basics of infectious diseases in neonatology

Ren Kornelisse (The Netherlands)
10:15 - 11:00 Early onset sepsis NICE guideline

Mark Turner (United Kingdom)
11:00 - 11:30 COFFEE BREAK
11:30 - 12:30 Adequate antibiotic dosing/TDM

Karel Allegaert (Belgium)
12:30 - 13:00 Time for questions
13:00 - 14:00 LUNCH BREAK
14:00 - 15:00 Infection prevention

Agnes van den Hoogen (The Netherlands)
15:00 - 15:45 Emerging resistance patterns of microbial pathogens and

how these relate to the choice of antibiotics
Christoph Bhrer (Germany)
16:00 - 17:00 Heart rate variability and physiologic monitoring of

neonatal sepsis / probiotics in necrotizing enterocolitis
Irwin Reiss (The Netherlands)
17:00 - 17:30 Discussion
30th October, 2017 99

DARSENA VENEZIA ROMA FIRENZE CAPRI COMO NAPOLI
GOUND FLOOR GOUND FLOOR GOUND FLOOR GOUND FLOOR PALAZZO DEL CINEMA PALAZZO DEL CINEMA GOUND FLOOR
09:00 09:00
PRE- PRE- PRE- ESN PRE-
CONGRESS CONGRESS CONGRESS COURSE 2 CONGRESS
COURSE 2 COURSE 3 COURSE 4 COURSE 1
MULTIMODAL UNMET NEEDS: CONTROVERSY IN NEONATAL VENTILATORY

NEURO-IMAGING IMPROVING PHARMACOLOGY HAEMODYNAMICS SUPPORT-
AND NEURO- THE QUALITY OF MATCHING
MONITORING IN NEONATAL CARE PHYSIOLOGY?
NEONATES - APPROACHES
AND STRATEGIES
13:00 13:00
14:00 14:00
PRE-
CONGRESS
COURSE 5
NEONATAL
GASTROENTEROLOGY,
SURGERY AND
NUTRITION
17:00 17:00
17:30 17:30
PLENARY
SESSION 1
OPENING
CEREMONY
18:30 18:30
Join our Symposium
Strategies and modern 09:00 17:00 PRE-CONGRESS COURSE 1
technologies of continuous noninvasive VENTILATORY SUPPORT- MATCHING
blood gas monitoring PHYSIOLOGY? | COMO ROOM (PALAZZO DEL CINEMA)
Mosaici 2, November 1st, 12.30 pm 1.30 pm Industry Supported session - please see page 125

09:00 11:00 New insights in pathophysiology of neonatal
lung disease
Robin Steinhorn (United States)
jENS 2017
Congress of joint European
Neonatal Societies 11:00 11:30 COFFEE BREAK
October 31st November 4th
11:30 13:00 News in NIV 1: Understanding the controversy of HFNC
early in life
Anna Lavizzari (Italy)
Intraoperative use of transcutaneous
CO2 measuring in paediatric and neonatal 13:00 14:00 LUNCH BREAK
anaesthesia
Michael Brackhahn 14:00 15:30 News in NIV 2: nasal HFOV
Consultant Anaesthetist Daniele De Luca (France)
Department of Anaesthesia, PICU and Emergency
Auf der Bult, Kinder- und Jugendkrankenhaus 15:30 17:00 News in NIV 3: Synchronised NIPPV
Hannover Camilla Gizzi (Italy)
Validation of novel combined

transcutaneous sensor virtually drift
free tcPO2 sensing technology
Irwin Reiss
Professor of Neonatology, Department of Paediatrics
Head Division of Neonatology
Erasmus MC
Rotterdam
Visit SenTec booth No 17 and inform

yourselves about the OxiVenTTM Sensor
a new generation of transcutaneous
monitoring of ventilation and oxygenation.
10
10 31st October, 2017 11
11
09:00 - 17:00 PRE-CONGRESS COURSE 2 | VENEZIA ROOM 09:00 - 17:00 PRE-CONGRESS COURSE 3 | ROMA ROOM
MULTIMODAL NEURO-IMAGING AND UNMET NEEDS: IMPROVING THE
NEURO-MONITORING IN NEONATES QUALITY OF NEONATAL CARE - APPROACHES
AND STRATEGIES
09:00 - 09:45 The early development of brain white matter
Jessica Dubois (France) 09:00 - 11:00 Meeting the patients needs
Jos Latour (United Kingdom)
09:45 - 10:15 Quality assurance of MR images: why is it important and
what does an MR physicist do anyway?
Zoltan Nagy (Hungary)
10:15 - 11:00 How to measure brain prefusion in the newborn 11:30 - 13:00 Parent-infant closeness - developmentally supportive
Steven Miller (Canada) environment
Liisa Lehtonen (Finland)

11:30 - 12:15 How to diagnose cerebral venous thrombosis in the newborn
Luca Ramenghi (Italy) 14:00 - 16:00 Treatment of pain in the NICU Do we treat our patients
with respect of their needs?
12:15 - 13:00 fMRI in the newborn-what do we learn? Marsha Campbell-Yeo (Canada)
Petra Hppi (Switzerland)
16:00 - 17:00 Becoming parent of a preterm baby -
what does that mean
in Sweden
14:00 - 15:00 Connectomics and development Karl Rombo (Sweden)
Martijn Van De Heuvel (The Netherlands)
in Romania
15:00 - 16:00 Strength and pitfalls of (a)EEG Diana Gamulescu (Romania)
Laura Weeke (The Netherlands)
16:00 - 17:00 How to detect seizures in the newborn

Geraldine Boylan (Ireland)
12
12 31st October, 2017 31st October, 2017 13
13
09:00 - 17:00 ESN COURSE 2 | CAPRI ROOM (PALAZZO DEL CINEMA) 09:00 - 13:00 PRE-CONGRESS COURSE 4 | FIRENZE ROOM
NEONATAL HAEMODYNAMICS CONTROVERSY IN PHARMACOLOGY
Industry Supported session - please see page 125
09:00 - 09:30 Introduction: what would you like to learn?
09:00 - 09:10 Welcome and introduction Sinno Simons (The Netherlands)
Willem de Boode (The Netherlands)
09:30 - 10:15 Basics in neonatal pharmacology:
09:10 - 09:50 Cardiovascular physiology what the clinician needs to know!
Shahab Noori (United States) Karel Allegaert (Belgium)
09:50 - 10:30 Advanced haemodynamic monitoring 10:15 - 11:00 PK-PD modeling: what is it, and how can we use it?
Willem de Boode (The Netherlands) Catherijne Knibbe (The Netherlands)
10:30 - 11:00 COFFEE BREAK 11:00 - 11:30 COFFEE BREAK
11:00 - 11:40 Echocardiography on the NICU 11:30 - 12:15 Pharmacology in neonatal research: anything new?
Afif El-Khuffash (Ireland) Sinno Simons (The Netherlands)
11:40 - 12:20 Advanced echocardiographic technologies 12:15 - 13:00 Inotropes in newborn care: an update
Eirik Nestaas (Norway) Eugene Dempsey (Ireland)
12:20 - 13:00 Assessment and management of the PDA 13:00 - 14:00 LUNCH BREAK
Patrick McNamara (Canada)
13:00 - 13:40 LUNCH

14:00 17:00 PRE-CONGRESS COURSE 5 | FIRENZE ROOM
13:40 - 14:20 Assessment and management of PPHN NEONATAL GASTROENTEROLOGY,
Nim Subhedar (United Kingdom) SURGERY AND NUTRITION
14:20 - 15:00 Assessment and management of shock
Colm Breatnach (Ireland) 14:00 15:00 Feeding strategies and the risk of NEC: an overview
Jon Dorling (United Kingdom)
15:00 - 15:40 Longterm outcome of circulatory failure
Mayka Bravo (Spain) 15:00 16:00 Nutritional assessment in surgical neonates
Mark Johnson (United Kingdom)
15:40 - 16:00 COFFEE BREAK 16:00 17:00 Nutritional management of an infant with ileostomy:
practical aspects
16:00 - 16:40 Case histories faculty Alexandre Lapillonne (France)
16:40 - 17:00 Plenary discussion, summary and close

14
14 31st October, 2017 31st October, 2017 15
15
DARSENA VENEZIA ROMA FIRENZE SORRENTO LECCE NAPOLI VERONA
ROOM ROOM ROOM ROOM ROOM ROOM ROOM ROOM
(Mosaici 1) (Mosaici 2)
GROUND FLOOR GROUND FLOOR GROUND FLOOR GROUND FLOOR THIRD FLOOR THIRD FLOOR GROUND FLOOR SECOND FLOOR
08:00 08:00
POSTER WALK
09:00 09:00
Parallel Parallel Parallel Parallel Parallel Parallel
Session 1 Session 2 Session 3 Session 4 Session 5 Session 6
(BRAIN 1) (RESUSCITATION) (EFCNI 1) What can we (NUTRITION 1) (CIRCULATION 1)
Neurodevelopmental New techniques for Pain reduction - does learn from Nutrition and the Brain Who owns the
outcome and optimising newborn a partnership with Neonatal Networks placental blood?
congenital heart resuscitation parents reduce pain in
disease newborns?
11:00 11:00
COFFEE BREAK
11:30 11:30
PLENARY
SESSION 2
Regenerative
Medicine
12:30 12:30
LUNCHEON LUNCHEON
SYMPOSIUM SYMPOSIUM
Early Optimal Strategies and modern
LUNCH BREAK Nutrition in the NICU technologies of con-
tinuous noninvasive
blood gas monitoring
13:30 13:30
POSTER POSTER POSTER ROUND TABLE POSTER SATELLITE POSTER
SESSION 1 SESSION 2 SESSION 3 Interactive clinical ses-
SESSION 4 SYMPOSIUM SESSION 5
sion: are babies with Respiratory Syncytial
LUNG 1 NICU + PARENTS CARDIOLOGY + serious hypoxemic GI + NEC + Virus: Should We NUTRITION 1
conditions still being Identify Paediatric
MICROCIRCULATION 1 missed? BILIRUBIN Patients at Risk for
Severe Disease?
15:00 15:00
(PULMONOLOGY 1) (BRAIN 2) (CIRCULATION 2) (PHARMA 1) (NUTRITION 2) (EFCNI 2)
Pulmonary Monitoring for infants What should we moni- Challenges in Controversies in Family centred deve-
symposium at risk tor? Global neonatal drug neonatal nutrition lopmental supportive
development care evidence or
haemodynamics
(systemic blood flow) philosophy?
17:00 17:00
PHARMACOLOGY
COFFEE BREAK
SECTION MEETING
17:30 17:30
PLENARY
SESSION 3
Bengt Robertson
award
18:30 18:30
BRAIN SECTION
MEETING
08:00 - 09:00 POSTER WALK | GROUND FLOOR

Epidemiology & Networks
Chairs: Niels Bjerregaard Matthiesen (Denmark)
Cathrine Carlsen Bach (Denmark)
ID 004 AN EVALUATION OF DOCTORS AND MEDICAL STUDENTS

KNOWLEDGE OF PAEDIATRIC VACCINATIONS IN PAKISTAN
N. Nadeem (United Kingdom)
PLENARY SESSION 1 | DARSENA ROOM

17:30 - 18:30
ID 005

AN EVALUATION OF DOCTORS AND MEDICAL STUDENTS ATTITUDES
AND BELIEFS OF PAEDIATRIC VACCINATIONS IN PAKISTAN
OPENING CEREMONY N. Nadeem (United Kingdom)
Chairs: Luc Zimmermann (The Netherlands); ID 115 MORTALITY; MORBIDITY AND SHORT-TERM RETINOPATHY OF
Silke Mader (Germany); Manuel Sanchez Luna (Spain); PREMATURITY OUTCOMES IN EXTREME PRETERM NEONATES: A
Morten Breindahl (Sweden) 5 YEAR STUDY
H. Jarvis; M. Sdobnikovs; J. William; F. Dean; P. Satodia (United Kingdom)
17:30 - 17:50 Roundtable The next step to fulfill the unmet needs in
neonatology ID 138 NEONATAL MORTALITY AND MORBIDITY IN FIVE PROVINCIAL
HOSPITALS IN THE PEOPLES DEMOCRATIC REPUBLIC OF LAOS AFTER
Moderator: Michael Kary (Germany); Silke Mader (Germany); IMPLEMENTATION OF A TEACHING PROGRAM FOR NEONATAL CARE
Discussants: Luc Zimmermann (The Netherlands); S. Schmidt 1; B. Saysanasongkham 2; T. Hoehn 1 (1. Germany; 2. Laos)
Manuel Sanchez Luna (Spain); Morten Breindahl (Sweden);
ID 212 DOWNS SYNDROME PREVALENCE AND PRENATAL DIAGNOSIS IN
LATVIA
I. Zile; I. Gavare; I. Grinfelde; I. Malniece; Z. Baltane; A. Maurina (Latvia)
17:50 - 18:10 Extreme Everest: lessons learnt from high altitude
Daniel Martin (United Kingdom) ID 294 THE CHANGING OF LATE FETAL DEATH IN LATVIA BETWEEN 2000 AND
2014
18:10 - 18:30 Learning from our mistakes I. Zile; I. Ebela; V. Folkmanis; I. Rumba-Rozenfelde (Latvia)
Martin Elliott (United Kingdom)
ID 312 HOW BABY FRIENDLY CAN A BABY-FRIENDLY HOSPITAL BE?
EXPERIENCE IN A ROMANIAN NEONATAL CLINIC
M. Simon; R. Snta; Zs. Gll; L. Suciu; R. Marian; M. Rusneac; C. Gliga;
M. Cucerea (Romania)
ID 369 THE EFFECTIVENESS OF PRENATAL ULTRASOUND DIAGNOSIS IN

RECOGNITION OF MUSCULOSCELETAL MALFORMATIONS
A. Beke; Z.S. Tidrenczel; F.R. Eros (Hungary)
ID 409 PREVALENCE OF LATE PRETERM INFANTS IN THE UNIVERSITY HOSPITAL

OF THE SOUTH REGION OF BRAZIL: INCREASED NEONATAL MORBIDITY
RISK COMPARED WITH TERM INFANTS
P.J.H. Nader; S.S. Nader; L. Acosta; A. Sangalli (Brazil)
ID 434 THE INFLUENCE OF TWO DIFFERENT FAT EMULSIONS USED FOR

PARENTERAL NUTRITION ON THE INCIDENCE OF SELECTED
COMPLICATIONS OF PREMATURITY
Z. Owsiaska; G. Matusiak; K. Mielnik; T. Szczapa; J. Gadzinowski (Poland)
16
16 31st October, 2017 1st November, 2017 17
17
ID 440 RIGHT PLACE - RIGHT TIME ? PLACE OF BIRTH AND TRANSFERS OF ID 289 NEONATAL MORBIDITY OF EXTREME PRETERM INFANTS
EXTREME PRETERM NEONATES WITHIN TWO ADJACENT NEONATAL BEFORE AND AFTER THE INTRODUCTION OF A DONOR HUMAN
OPERATIONAL DELIVERY NETWORKS MILK BANK AT THE PERINATAL CENTER GROHADERN
D. Vieten; M. Sutcliffe; S.V. Rasiah; A. Philpott (United Kingdom) V. Lieftchter; M. Kujawa; A. Schuze; A.W. Flemmer; S. Herber-Jonat
(Germany)
ID 490 PHENOTYPIC SPECTRUM OF GOLDENHAR SYNDROME:
A DESCRIPTIVE STUDY ID 320 OPTICAL PROPERTIES OF EARLY STOOL FROM PRETERM INFANTS:
N. Kasdallah; M.T. Lamouchi; M. Sallemi; W. Barbaria; Kasraoui; IMPORTANT TO CONSIDER FOR ABDOMINAL OXIMETRY BASED ON
H. Ben Salem; H. Kbaier; S. Blibech; M. Douagi (Tunisia) NEAR-INFRARED SPECTROSCOPY
H. Isler; D. Schenk; J. Bernhard; F. Scholkmann; S. Kleiser; D. Ostojic;
ID 521 RETURN TO WORK TRAINING REQUIREMENTS FOR NEONATAL NURSES: D. Bassler; M. Wolf; T. Karen (Switzerland)
A NETWORK SURVEY
C. Hiatt; R. Blake; J. Furness; K. Dewitt; N. Shankle; V. McFadden; P. Nath; ID 407 REFERENCE VALUES OF ZONULIN IN TERM NEONATES
P. Satodia (United Kingdom) A. Tarko; A. Suchojad; A. Jarosz-Lesz; M. Majcherczyk; M. Michalec;
I. Maruniak-Chudek (Poland)
ID 560 TRENDS IN MAJOR MORBIDITY RATES AT THE LIMIT OF VIABILITY IN THE
LAST DECADE ID 472 DETERMINANTS OF THE NEED FOR TREATMENT IN PREMATURE INFANTS
S. Zeballos Sarrato; A. Rodriguez Snchez de la Blanca; S. Villar Castro; WITH SUSPECTED NECROTISING ENTEROCOLITIS
C. Ramos Navarro; G. Zeballos Sarrato; M. Snchez Luna (Spain) N. Bussmann; A. El-Khuffash; D. Corcoran (Ireland)
ID 830 PAEDIATRIC HEAD TRAUMA IN THE EMERGENCY DEPARTMENT ID 589 NEWBORNS WITH ULTRASOUND FINDING OF GAS IN HEPATIC PORTAL
E. Ryan; T. Bolger; I. Okafor; M. Barrett; E.J. Molloy (Ireland) VENOUS SYSTEM: ANALYSIS OF RISK FACTORS; CLINICAL AND
LABORATORY FINDINGS AND DEVELOPMENT OF ALLERGY
J. Lozar Krivec; A. Nyasha Zimani; N. Zupani; D. Paro-Panjan (Slovenia)
Ethics ID 621 NEONATAL FECAL BIOMARKERS OF NECROTIZING ENTEROCOLITIS
Chairs: Charles C. Roehr (United Kingdom) I. Tof; M.V. Rodriguez-Benitez; C. Hernandez-Chirlaque; M. Gil-Campos;
M.D. Ruiz-Gonzalez; A. Martinez (Spain)
ID 657 INGEBORG SYLLM-RAPOPORT (1912-2017) AN EXEMPLARY LIFE FOR
CHILDREN AND PAEDIATRICS ID 664 THE PRETERM INFANT GASTRIC EMPTYING RATE IS DEPENDENT ON THE
H. Sallmon 1; R.R. Wauer 1; C.C. Roehr 1;2 FEED VOLUME AND NOT POSTNATAL AGE
(1. Germany; 2. United Kingdom) C.H. Ferreira 1; F.E. Martinez 1; G.C. Crott 1; J. Belik 2 (1. Brazil; 2. Canada)
ID 675 NECROTIZING ENTEROCOLITIS IN A NEONATAL INTENSIVE CARE UNIT

M. Branco; I. Falco; T. Lopes; E. Proena; A. Almeida; C. Carvalho; L. Pinho
Neonatal GI Physiology & NEC (Portugal)
Chairs: Jon Dorling (United Kingdom)
ID 678 SPONTANEOUS INTESTINAL PERFORATION: A DIAGNOSTIC
ID 204 CORRELATION BETWEEN CALPROTECTIN LEVELS IN MECONIUM AND CHALLENGE IN THE NEWBORN
VITAMIN D STATUS IN CORD BLOOD: ASSOCIATION WITH INTESTINAL M. Branco; T. Lopes; I. Falco; L. Pinho; C. Enes; A. Almeida; C. Carvalho;
DISTRESS DURING NEONATAL PERIOD E. Proena (Portugal)
S.H. Park; W.H. Kim; Y.M. Lee (Korea)
ID 806 NECROTIZING ENTEROCOLITIS: WHAT ASPECTS IN 2017?
ID 244 COMPARISON OF FECAL CALPROTECTIN LEVELS ACCORDING TO H. Ben Salem; I. Kasraoui; M.T. Lamouchi; E.D. Bouaicha; N. Kasdallah;
FEEDING KINDS IN VERY PRETERM INFANTS S. Blibech; M. Doagi (Tunisia)
J.H. Park; N.H. Lee; S.Y. Shin; C.S. Kim; S.L. Lee; W.M. Lee (Korea)
18
18 1st November, 2017 1st November, 2017 19
19
ID 853 MATERNAL RISK FACTORS FOR NEC IN PREMATURES INFANTS WITH GA ID 148 TRANSPORT OF HIGH-RISK NEONATES WITH RESPIRATORY
UNDER 28 WEEKS FAILURE: A SINGLE CENTER COHORT ANALYSIS BASED ON THE
L. Olariu; G. Olariu; L. Olariu; S. Olariu (Romania) TRANSPORT RISK INDEX OF PHYSIOLOGIC STABILITY VERSION II
(TRIPS-II)
M. Klemme 1; A. Staffler 2; K. M. Frster 1; A. Schulze 1; S. Herber-Jonat 1;
J. Kappeler 1; A. W. Flemmer 1
Neonatal Pulmonology, Neonatal Respiratory (1. Germany; 2. Italy)
Support, Resuscitation
Chairs: Kajsa Bohlin (Sweden); Daniele De Luca (France) ID 193 FACTORS ASSOCIATED WITH EXTUBATION FAILURE IN VERY LOW BIRTH
WEIGHT INFANTS
ID 031 TIMING OF KEY EVENTS IN NEONATAL RESUSCITATION A. Menshykova; D. Dobryanskyy (Ukraine)
A. Heathcote; J. Jones; P; Clarke (United Kigdom)
ID 197 A COST IMPROVEMENT PROJECT: REVIEW OF THE USE OF INHALED
ID 051 COMPARING NON-INVASIVE VENTILATION METHODS IN NITRIC OXIDE (INO) IN A NEONATAL INTENSIVE CARE
RESPIRATORY SUPPORT OF PRETRM NEONATES WITH RESPIRATORY B. Zanetti; R. Roy (United Kingdom)
DISEASS
A. Shah Farhat; A. Mohammadzadeh; G. Ali Mamuri; R. Saeidi; ID 200 IMPROVED SURVIVAL AND DECREASED INCIDENCE OF
S. Noorizadeh (Iran) BRONCOPULMONARY DYPLASIA IN INFANTS LESS THAN 27 WEEKS
GESTATION AFTER A RESPIRATORY CARE BUNDLE
ID 062 NEONATAL NON-INVASIVE RESPIRATORY SUPPORT APPROACH: J. Soliz; A. Soliz (United States)
A TWO COUNTRIES COMPARISON
I. Bresesti 1; S. Zivanovic 2; G. Lista 1; C.C. Roehr 2,3 ID 233 LUNG FUNCTION AND IGE RESPONSE ARE REDUCED IN 9 TO 10 YEARS
(1. Italy; 2. United Kingdom; 3. Germany) OLD ASTHMATIC CHILDREN WITH PRETERM BIRTH
L.C. Fang; J.Y. Wang; S.D. Shyur; S.H. Chu; Y.H. Kao; W.T. Lei (Taiwan)
ID 064 PREDICTORS OF EARLY CPAP FAILURE IN VERY LOW BIRTH WEIGHT PRE
TERM INFANTS ID 249 PRETERM BIRTH REDUCES ATOPIC SENSITIZATION IN PRESCHOOL
W.A. Gonalves-Ferri; F.P. Martins-Celini; G.H. Seribeli; E. Sacramento; CHILDREN WITH ALLERGIC DISEASE
C. Calixto; M. Bertoldi; D.C. Aragon (Brazil) J.Y. Wang; L.C. Fang (Taiwan)
ID 069 LENGTH OF MECHANICAL VENTILATION AND CLINICAL FEATURES AT ID 261 LOSS OF SURFACTEN DURING BOLUS ADMINISTRATION USING A
BIRTH IN PREMATURE INFANTS FEEDING CATHETER
A.M. Nakato; R.P.G.V.C. Silva; N. Rosario Filho (Brazil) K. Fujioka; J. Kuroda; K. Yamana; M. Ashina; T. Ikuta; S. Fukushima;
S. Ohyama; S. Okubo; K. Iijima; I. Morioka (Japan)
ID 071 MATERNAL MUTATIONS OF FOXF1 CAUSE ALVEOLAR CAPILLARY
DYSPLASIA DESPITE NOT BEING IMPRINTED ID 278 EXPRESSION OF THE HYALURONAN RECEPTOR RHAMM IN
M. Alsina; A. Monteagudo-Snchez; L. Rodriguez Guerineau; BRONCHIOLAR EPITHELIUM OF NEONATES NEGATIVELY CORRELATES
C. Rovira Zurriaga; D. Monk; J. Moreno Hernando (Spain) WITH AIR CONTENT IN THE LUNG
L. Markasz 1; G. Sedin 1; R. C. Savani 2; R. Sindelar 1
ID 073 CONGENITAL LOBAR EMPHYSEMA MISDIAGNOSED AS (1. Sweden; 2. United States)
PNEUMOTHORAX
I. Bakalli; E. Kola; R. LLuka; E. Celaj; D. Sala; I. Gjeta; S. Sallabanda (Albania) ID 298 BIPAP REDUCES EXTUBATION FAILURE IN THE FIRST WEEK COMPARED
TO CPAP IN NEONATES < 30 WK OF GA WITHOUT INCREASED RISK OF
ID 137 A CLINICAL CASE OF A CHILD WITH CCHS IN THE EARLY NEONATAL PNEUMOTHORAX
PERIOD L. Capasso; A.C. Borrelli; M.A. Caiazzo; C. Parrella; R. Albachiara;
R. Maslarska; M. Kalaydzhieva; S. Deneva; V. Konstantinova; S. Kontilska; F. Raimondi (Italy)
I. Ilieva; J. Ivanova; V. Ivanova; E. Kerinova; R. Georgieva; T. Todorov
(Bulgaria)
20
21
ID 326 THE EFFECT OF SUSTAINED LUNG INFLATION ON EARLY RESPIRATORY ID 395 INHALED NITRIC OXIDE AND PRETERMS: DOOM; GLOOM
OUTCOMES IN TERM INFANTS OR RIGHT? 11 YEARS EXPERIENCE AT TERTIARY CENTRE
M. Cetinkaya; D. Kilic; S. Ylmaz Semerci; B. Cebeci; O. Saglam (Turkey) E. Syrimi; H. Warwick; P. Satodia; P. Nath (United Kingdom)
ID 332 PROLONGED AIR RETRIEVAL OF A NEWBORN INFANT WITH TOTAL ID 405 CURRENT PRACTICE OF NEUTRALLY ADJUSTED VENTILATOR ASSIST IN
ANOMALOUS PULMONARY VENOUS DRAINAGE THE NEONATAL INTENSIVE CARE UNIT: A TAIWAN SURVEY
R. Pal; B. Carter; K. McDonald; J. Tan; D. Wagh; J. Davis (Australia) C.E. Chiang; Y.L. Chen; L.Y. Tsai; Y.H. Chien; S.C. Mu; K.Y. Chao (Taiwan)
ID 340 PERINATAL FACTORS ASSOCIATED TO THE FAILURE OF EARLY NASAL ID 439 THE EFFECT OF HYDROCHLOROTHIAZIDE WITH SPIRONOLACTONE
CONTINUOUS POSITIVE PRESSURE IN VERY LOW BIRTH WEIGHT TREATMENT ON BRONCHOPULMONARY DYSPLASIA DEVELOPMENT IN
INFANTS VERY-LOW-BIRTH-WEIGHT INFANTS
T.S. Souza; A.A.Vieira; C. Morcelli-Tovar (Brazil) M. Buyuktiryaki; E. Alyamac Dizdar; N. Uras; N. Okur; O. Ertekin; S.S. Oguz
(Turkey)
ID 357 IMPACT OF THE USE OF HIGH POSITIVE END EXPIRATORY PRESSURE
ON EXTUBATION OF PREMATURE INFANTS WITH SEVERE ID 443 NONINVASIVE RESPIRATORY SUPPORT VIA NASAL CANNULA IN
BRONCHOPULMONARY DYSPLASIA PREMATURE INFANTS: IS IT REALLY SAFE?
W. Assad Gonalves-Ferri; F. Pereira Martins-Celini; D. Cristina Troiano; M. Buyuktiryaki; N. Okur; G. Kadioglu Simsek; H.G.Kanmaz; F.E. Canpolat
D. Casale Aragon (Brazil) (Turkey)
ID 361 THE USE OF DEXAMETHASONE IN PRETERM INFANTS FOR LUNG ID 453 BOCHDALEK HERNIA WITH INTRATHORACIC KIDNEY ASSOCIATED
DISEASE IN A TERTIARY NICU WITH AORTIC COARCTATION
B. Skenderi Mustafa; H. Ismaili; F. Kajtazi; G. Hazbahta; F. Krasniqi (Kosovo)
K.M. Sun; H. Gowda (United Kingdom)
ID 462 THE LARYNGEAL MASK AIRWAY AND ITS USE IN NEONATAL
ID 366 CONSULTANT PRESENCE AT DELIVERY: A RETROSPECTIVE AUDIT OF
RESUSCITATION - A CRITICAL REVIEW OF WHERE WE ARE IN 2017
DEMOGRAPHICS AND OUTCOMES IN A TERTIARY UK CENTRE
S.C. Bansal 1; S. Caoci 2; D. Trevisanuto 2; C.C. Roehr 1; E.M. Dempsey 3
L. Mahoney; T. Hunt; H. Rabe; P. Amess; N. Aiton; N. Bhat; R. Bomont; (1. United Kingdom; 2. Italy; 3. Ireland)
N. Drenchev; C. Garland; C. Lawn; B. Reulecke; R. Watkins; R. Fernandez
(United Kingdom) ID 467 RETROSPECTIVE AUDIT OF POSTNATAL OUTCOME OF ANTENATALLY
DIAGNOSED RENAL PELVIS DILATATION
ID 379 COMPARISON BETWEEN OUTCOMES OF MINIMALLY INVASIVE S. Vora; N. Kavalloor; T.L. Yap; PC Khoo; V. Rajadurai (Singapore)
TECHNIQUE AND INTUBATION SURFACTANT EXTUBATION IN PRETERM
INFANTS LESS THAN 1500 GRAMS IN A DEVELOPING COUNTRY ID 511 OUTCOMES OF POSTNATAL DEXAMETHASONE USE IN EXTREME
W.A. Gonalves-Ferri; P. Paiva; L. Scalioni; E. Sacramento; C. Calixto; PRETERM NEONATES IN A TERTIARY NEONATAL UNIT
A.C. Hallak; D.C. Aragon (Brazil) A. Holt; L. Osborne; P. Satodia (United Kingdom)
ID 381 PREMATURE INFANTS WITH VERY LOW WEIGHT WITH APNEA HAVE ID 516 VALIDATION OF A TRANSCUTANEOUS TCPO2/TCPCO2 SENSOR WITH
POOR RESULTS DESPITE TREATMENT AN OPTICAL OXYGEN MEASUREMENT IN PRETERM NEONATES
A.B. Gonalves; M.M. Loureno; L. Scacioli; E. Sacramento; C. Calixto; W. van Weteringen; T.G. Goos; T. van Essen; N.H. Gangaram-Panday;
D.C. Aragon; W.A. Gonalves-Ferri (Brazil) R.C.J. de Jonge; I.K.M. Reiss (The Netherlands)
ID 388 EARLY HIGH FREQUENCY VENTILATION A PROMISE OF PROTECTIVE ID 524 SUCCESSFUL VENTILATION VIA ACCIDENTAL OESOPHAGEAL
VENTILATION? INTUBATION IN A CASE OF FLOYD TYPE III/FARO TYPE B TRACHEAL
W.A. Gonalves-Ferri; M. Bertoldi; A.B. Gonalves; E. Sacramento; AGENESIS IN A DISCORDANT MONOZYGOTIC TWIN
C. Calixto; D.C. Aragon (Brazil) M. Noureldein; A. Olariu; J. Egyepong (United Kingdom)
22
23
ID 528 WHAT IS THE IDEAL TARGET PRETERM POPULATION THAT MIGHT ID 660 PERI-OPERATIVE MANAGEMENT OF NEONATES WITH
BENEFIT FROM THE EXPENSIVE PALIVIZUMAB PROPHYLAXIS? OESOPHAGEAL ATRESIA IN LOW- INCOME COUNTRIES:
S. Tsilika; D. Batra (United Kingdom) EXPERIENCE OF TUNISIA
F.Z.Chioukh; K. Ben Ameur; T. Khemis; A. Ksia; A. Ben Salem; H. Ben Hamida;
ID 538 INCIDENCE AND OUTCOME OF PNEUMOTHORACES IN A TERTIARY K. Monastiri (Tunisia)
NEONATAL INTENSIVE CARE UNIT
R.C. Ramaswamy; M.K. Brom; S.V. Rasiah (United Kingdom) ID 662 LESS INVASIVE SURFACTANT ADMINISTRATION IN PRETERM
INFANTS. REVIEW AFTER 4 YEARS OF IMPLEMENTATION
ID 546 CLINICAL IMPACT OF THE RESPIRATORY SYNCYTIAL VIRUS INFECTION C. Ramos-Navarro; S. Zeballos-Sarrato; N. Gonzalez-Pacheco;
IN INFANTS WITH A HISTORY OF PREMATURITY BETWEEN 32-34 WEEKS A. Rodriguez- De la Blanca; M. Arriaga-Redondo; S. Villar-Castro;
N. Ramos; C.M. Martn; G. Ucls; R.C Raynero; I. Prez; I. Pescador-Chamorro; N. Navarro-Patio (Spain)
M. Gonzlez-Valcrcel; M.D Snchez-Redondo; A. Pantoja; J. Cobas;
A. Escobar; A. Martnez (Spain) ID 693 VERY LOW BIRTH WEIGHT PRETERM BABY PRESENT HIGH INCIDENCE
OF RETINOPATHY OF PREMATURITY AND BRONCHOPULMONARY
ID 554 LATE PRETERM INFANTS: WHAT IS THEIR REAL RESPIRATORY DYSPLASIA DESPITE DRUG TREATMENT
MORBIDITY? A.B. Gonalves; M.M. Loureno; L. Scacioli; A. Borges; A.C. Hallak;
A.M. Gil Fenoy; F.J. Pacheco Snchez La Fuente; P. Miranda Romera; M. Bertoldi; D. Testoni; G.H. Seribelli; B.B. Lima; E. Sacramento; C. Calixto;
L. Serrano Lpez; E. Martn lvarez; J.A. Hurtado Suazo (Spain) D.C. Aragon; W.A. Gonalves-Ferri (Brazil)
ID 565 REVIEW OF OUTCOMES IN PRETERM NEONATES FOLLOWING ID 697 AN UNUSUAL CAUSE OF RESPIRATORY DISTRESS IN NEONATES:
CHANGE OF VENTILATORY PRACTICE TO VOLUME-TARGETED CONGENITAL PULMONARY LYMPHANGIECTASIS (TWO CASE
VENTILATION IN A NEONATAL INTENSIVE CARE UNIT REPORTS)
I. Fernando; H. McDermott; A. Singh; S. Rasiah (United Kingdom) S. Nouri Merchaoui; N. Mahdhaoui; H. Ayache; M. Bellalah; I. Kacem;
H. Barbouche; A. Ghith; M.T.Yacoubi; J. Methlouthi; H. Seboui (Tunisia)
ID 569 THYROID STATUS MONITORING DURING FIRST YEAR OF LIFE IN
INFANTS WITH CONGENITAL HYPOTHYROIDISM DETECTED BY ID 711 APGAR SCORE OF 5 MINUTES LESS THAN 5 IS NOT RELATED TO POOR
NEWBORN SCREENING OUTCOMES IN VERY LOW BIRTH WEIGHT PRETERM INFANTS
N. Zdraveska; V. Anastasovska; A. Kostovski Mirjana Kocova (Macedonia) W.A. Gonalves-Ferri; P. Paiva; A. Borges; E. Sacramento; C. Calixto;
D.C. Aragon (Brazil)
ID 601 DIURETICS FOR EVOLVING CHRONIC LUNG DISEASE OF PREMATURITY:
WHO ARE WE TREATING? ID 714 ETIOLOGICAL AND PATHOLOGICAL CORRELATIONS IN PERSISTENT
A.K. Linklater; R. Cuzzilla; S.E. Jacobs (Australia) PULMONARY HYPERTENSION OF THE NEWBORN
M.L. Ognean; R. Dumitra; O. Boant; C. Zgrcea; E. Olariu; S. Kovacs
(Romania)
ID 629 CAN TcCO2 MONITORIZATION IN THE DELIVERY ROOM BE HELPFUL
FOR DIFFERENTIATING TERM NEWBORNS IN NEED OF
HOSPITALIZATION FOR RESPIRATORY MORBIDITIES? ID 717 BRONCHOPULMONARY DYSPLASIA - ARE THERE NEW RISK FACTORS
I. Mungan Akin; E. Bocu; M. Uygun; S. Sevuk Ozumut; D. Buyukkayhan; IN VERY PRETERM INFANTS?
M.L. Ognean; O. Boant; E. Olariu; S. Kovacs; C. Zgrcea; R. Dumitra;
S. Arslanoglu; F. Ovali (Turkey)
D. Andreicu (Romania)
ID 635 MANAGEMENT OF PNEUMOTHORAX IN NEWBORNS: NEONATAL
INTENSIVE CARE UNIT EXPERIENCE IN TUNISIA ID 729 OUTCOMES OF PRETERM INFANTS LESS THAN 26 WEEKS GESTATION AT
K. Ben Ameur; T. Khemis; A. Ben Salem; H. Ben Hamida; F.Z. Chioukh; BIRTH WHO RECEIVED CHEST COMPRESSION OR ADRENALINE DURING
K. Monastiri (Tunisia) RESUSCITATION AT BIRTH
H. Shing; H. Gowda (United Kingdom)
ID 642 MALIGNANT PERTUSSIS. IS IT TIME FOR EXCHANGE TRANSFUSSION?
R. Roldn; M. Huescar; M.G. Espinosa; A. Morales; E. Salguero (Spain)
24
25
ID 741 LUNG ULTRASOUND (LUS) TO ASSESS PERSISTENT PULMONARY ID 804 NEONATAL CHYLOTHORAX: 20 YEARS EXPERIENCE IN A
HYPERTENSION OF THE NEWBORN (PPHN) ETIOLOGY TERTIARY NEONATAL UNIT
B. del Rey Hurtado de Mendoza; J. Moreno Hernando; H. Sharp; C. Kortsalioudaki; M. Sellwood; G. Kendall (United Kingdom)
J. Snchez-de-Toledo; J. Rodrguez-Fanjul (Spain)
ID 832 PREDICTIVE AND RISK FACTORS FOR EARLY NON-INVASIVE
ID 745 NEURALLY ADJUSTED VENTILATION IN PATIENTS WITH CONGENITAL RESPIRATORY SUPPORT FAILURE IN A COHORT OF PRETERM INFANTS:
DIAPHRAGMATIC HERNIA A RETROSPECTIVE STUDY
A.M. Sanchez-Torres; H. Peinado; R. Madero; M.D. Elorza (Spain) I. Bresesti; F. Viaroli; F. Castoldi; F. Scopesi; B. Roviglione; L. Ramenghi;
F. Cerritelli; G. Lista (Italy)
ID 746 NON-INVASIVE NEURALLY ADJUSTED VENTILATION (NIV-NAVA) IN
THE NEWBORN ID 854 HOW SAFE IS NASAL CANNULAE OXYGEN THERAPY DURING
H. Peinado; H. Snchez-Torres; R. Madero; M.D. Elorza (Spain) NEONATAL TRANSPORT?
A. Brunton; J. OShea; A. Jackson (United Kingdom)
ID 748 THE NON INVASIVE RESPIRATORY SUPPORT FAILURES IN PRETERM
INFANTS. RISK FACTORS AND OUTCOMES ID 855 THE INCIDENCE OF RESPIRATORY MORBIDITY IN LATE PRETERM INFANT
C. Ramos-Navarro; I. Marsinyach Ross; G. Zeballos-Sarrato; G. Olariu; S. Olariu; M. Tunescu (Romania)
P. Chimenti-Camacho; A. Perez-Perez; R. Gregorio-Hernndez;
M. Snchez-Luna (Spain) ID 860 MATERNAL SMOKING IN PREGNANCY INCREASES THE DURATION OF
HOME OXYGEN THERAPY IN INFANTS WITH BRONCHOPULMONARY
ID 749 SELECTIVE LUNG VENTILATION: A THERAPEUTIC STRATEGY FOR DYSPLASIA
ACQUIRED LUNG COLLAPSE IN A TERM INFANT A. Prayle; A. Davies; A. Silverman; S. Spencer; M. Hurley; J. Bhatt
H. Gowda; S. Bhayat (Spain) (United Kingdom)
ID 759 INCIDENCE OF RESPIRATORY MORBIDITY IN LATE PRETERM AND TERM ID 862 CONTROLLED VENTILATION WITH A LARYNGEAL MASK AIRWAY FOR
INFANTS IN RESPECT TO DELIVERY MODE 48 HOURS IN A NEWBORN WITH TRACHEAL AGENESIS
J. Gromann; T. Burkhardt; R. Arlettaz; S. Wellmann (Switzerland) R.H. Mupanemunda; R.F. Danha (United Kingdom)
ID 788 RISK FACTORS ASSOCIATED TO SURVIVAL FREE ID 863 ASSESSMENT OF A NEONATAL INTUBATION SCORING INSTRUMENT:
BRONCHOPULMONARY DYSPLASIA ACCORDING TO GESTATIONAL A PROSPECTIVE OBSERVATIONAL STUDY
AGE R. Bouwmeester; M. Binkhorst; N. Yamada; R. Geurtzen; A. van Heijst;
C. Ramos-Navarro; G. Zeballos-Sarrato; E. Sanz-Lopez; L. Halamek; M. Hogeveen (United States)
E. Maderuelo-Rodriguez; N. Gonzalez-Pacheco;
M. Snchez-Gmez de Orgaz; M. Snchez-Luna (Spain)
Perinatal Pharmacology and Anethesia
ID 792 OUTCOME OF INFANTS BORN AFTER MID-TRIMESTER RUPTURE OF Chairs: Sinno Simons (The Netherlands)
MEMBRANES
T. Hurley 1; J. Miletin 1, 2; A. Martin 1; C. Fitzpatrick 1; J. Semberova 1, 2
(1. Ireland; 2. Czech Republic) ID 027 UNDERSTANDING THE RELATIONSHIP BETWEEN DOPAMINE
CONCENTRATION AND BLOOD PRESSURE IN NEONATES: INCUBATORS
ID 793 NEURALLY ADJUSTED MECHANICAL VENTILATION (MV-NAVA) IN THE VERSUS COT
NEWBORN K. Kirupakaran; H. Rabe; B. Patel (United Kingdom)
A.M. Snchez Torres; H. Peinado; R. Madero; M.D. Elorza (Spain)
ID 104 EFFECT OF CHRONIC EXPOSURE OF LOSARTAN IN MOUSE PRENATAL
ALCOHOL EXPOSURE (PAE) MODEL
ID 803 CHYLOTHORAX: CASE SERIES OF 20 YEARS
A. Takyi (United Kingdom)
M. Rosrio; A. Reis e Melo; S. Pissarra; G. Rocha; H. Guimares (Portugal)
26
27
ID 187 EFFECT OF POSTNATAL CORTICOSTEROID ON BROWN ADIPOSE TISSUE 09:00 11:00 PARALLEL SESSION 1 (BRAIN 1)|DARSENA ROOM
THERMOGENESIS IN NEONATAL RAT
Y-S. Chang; C.H. Lin; Y.S. Tsai (Taiwan)
NEURODEVELOPMENTAL OUTCOME AND
CONGENITAL HEART DISEASE
ID 492 VENO-ARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION Chairs: Bea Latal (Switzerland);
IMPAIRS ACETYLCHOLINE-INDUCED CONTRACTION IN NEONATAL Nathalie Claessens (The Netherlands)
PORCINE CORONARY ARTERIES
L. Provitera 1; G. Cavallaro 1; G. Raffaeli 1; I. Amodeo 1; S. Gulden 1; 09:00 09:20 Brain health in neonates with CHD: timing is everything
G. Zuanetti 1; V. Gentilino 2; F. Macchini 2; E. Villamor 1; F. Mosca 1 Steven Miller (Canada)
(1. Italy; 2. The Netherlands)
09:20 09:40 Neurodevelopmental outcome and congenital heart
ID 875 POINT-OF-CARE ANALYSIS OF BETA-HYDROXYBUTYRATE disease
CONCENTRATIONS IN BABIES IS A USEFUL ALTERNATIVE TO Bea Latal (Switzerland)
LABORATORY TESTING
D.L. Harris; P.J. Weston; J.E. Harding (New Zealand) 09:40 10:10 Neonatal surgery and brain injury
Petra Lemmers (The Netherlands)
10:10 10:25 Cognitive stability in children with congenital heart disease

N. Naef; C. Schaefer; V. Rousson; R. Liamlahi; S. Polentarutti;
I. Beck; V. Bernet, D. Hitendu; W. Knirsch; B. Latal (Switzerland)
10:25 10:40 Congenital heart defects and academic performance in a

nationwide cohort of 458,318 Danish children
N.B. Matthiesen; S.H. Larsen; T.B. Henriksen; C.C. Bach;
J.R. stergaard; V. Hjortdal (Denmark)
10:40 10:55 Early postoperative amplitude-integrated electroence

phalography: biomarker of new brain injury in neonates
with congenital heart disease
N.H.P. Claessens; L. Noorlag; L. Weeke; M. Toet; J.M.P.J. Breur;
M.J.N.L. Benders; F. Groenendaal; N.J.G. Jansen; L.S. de Vries
(The Netherlands)
09.00 11.00 PARALLEL SESSION 2 (RESUSCITATION) |VENEZIA ROOM

Chairs: Hans Fuchs (Germany); Claus Klingenberg (Norway)
09:00 - 09:20 New techniques for optimising newborn resuscitation

Peter Davis (Australia)
09:20 - 09:40 Unravelling the physiology of haemodynamic transition

at birth
Stuart Hooper (Australia)
09:40 - 09:55 Delayed cord clamping during resuscitation -

a randomized trial
O. Andersson; A. KC; N. Rana; U. Ewald; M. Mlqvist (Sweden)
28
29
09:55 - 10:10 Sustained versus standard inflations during neonatal 10:45 - 11:00 Valid pain assessment in extreme prematures:
resuscitation to reduce mortality and improve respiratory a long way to go?
outcomes: a systematic review and meta-analysis N. Meesters; S.H.P. Simons; J. van Rosmalen; L. Holsti;
M. Bruschettini 1; C.P.F. ODonnell 2; P.G. Davis 3; C.J. Morley 4; Irwin Reiss; M. van Dijk
L. Moja 4; M.G. Calevo 4; S. Zappettini 4
(1. Sweden; 2. Ireland; 3. Australia; 4. Italy)
10:10 - 10:25 nCPAP pressure at initiation: is higher pressure better? 09.00 11.00 PARALLEL SESSION 4 |FIRENZE ROOM
S. Bhisikar; S. Goel; S. Manerkar; J. Mondkar (India) WHAT CAN WE LEARN FROM NEONATAL
NETWORKS
10:25 - 10:40 Bradyprem study: is heart rate the most vital of all vital
signs during preterm resuscitation? Chairs: Neena Modi (United Kingdom);
Dominique Haumont (Belgium)
V. Kapadia 1; J. Oei 2; O.D. Saugstad 3; Y. Rabi 4; N. Finer 1;
I. Wright 2; W. Tarnow-Mordi 2; W. Rich 1; D. Rook 5; J. Smyth 2;
K. Lui 2; S. Brown 1; M. Vento Torres 6 09:00 09:10 eNewborn, the journey thus far
(1. United States; 2. Australia; 3. Norway; 4. Canada; Dominique Haumont (Belgium)
5. The Netherlands; 6. Spain)
09:10 09:20 Population data sharing: the UK experience
10:40 - 10:55 Predicting developmental outcomes in extremely low Neena Modi (United Kingdom)
birth weight infants: a statistical learning approach
C. Keogh; B. Arthurs; S. Atikah; P. Carr; N. Grayson; E. Horgan; 09:20 09:50 Big data opportunities for European Neonatology
E. Moran; S. ORegan; E.J. Molloy (Ireland) Mark Turner (United Kingdom); Lisa Lehtonen (Finland);
Ola D. Saugstad (Norway); Maximo Vento Torres (Spain);
Charles C. Roehr (United Kingdom)
09.00 11.00 PARALLEL SESSION 3 (EFCNI 1) |ROMA ROOM 09:40 - 09:51 Predicting bleeding risk in thrombocytopenic preterm
PAIN REDUCTION DOES A PARTNERSHIP WITH neonates: the MONET study
S.F. Fustolo-Gunnink; K. Fijnvandraat; I.M. Ree; C. Caram-Deelder;
PARENTS REDUCE PAIN IN NEWBORNS? P. Andriessen; E.J. dHaens; C.V. Hulzebos; W. Onland; A.A. Kroon;
Chairs: Mats Eriksson (Sweden); D.C. Vijlbrief; H. Putter; E. Lopriore; J.G. van der Bom (Netherlands)
09:51 - 10:02 A pilot study: implementing a structured amplitude
09:00 - 09:30 The power of parents to reduce newborn pain integrated electroencephalography (AEEG) education
Marsha Campbell-Yeo (Canada) programme in an irish neonatal intensive care unit (NICU)
setting
09:30 - 10:00 Facilitators and barriers for parents involvement in pain A. Jenkinson; M. Boyle; D. Sweetman (Ireland)
management
Anna Axelin (Finland) 10:02 - 10:13 Fetal heart defects and disrupted cerebral growth: a cohort
study in 63,371 fetuses
10:00 - 10:30 Working with parents to build better pain management M.H. Lauridsen; O.B. Petersen; E.M. Vestergaard; N. Uldbjerg;
for newborn infants T.B. Henriksen; J.R. stergaard; N.B. Matthiesen; V.E. Hjortdal
Mats Eriksson (Sweden) (Denmark)
10:30 - 10:45 A user centered design approach to evaluate a alidated 10:13 - 10:24 Characterisation and burden of 1-year chronic respiratory
infant pain measure e- learning module morbidity among extremely preterm infants: a retrospective
B. Stevens; S. Gibbins; M. Campbell-Yeo; C. McNair; J. Yamada; claims analysis
K. Dionne; Sarah Dinsdale; C. Johnston; A. Taddio (Canada) M. Mowitz; A. Mangili; L. von Krusenstiern; R. Ayyagari; W. Gao;
J. Wang; J. Zhao; S. Sarda (United States)
30
31
10:24 - 10:35 STOP (Septum Trauma Occurrence Prevention) in babies 10:40 - 10:55 The maternal-fetal gradient of free and esterified
on nasal CPAP-A quality improvement project phytoste rols at the time of delivery in humans
R. Mc Coy; K. Singh; V. Kairamkonda (United Kingdom) A. Correani; S. Visentin; E. Cosmi; E. Ponchia; S. DAronco;
M. Simonato; L. Vedovelli; P. Cogo; V.P. Carnielli (Italy)
10:35 - 10:46 Predictive value of early EEG for seizures during
hypothermia in neonates with hypoxic ischemic
encephalopathy
M.C. Cornet; A. Pasupuleti; A. Fang; H.C. Glass; M.R. Cilio 09.00 11.00 PARALLEL SESSION 6 (CIRCULATION 1) |LECCE ROOM
(United States) WHO OWNS THE PLACENTAL BLOOD?
Chairs: Eirik Nestaas (Norway); Colm Breatnach (Ireland)
09:00 - 09:25 The case for the term infant

09.00 11.00 PARALLEL SESSION 5 (NUTRITION 1) |SORRENTO ROOM Ola Andersson (Sweden)
NUTRITION AND THE BRAIN
Chairs: Colin Morgan (United Kingdom); Elsa Kermorvant (France) 09:25 - 09:50 The case for the preterm infant
Heike Rabe (United Kingdom)
09:00 - 09:20 Neuroimaging, a new tool for investigating the effects of
early diet on cognitive and brain development 09:50 - 10:15 Harvesting placental blood: what is it for?
Helle Pfeiffer (Norway) Anders Fasth (Sweden)
09:20 - 09:40 Improving neurological outcomes of preterm infant: update 10:15 - 10:30 Delayed cord clamping in preterm infants with suspected
on the role of early nutrition intrauterine growth restriction
Sissel Moltu (Norway) J. Mercer; M. Wang; J. Padbury (United States)
09:40 - 09:55 Early parenteral use of a lipid emulsion containing fish oil 10:30 - 10:45 The effects of delayed cord clamping on 12-months brain
results in improved longitudinal growth in extremely preterm myelin content: a randomized controlled trial
infants a randomized controlled trial D. Erickson-Owens; J. Mercer; S. Deoni 3; A. Parker 2; J. Collins 2;
S. Najm; C. Lfqvist; G. Hellgren; E. Engstrm; A.K. Nilsson; J. Padbury (United States)
M.X. Andersson; K. Svman; A. Hellstrm (Sweden)
10:45 - 11:00 The use of speckle tracking echocardiography to assess
09:55 - 10:10 Growth and body composition up to 4 months of age in myocardial performance in monochorionic diamniotic twins
preterm infants and term controls (PeaPod study) with and without twin to twin transfusion syndrome
A. Chmielewska; A. Farooqi; M. Domellf; I. Ohlund (Sweden) C.R. Breatnach; A.T. James; F. Malone; N. McCallion; O. Franklin;
A. EL-Khuffash (Ireland)
10:10 - 10:25 Personalised prediction of weight changes in the first week
of life
S. Kasser; M. Wilbaux; J. Gromann; I. Mancino; T. Coscia; O. Lapaire; 11:00 - 11:30 COFFEE BREAK
J.N. van den Anker; M. Pfister; S. Wellmann (Switzerland)
10:25 - 10:40 Z-score differences based on cross-sectional

growth charts do not reflect weight gain in preterm
infants: an adjusted Z-score for longitudinal assessment of
growth
N. Rochow 1; E. Landau-Crangle 1; A. Alkhoraidly 2; A. Bhatia 1;
G. Fusch 1; P. Muppidi 1; W. Gpel 3; C. Fusch 1, 3
(1. Canada; 2. Saudi Arabia; 3. Germany)
32
33
10:00 - 13:00 Respiratory Support in Neonates: How to ventilate term 12:30 - 13:30 Strategies and modern technologies of
and preterm infants Insights into new possibilities and countinuous noninvasive blood gas
neonatal ventilation strategies |MILANO ROOM monitoring |LECCE ROOM
10:10 - 10:30 Invasive closed loop ventilation (Lunch will be provided)
Andreas W. Flemmer (Germany)
12:30 - 13:00 Intraoperative use of transcutaneous CO2 measuring in
10:30 - 11:00 Basic principles of high frequency ventilation (HFOV)
Roland Hentschel (Germany) paediatric and neonatal anaesthesia
Michael Brackhahn (Germany)
11:00 - 11:15 New possibilities in non-invasive closed loop ventilation
Andreas W. Flemmer (Germany) 13:00 - 13:30 Validation of novel combined transcutaneous
sensor - virtually drift free tcPO2 sensing technology
11:00 - 11:15 New insights into HFOV Irwin Reiss (The Netherlands)
Roland Hentschel (Germany)
11:40 - 13:20 Hands on closed loop ventilation / HFOV in two groups

Andreas W. Flemmer (Germany); Roland Henschel (Germany) 13:30 - 15:00 Interactive Clinical Session: Are Babies with Serious
Hypoxemic Conditions Still Being Missed?
11:30 - 12:30 PLENARY SESSION 2 |DARSENA ROOM |FIRENZE ROOM
REGENERATIVE MEDICINE Industry Supported session - please see page 125
Chairs: Pierre Gressens (France); Petra Hppi (Switzerland) Interactive session with audience participation
11:30 - 12:00 Stem cell therapy for neonatal disorders; Chair: Augusto Sola (United States)
Prospects and challenges
Won Soon Park (South Korea) Early detection of neonatal sepsis and other hypoxemic
conditions
12:00 - 12:30 Stem cells for neonatal disorders Andrew Ewer (United Kingdom)
Paolo De Coppi (United Kingdom)
Recent recommendations from European and Spanish
societies for pulse oximetry screening for critical congenital
12:30 - 13:30 LUNCH BREAK heart defects
Maximo Vento Torres (Spain)
12:30 - 13:30 Early optimal nutrition in the NICU The controversies in screening for critical congenital heart
A meet-the-expert event |SORRENTO ROOM defects
Industry Supported session - please see page 125 Thorsten Orlikowsky (Germany)
(Lunch will be provided)
Chair: Mary Brown-Hise (United States); Boubou Hallberg (Sweden) Perfusion index: can it be a predictive monitoring tool in
neonatal illnesses?
12:30 - 12:35 Welcome & conference objectives Augusto Sola (United States)
Mary Brown-Hise (United States)
12:35 - 13:15 Early optimal nutrition in the NICU

Boubou Hallberg (Sweden)
13:15 - 13:25 Q&A
13:25 - 13:30 Concluding remarks

Mary Brown-Hise (United States)
34
35
13:30 - 15:00 POSTER SESSION 1 (LUNG 1) |DARSENA ROOM 14:00 - 14:05 Effects of surfactant replacement therapy with
porcine vs. bovine preparations on cerebral
Chairs: Mats Blennow (Sweden); Anna Lavizzari (Sweden)
oxygenation and bioelectric activity of preterm infants
T. Szczapa; L. Karpinski; H. Szczapa-Krenz; B. Witoslaw;
13:30 - 13:35 Less invasive administration (LISA) not only A. Adamczak; J. Moczko; I. Miechowicz; P. Niedbalski;
improves mortality and morbidity but also J. Gadzinowski1; J. Mazela (Poland)
neurodevelopmental outcome of preterm infants
K. Klebermass-Schrehof; A. Grill; M. Hayde; N. Haiden; A. Flunt; 14:05 - 14:10 Nasal high-flow therapy (NHFT) as primary respiratory
R. Fuiko; S. Brandstetter; A. Berger (Austria) support for preterm infants without use of nasal continuous
positive airways pressure (NCPAP)
13:35 - 13:40 Surfactant administration and non-invasive ventilation in S. Zivanovic 1; A. Scrivens 1; R. Panza 2; P. Reynolds 1; K. Ives 1;
surfactant deficiency newborn piglets N. Laforgia 2; C.C. Roehr 1
C. Rey-Santano 1; V. Mielgo 1; M. Gomez-Solaetxe 1; F. Ricci 2; (1. United Kingdom; 2. Italy)
F. Bianco 2; F. Salomone 2; B. Loureiro 1; J. Lpez-de-Heredia 1
(1. Spain; 2. Italy) 14:10 - 14:15 Risk factors associated with CPAP failure in very low birth
weight infants
13:40 - 13:45 Characterization of poractant alfa and budesonide D. Dobryanskyy; O. Borysiuk; L. Sekretar; S.Yaremchuk;
extemporaneous combination for safe and effective S. Vereshchak; Z. Salabay (Ukraine)
intratracheal administration
F. Salomone; F. Ricci; C. Catozzi; F. Ravanetti; F. DAl; 14:15 - 14:20 Weaning premature infants from nasal continuous positive
N. Machidani; E. Sgarbi; V. Di Lallo; F. Saccani; M. Pertile; airway pressure current practice in Germany
A. Cacchioli; P. Puccini; S. Catinella; G. Villetti; M. Civelli; F. Amadei; A. Kidszun; C. Arnold; J. Winter; C. Whybra-Trmpler;
G. Aquino; F.F. Stellari; B. Pioselli (Italy) E. Mildenberger (Germany)
13:45 - 13:50 The effect of minimally invasive surfactant therapy on 14:20 - 14:25 Non-invasive high frequency oscillatory ventilation in
diaphragmatic activity preterm infants: a randomised controlled crossover trial
C.G. de Waal; G.J. Hutten; F.H.C. de Jongh; A.H.L.C. van Kaam D. Klotz; H. Schneider; S. Schumann; B. Mayer ; H. Fuchs (Germany)
(The Netherlands)
14:25 - 14:30 Nasal high flow support during neonatal retrieval in Victoria,
13:50 - 13:55 Evaluation of surfactant dose administered in clinical Australia
practice for the treatment of respiratory distress syndrome V. Abraham; C. Roberts; B. Manley; L. Owen; M. Stewart; P. Davis
(RDS): retrospective observational study. Surprais study (Australia)
H. Boix; D. Elorza; S. Rite; L. Arruza; C. Fernndez; I. Serrano;
I. Baquedano; A. Sanchez; E. Ferreira; V. Martinez ; P. Fernandez; 14:30 - 14:35 The Comparison of heated humidified high-flow nasal
R. Gonzalez (Spain) cannula versus nasal continuous positive airway pressure for
respiratory support in NICU
13:55 - 14:00 Respiratory distress syndrome: genetic polymorphism of K. Y. Chao; C. E. Chiang; Y. L. Chen; L.Y. Tsai; Y. H. Chien; S. C. Mu;
genes encoding surfactant protein B and xenobiotic (Taiwan)
biotransformation enzymes
G. Shishko; M. Artsiusheuskaya; A. Sukharava; E. Mikhalenka; 14:35 - 14:40 Which nasal CPAP system to use in preterm newborns with
K. Hamolko; I. Valentsiukevich; A. Kilchevski (Belarus) respiratory distress syndrome
E. JazexhiuPostoli; E. Vevecka; E. Petrela; D. Bujari; E. Rapushi
(Albania)
36
37
14:40 - 14:45 Nasal trauma in preterm infants receiving binasal 13:50 - 13:55 Is breast milk odor appropriate to manage pain
non-invasive respiratory support: a systematic review in preterm neonates?
D. Imbulana; B. Manley; P. Davis; L. Owen (Australia) G. De Clifford-Faugre; A. Lavalle; M. Aita (Canada)
13:55 - 14:00 Kangaroo families - the meaning of sound environment for

14:45 - 14:50 High frequency oscillatory ventilation combined with volume the development of prematurely born infants
guarantee using very low tidal volumes to prevent lung K. Kostilainen 1; K. Mikkola 1; E. Partanen 1; S. Pakarinen 1;
damage in immature newborns M. Huotilainen 1, 2; V. Fellman 1
N. Gonzlez-Pacheco; A. Rodrguez-Snchez de la Blanca; (1. Finland; 2. Sweden)
C. Ramos-Navarro; M. Velilla-Aparicio; I. Marsinyach-Ross;
I. Pescador-Chamorro; M. Snchez-Luna (Spain)
14:00 - 14:05 Parents experiences of active participation during the ward
round in a neonatal intensive care unit
14:50 - 14:55 Continuous positive airway pressure is not well transmitted L. Brjesson; T. Stendahl (Sweden)
during less invasive surfactant administration: a physiologic
study 14:05 - 14:10 The role of paediatric physio-/occupational therapists in
G. Jourdain 1; M. De Tersant 1; V. DellOrto 1; G. Conti 2; parental empowerment at the NICU
D. De Luca 1
M.J.C. Eijsermans; M.J. Jongmans; C.H. Verhage; F. Jenken;
(1. France; 2. Italy)
J. van der Net; M.J.N.L. Benders; A. van den Hoogen
(The Netherlands)
14:55 - 15:00 The impact of lung ultrasound in the reduction of radiation
exposure in NICU 14:10 - 14:15 Pathways to emotional closeness in neonatal units
C. Barone; L. Balestriere; A. Faiella; G. Montesano; B. Orsini;
a cross-national qualitative study
I. Perrotta; D. Riccardi; V. Roseto; I. Rotta; F. Toro; M. Napolitano
R. Flacking 1; G. Thomson 2; A. Axelin 3
(1. Sweden; 2. United Kingdom; 3. Finland)
13:30 15:00 POSTER SESSION 2 (NICU + PARENTS) |VENEZIA ROOM 14:15 - 14:20 Employing a nutrition nurse in neonatal intensive care unit
improved nutrition and growth outcomes in preterm
Chairs: Agnes van den Hoogen (The Netherlands); neonates
O. Aydemir; A. Calik Saglik; Z Sekili; N. Tekin (Turkey)
13:30 - 13:35 Clinical decision support systems for neonatal care - 14:20 - 14:25 Name bands in preterm infants - what is the nation doing?
an updated Cochrane systematic review A. Doerr; A. Glover; F. Emery (United Kingdom)
K. Tan 1; P. Dear 2; S. Newell 2
(1. Australia; 2. United Kingdom) 14:25 - 14:30 Reducing unnecessary blood sampling in neonatal unit -
a quality improvement initiative
13:35 - 13:40 Skin-to-skin contact in extremely preterm newborns H. McDermott; A. Smith; P. Nath (United Kingdom)
H. Pavlyshyn; I. Sarapuk; O. Klishch (Ukraine)
14:30 - 14:35 NIoSIM: Northern Ireland simulation and human factor
13:40 - 13:45 Prospective surveillance of risk factors for Intracranial training
hemorrhage in preterm infants decreases the rate of R. Little; C. Anderson; M. ODowd; R.Tubman (Ireland)
intracranial hemorrhage and improves
neurodevelopmental outcome at the age of 24 months 14:35 - 14:40 Current parent feedback response rates and feedback
L. Schiefele 1; F. Reister 1; J. Essers 1; B. Mayer 1; M. Schmid 2; methods in neonatal transport service across the UK
H. Hummler 1, 5 P. Bhat; D. Winderbank-Scott; C. Garland; L. Watts; C. Leach;
(1. Germany; 2. Switzerland; 3. Qatar) A. Frame; G. Bullimore; C. Lawn (United Kingdom)
13:45 - 13:50 Thermoregulation and physiological stabilization by

skin-to-skincontact at birth in preterm infants
A. Linnr; B. Sundberg; B. Westrup; B. Skiold (Sweden)
38
39
14:40 - 14:45 Satisfaction level of parents of NICU services provided and 13:50 - 13:55 Hemodynamic changes related to ductus closure
connection with their educational attainment in preterms
E. Papamichael; E. Polycarpou; M. Talias (Cyprus) A. Rodrguez Snchez de la Blanca; N.Gonzlez Pacheco;
C. Ramos Navarro; M. Arriada Redondo; N. Navarro Patio;
E. Sanz Lpez; M. Snchez Luna (Spain)
14:45 - 14:50 Delivering evidence-based information at the
point of care
A. Dunlop; L. Osborne; P. Satodia (United Kingdom) 13:55 - 14:00 A clinical scoring system as a diagnostic tool for
hemodynamically significant patent ductus arteriosus in
14:50 - 14:55 Increased breast milk use reduced severity of necrotizing preterm infants
enterocolitis in a quality improvement project in a Chinese N. Okur; H.G. Kanmaz; M. Buyuktiryaki; G. Kadioglu Simsek;
NICU F.E. Canpolat; N. Uras; S.S. Ouz (Turkey)
Q. Zhou 1; S.K. Lee 2; X.J. Hu 1; S.J. Lee 1; S.Y.Jiang 1; Y. Cao 1
(1. China; 2. Canada) 14:00 - 14:05 New ibuprofen dosage regimen for patent ductus arteriosus
following simulations based on pharmacokinetic-
14:55 - 15:00 Online parent satisfaction survey is representative despite pharmacodynamic evidence
low response R. Flint 1; R. ter Heine 1; E. Spaans 1; D. Burger 1; J. de Klerk 1;
K. Allegaert 2; C. Knibbe 1; S.H.P. Simons 1
J. de Boer; M. van Dijk (The Netherlands) (1. The Netherlands; 2. Belgium)
14:05 - 14:10 Association between size of patent ductus arteriosus and

13:30 15:00 POSTER SESSION 3 |ROMA ROOM co-morbidities
S. Bellis; Y. Singh (United Kingdom)
(CARDIOLOGY + MICROCIRCULATION 1)
Chairs: Afif El-Khuffash (Ireland); Eirik Nestaas (Norway) 14:10 - 14:15 Myocardial deformation and rotational mechanics in infants
with down syndrome in the early neonatal period
13:30 - 13:35 Ibuprofen and indomethacin differentially regulate VEGF C.R. Breatnach 1; A. Smith 1; P.T. Levy 2; N. McCallion 1;
and its receptors in ductus arteriosus endothelial cells O. Franklin 1; A. EL-Khuffash 1
H. Sallmon; S. Akanbi; S.C. Weber; A. Gratopp; C. Rheinlnder; (1. Ireland; 2. United States)
P. Koehne (Germany)
14:15 - 14:20 Left and right myocardial performance assessment in infants
13:35 - 13:40 Effectiveness of indomethacin, ibuprofen and paracetamol born to mothers with gestational hypertension
for patent ductus arteriosus (PDA) in preterm infants: C.R. Breatnach; C. Monteith; L. McSweeney; E.C. Tully; F.D. Malone;
a network meta-analysis E. Kent; A. Doherty; O. Franklin; A. EL-Khuffash (Ireland)
S. Mitra; I.D. Florez; M.E. Tamayo; Y. Zhang; B. Sadeghirad; A.M. Zea;
L. Mbuagbaw; T. Vanniyasingam; L. Thabane (Canada) 14:20 - 14:25 Left ventricular function in preterm neonates assessment of
LV rotational mechanics from 32 weeks post-menstrual age
13:40 - 13:45 Evaluation of the relationship patent ductus arteriosus and to one year
the platelet mass index in preterm infants G. Lehman; M.D. Patel; P.T. Levy; S. Choudhry; T.J. Sekarski;
M. Kara; . Caner; K.. Tekgndz; . Polat; H. Keskin (Turkey) A. Hamvas; G.K. Singh (United States)
13:45 - 13:50 Treatment for patent ductus arteriosus in preterm infants - 14:25 - 14:30 Predictions of cardiorespiratory morbidity after discharge
less is more? from the NICU in the extreme preterm infant without chronic
T. Hundscheid; W. de Boode (The Netherlands) lung disease
P.T. Levy; M.D. Patel; S. Choudhry; A.A. Sanchez; M. Wallendorff;
G. Hongjie; M.R. Holland; B. Warner; J. Kemp; T. Ferkol; A. Hamvas;
G.K. Singh (United States)
40
41
14:30 - 14:35 Neonatalogist-performed echography in neonatology: 13:45 - 13:50 Outcomes of extremely low birth weight babies
a Tunisian experience receiving surgical treatment for necrotising
F.Z. Chioukh; K. Ben Ameur; T. Khemis; H. Ajmi; A. Ben Salem; enterocolitis
S. Hamdi; H. Ben Hamida; K. Monastiri (Tunisia) J. Ashton; C. Charlesworth; P. Yajamanyam (United Kingdom)
14:35 - 14:40 Non-invasive cardiac output monitoring by electrical 13:50 - 13:55 Early biochemical markers associated with development of
cardiometry in hemodynamically stable neonate infants necrotizing enterocolitis
J. Shin; E.H. Lee; B.M. Choi (Korea) K.W. Olsson; R. Sindelar (Sweden)
14:40 - 14:45 Comparison of two techniques of superior vena cava 13:55 - 14:00 Effect of antibiotic prophylaxis during removal of a central
measurement in preterm neonates with birth weight less than venous catheter on development of the neonatal intestinal
1250g microbiota
J. Semberova 1, 2; Z. Stranak 2; J. Miletin 1, 2 E. dHaens; R. Zwittink; C. Belzer; M. Hemels; R. van Lingen;
(1. Ireland; 2. Czech Republic) I. Renes; J. Knol; D. van Zoeren-Grobben (The Netherlands)
14:45 - 14:50 Gut and cerebral oxygenation from birth to six weeks of life 14:00 - 14:05 Stooling pattern and gastric residuals are not useful tools for
in preterm infants: what is normal? early diagnosis of necrotising enterocolitis in preterm infants
C.N. Howarth; T. Leung; J. Banerjee; J. Morris; N. Aladangady S. Carlsson; M. Domellf; A. Elfvin 3 (Sweden)
(United Kingdom)
14:05 - 14:10 Is near infrared spectroscopy a reliable technique to
14:50 - 14:55 Precision assessment of a novel cerebral tissue oximeter and measure gut perfusion in preterm infants?
effects of fluctuations in systemic and cerebral physiological J. Banerjee; T.S. Leung; N. Aladangady (United Kingdom)
parameters
S. Kleiser; D. Ostojic; N. Nasseri; H. Isler; H.U. Bucher; D. Bassler; 14:10 - 14:15 Prediction of major bleeding in extremely low birth weight
M. Wolf; F. Scholkmann; T. Karen (Switzerland) infants (<1000g) by sequential coagulation monitoring
M. Thanhaeuser; C. Binder; M. Kornsteiner-Krenn; U. Derhaschnig;
B. Jilma; A. Repa; A. Berger; N. Haiden (Austria)
13:30 15:00 POSTER SESSION 4 (GI + NEC + BILIRUBIN) 14:15 - 14:20 Investigation of the relationship between umbilical cord
|SORRENTO ROOM blood IRF level and perinatal events
Chairs: Jon Dorling (United Kingdom); Elsa Kermovant (France) Z.E. Erdem Dursun; N. Guzoglu; D. Aliefendioglu (Turkey)
13:30 - 13:35 The open abdomen: a challenge for neonatologists and 14:20 - 14:25 Relationship between plasma levels of bilirubin and oxidant/
neonatal surgeons. The Karolinskas experience antioxidant status in the early neonatal period in preterm
M. Bartocci; E. Palleri; A. Svenningsson; T. Wester (Sweden) infants
G.I. Zoutkamp 1; K. Suzuki 2; C.H.P. van den Akker 1
13:35 - 13:40 Anogenital stimulation in rats does not increase gastric (1. The Netherlands; 2. Japan)
emptying
C.H. Faleiros Ferreira 1; J. Belik 2 14:25 - 14:30 The coagulation screen as a biomarker of neonatal
(1. Brazil; 2. Canada) encephalopathy outcomes
D. Sweetman; J. Murphy; E.J. Molloy (Ireland)
13:40 - 13:45 Routine probiotics for preterm neonates: experience in a
tertiary Australian neonatal unit sive care 14:30 - 14:35 A preterm model of hyperbilirubinemia-induced cerebellar
G. Deshpande; V. Shingde; L. Downe; J. Xiao; M. Taber (Australia) dysfunction
C.F. Bearer; M. He; J.F. Watchko; J.M. Simard; N. Tang
(United States)
42
43
14:35 - 14:40 Comparisons between transcutaneous bilirubinometry, 13:50 - 13:55 Elevated essential amino acid levels in very
point-of-care whole blood bilirubin and total plasma bilirubin preterm infants on total parenteral nutrition
measurement in neonates L. Burgess; M. Turner; B. Flanagan; C. Morgan
K. Palmkvist Kaijser; C. Backman Johansson; K. Hemse Nojd; (United Kingdom)
C. Bemgard; K. Kjellson; G. Marchini (Sweden)
13:55 - 14:00 Effect of enteral iron supplementation on health outcomes in
14:40 - 14:45 Physiologic free bilirubin redistributes L1 cell adhesion preterm and low birth weight infants: a systematic review
molecule (L1) in lipid rafts E. McCarthy; M. Kiely (Ireland)
N. Tang; M. He; J.F. Watchko; C.F. Bearer (United States)
14:00 - 14:05 Improved nutrition for extremely preterm infants -
14:45 - 14:50 Reticulocyte haemoglobin content as an early a population based observational study
index of iron deficiency in neonatal period V. Westin; S. Klevebro; M. Domellf; M. Vanpe; B. Hallberg;
P. Karagianni; E. Chatzitoliou; V. Antari; M. Lithoxopoulou; E. Stoltz Sjstrm (Sweden)
G. Mitsiakos; C. Tsakalidis; A. Kioumi; V. Soubasi (Greece)
14:05 - 14:10 Nutrient intake in the first two weeks of life predicts brain
14:50 - 14:55 Effect of probiotic supplementation on breast milk jaundice macro- and microstructural growth in preterm neonates
N. Koksal; O. Bagc; H. Ozkan; I. Varal; P. Dogan (Turkey) J. Schneider 1, 2; L. Beauport 2; E. Duerden 1; T. Guo 1; J. Foong 1;
M. Bickle Graz 2; P. Hagmann 2; M. Chakravarty 1; P. Hppi 2;
14:55 - 15:00 An audit of use of emergency O negative blood in neonates C. Fischer Fumeaux 2; S. Miller 1; A. Truttmann 2
for emergency blood transfusions and exchange transfusions (1. Canada; 2. Switzerland)
P. Tormey; D. Sweetman; J. Quigley; J. Fitzgerald (Ireland)
14:10 - 14:15 Influence of human milk and parenteral lipid solutions on
serum fatty acid profiles in extremely preterm infants
A.K. Nilsson 1; C. Lfqvist 1; S. Najm 1; G. Hellgren 1; E. Engstrm 1;
13:30 15:00 POSTER SESSION 5 (NUTRITION 1) |VERONA ROOM P. Lundgren 1; A-L. Hrd 1; A. Lapillonne 2; K. Svman 1;
M.X. Andersson 1; L.E.H. Smith 3; A. Hellstrm 1
Chairs: Silvia Iacobelli (Italy); Sissel Moltu (Norway)
(1. Sweden; 2. France; 3. United States)
13:30 - 13:35 Comparative clinical effectiveness of two methods of 14:15 - 14:20 Evaluation of milk and blood irisin levels in preterm newborns
hyperglycemia correction in very low birth weight preterm diagnosed with either small or appropriate weight for
infants gestational age compared to full term newborns
O. Dobush; D. Dobryanskyy; Z. Salabay; O. Borysiuk (Ukraine) N. Ml; P. Tomasik; M. Zasada; P. Kwinta (Poland)
13:35 - 13:40 Role of breast milk and fecal microbial content in 14:20 - 14:25 Positive relationship between transthyretin and insulin-like
development of breast milk jaundice growth factor 1 during the anabolic period in very preterm
N. Koksal; O Bagc; H. Ozkan; I. Varal; P Dogan (Turkey) infants
I. Hansen Pupp; C. Lfqvist; D. Ley; A. Hellstrm (Sweden)
13:40 - 13:45 Protein and caloric deficit during the neonatal period in
infants with birth weight less than 1500 g and its association 14:25 - 14:30 Hormone profile and anthropometric assessment of very
with blood pressure in the adolescence preterm newborns at follow-up
A. Dinerstein; C. Solana; R. Nieto; M. Casale; R. Conti; M. Moiron; C. Balcells; B. del Rey Hurtado de Mendoza; M. Izquierdo-Renau;
F. General (Argentina) I. Iglesias-Platas (Spain)
13:45 - 13:50 Long term growth and neurodevelopmental outcome in 14:30 - 14:35 Human milk composition in relation to growth and body
preterm infants born small for gestational age (SGA) and composition in preterm infants at term age
infants with intrauterine growth restriction (IUGR) K.P.T. Vu; D.F.J. Yumani; A.R.C. Laarman; H.N. Lafeber;
C. Binder; A. Huber-Dangl; J. Binder; A. Kreissl; M. Thanhaeuser; M.M. van Weissenbruch (The Netherlands)
A. Repa; A. Berger; N. Haiden (Austria)
44
45
13:30 - 15:00 Respiratory Syncytial Virus: 15:00 - 17:00 PARALLEL SESSION 8 (BRAIN 2)
Should We Identify Paediatric Patients at MONITORING FOR INFANTS AT RISK
Risk for Severe Disease? |LECCE ROOM |VENEZIA ROOM
Industry Supported session - please see page 125 Chairs: Manon Benders (The Netherlands);
Juliane Schneider (Switzerland)
Chair: Paolo Manzoni (Italy)
15:00 - 15:20 Cerebral autoregulation in asphyxiated neonates treated
Severe RSV disease: the worldwide burden with hypothermia
Paolo Manzoni (Italy) A. Hendriksen; L. Dix; W. Baerts; F. van Bel; F. Groenendaal;
P. Lemmers (The Netherlands)
Who needs RSV infection prevention? A closer look at
children with chronic diseases 15:20 - 15:35 Asynchrony and spectral EEG coherence in term neonates
Bosco A. Paes (Canada) with intrauterine grow restriction
B. Reyes Milln; J.R. Castro Conde; C. Gonzlez Campo;
Cases in identifying children at risk of severe RSV disease I. Quintero Fuentes; N.L. Gonzlez Gonzlez; D. Gonzlez Barrios
Panel (Spain)
The acute and long-term consequences of severe RSV 15:35 - 15:50 Early amplitude integrated electroencephalogram as a
disease predictor of brain injury in newborns with very low birth
Maarten O. Blanken (The Netherlands) weight: a cohort study
R.C. Silveira; L.V. Magalhaes; M.I. Winckler; J.A. Bragatti;
Ask the Faculty and concluding remarks R.S. Procianoy (Brazil)
15:50 - 16:05 MRI-diagnosed white matter lesions in the brain of VLBW

babies: risk factor analysis
PARALLEL SESSION 7 (PULMONOLOGY 1)
15:00 - 17:00
A. Parodi; S. Raffa; M. Malova; A. Sannia; M. Severino; G. Morana;
PULMONARY SYMPOSIUM |DARSENA ROOM D. Tortora; M.G. Calevo; A. Rossi; L. A. Ramenghi (Italy)
Chairs: Charles C. Roehr (United Kingdom); Anna Lavizzari (Italy) 16:05 - 16:20 Perinatal associations with brain growth evaluated by
sequential cranial ultrasonography in very preterm infants
15:00 - 16:00 nCPAP vs HFNC R. Cuzzilla 1; A.J. Spittle 1; K.J. Lee 1; S. Rogerson 1; F.M. Cowan 2;
Haresh Kirpalani (United States) vs Peter Davis (Australia) L.W. Doyle 1; J.L.Y. Cheong 1
(1. Australia; 2. United Kingdom)
16:00 - 16:30 Newer strategies for surfactant delivery
who, when, where, why and how 16:20 - 16:35 Bedside monitoring of cerebral metabolism in neonates at
Peter Dargaville (Australia) risk for hypoxic-ischemic encephalopathy
M. El-Dib; S.J. Blackwell; F. Yi; R. Vyas; C.G. Ha; B. Walsh; T.E. Inder;
16:30 - 16:45 Sudden versus pressure wean from nasal CPAP in very P.E. Grant; S.L. Ferradal (United States)
preterm infants: a multicenter randomized controlled trial
C.F. Jensen; F. Ebbesen; A.S. Srensen; T.B. Henriksen (Denmark) 16:35 - 16:50 Early neonatal EEG markers for dyslexia risk: a pilot study
S. Martini; P. Cyr; L. Brightman; L. Amunts; G. Belteki; T. Austin;
16:45 - 17:00 Predictors and outcomes of continuous positive V. Leong (United Kingdom)
airway pressure and nasal high-flow treatment
failure in preterm infants: a secondary analysis of a
randomized trial
B. Manley 1; C. Roberts 1; D. Frisland 2; L. Doyle 1; P. Davis 1;
L. Owen 1 (1. Australia; 2. Norway)
46
47
15:00 - 17:00 PARALLEL SESSION 9 (CIRCULATION 2) 15:00 - 17:00 PARALLEL SESSION 10 (PHARMA 1)
WHAT SHOULD WE MONITOR? GLOBAL CHALLENGES IN NEONATAL DRUG DEVELOPMENT
HAEMODYNAMICS (SYSTEMIC BLOOD FLOW), |FIRENZE ROOM
END-ORGAN PERFUSION (REGIONAL BLOOD FLOW) Chairs: Sinno Simons (The Netherlands);
OR THE MICROCIRCULATION (CAPILLARY BLOOD Karel Allegaert (Belgium)
FLOW)? |ROMA ROOM 15:00 - 15:20 What you need to know from EMA PDCO
Chairs: Afif El-Khuffash (Ireland); Mayka Bravo (Spain) Mark Turner (United Kingdom)
15:00 - 15:20 Its all about the heart 15:20 - 15:40 The HIP trial story
Willem de Boode (The Netherlands) Eugene Dempsey (Ireland)
15:20 - 15:40 Its all about the brain 15:40 - 16:00 Experiences from the NEO-CIRC trial
Gorm Greisen (Denmark) Heike Rabe (United Kingdom)
15:40 - 16:00 Its all about the microcirculation 16:00 - 16:15 Adrin 1 methodology study: adverse drug reactions in
Dick Tibboel (The Netherlands) neonates: what are the best ways to evaluate suspected
adverse drug reactions in neonates?
16:00 - 16:15 Patent ductus arteriosus, cerebral haemodynamics and E. Roberts; D. Hawcutt; J.J. Kirkham; M.A. Turner (United Kingdom)
intraventricular haemorrhage in preterm neonates: a causal
pathway study 16:15 - 16:30 Large differences in off-label and neonatal drug use still
C. Kotidis; M. Weindling; A. Eleuteri; H. Rabe; M. Turner exist: time for consensus?
(United Kingdom) R. Flint; F. Van Beek; P. Andriessen; P. Degraeuwe; D. Liem; I. Reiss;
R. de Groot; D. Tibboel; D. Burger; S.H.P. Simons; DINO study group
16:15 - 16:30 Electrical velocimetry in preterm infants: (The Netherlands)
effect of time and gestational age
L. Van Wyk 1; W.P. De Boode 2; J. Smith 1; J. Lawrenson 1; 16:30 - 16:45 Urinary 17--hydroxy-progesterone as a potential marker of
C.J. Lombaard 1
(1. South Africa; 2. The Netherlands)
neonatal pain
M. Brasseler; T. Hoehn (Germany)
16:30 - 16:45 Molecular and genetic markers for prediction of resistance
16:45 - 17:00 3-adrenoceptor regulation of nitric oxide in the cord
to inotropic therapy in newborns with arterial hypotension
D. Kryuchko; A. Donnikov; E. Baibarina; I. Nikitina; O. Ionov; vascular system
D. Degtyarev (Russia) G. Cavallaro 1; A. Griggio 1; L. Provitera 1; G. Raffaeli 1;
I. Amodeo 1; S. Gulden 1; G. Zuanetti 1; D. Lattuada 1; G. Ercoli 1;
16:45 - 17:00 Glial fibrillary acidic protein plasma levels during congenital S. Gatti 1; E. Villamor 2; F. Mosca 1
heart diseases surgery inversely correlate with vineland (1. Italy; 2. The Netherlands)
adaptive behavior scales communication score
L.Vedovelli; M. Padalino; M. Salvagno; S. Sartori; A. Suppiej;
E. Cainelli; G. Stellin; G. Falasco; V.P. Carnielli; M. Simonato; P. Cogo
(Italy)
48
49
15:00 - 17:00 PARALLEL SESSION 11 (NUTRITION 2) |SORRENTO ROOM 15:00 - 17:00 PARALLEL SESSION 12 (EFCNI 2)
CONTROVERSIES IN NEONATAL NUTRITION FAMILY CENTRED DEVELOPMENTAL SUPPORTIVE
Chairs: Sissel Moltu (Norway); Alexandre Lapillonne (France) CARE EVIDENCE OR PHILOSOPHY? |LECCE ROOM
Chairs: Silke Mader (Germany); Jacques Sizun (France)
15:00 - 15:20 Preterm parenteral nutrition: too much too soon or too little
too late
Colin Morgan (United Kingdom) 15:00 15:40 Family integrated care in the NICU - feasible and good for
preterm infants?
15:20 - 15:40 Risks and benefits of insulin treatment in hyperglycaemic Shoo Lee (Canada)
preterm neonates
Elsa Kermorvant (France) 15:40 16:20 Developmental care impact on the brain
Stphane Sizonenko (Switzerland)
15:40 - 15:55 Target fortification of breast milk with protein, carbohydrate
and fat for preterm infants improves growth outcomes: a 16:20 17:00 Influence of auditive NICU environment on the preterm baby
doubleblind randomized controlled trial Pierre Kuhn (France)
N. Rochow 1; G. Fusch 1; A. Ali 1; A. Bhatia 1; S. Ahmad 1;
A. Nguyen 1; L. Chessell 1; S. el Helou 1; C. Fusch 1,2
(1. Canada; 2. Germany)
15:55 - 16:10 Targetting glucose control with real time continuous
glucose monitoring
L. Thomson; D. Elleri; D. Dunger; K. Beardsall (United Kingdom) 17:30 - 18:30 PLENARY SESSION 3 |DARSENA ROOM
BENGT ROBERTSON AWARD
16:10 - 16:25 Bovine colostrum for preterm infants in the first days of life:
a randomized controlled pilot trial Industry Supported session - please see page 126
S.M. Juhl 1; X. Ye 2; P. Zhou 2; Y. Li 1; E.O. Iyore 1; L. Zhang 2; Chairs: Kajsa Bohlin (Sweden); Virgilio P. Carnielli (Italy)
P. Jiang 1; J.B. v. Goudoever 3; G. Greisen 1; P.T. Sangild 1
(1. Denmark; 2. China; 3. The Netherlands) 17:30 17:40 Introduction
16:25 - 16:40 Reducing variability in macronutrient intakes improves 17:40 18:15 Steroids, surfactant and the preterm lung: bench to bedside
growth in preterm infants: target fortification of breast milk - and back again
a double-blind randomized controlled trial Roberta and Phil Ballard (United States)
A. Bhatia 1; N. Rochow 1; G. Fusch 1; A. Ali 1; A. Nguyen 1;
A. Bahonjic 1; C. Fusch 1,2 18:15 18:30 Impact of preterm birth on respiratory muscle function in
(1. Canada; 2. Germany) childhood
Aggeliki Vervenioti (Greece)
16:40 - 16:55 The effect of fish oil emulsions on lung function in preterm
infants receiving parenteral nutrition
V.P. Carnielli; C. Biagetti; P. Marchionni; A. Correani; M. Carfagna;
S. Nobile (Italy)
50
51
DARSENA VENEZIA ROMA FIRENZE SORRENTO LECCE NAPOLI
GROUND FLOOR GROUND FLOOR GROUND FLOOR GROUND FLOOR THIRD FLOOR THIRD FLOOR GROUND FLOOR
08:00 08:00
PLENARY Neonatologist
SESSION 4 Performed
Young Investigator
Prize session Echocardiography
10:00 (NPE) 10:00
COFFEE BREAK COFFEE BREAK
10:30 10:30
Parallel Parallel Parallel Parallel Parallel NUTRITION
Session 13 Session 14 Session 15 Session 16 Session 17 SECTION MEETING
(PULMONOLOGY 2) (BRAIN 3) (EFCNI 3) (EPIDEMIOLOGY 1) (INFECTIOUS DISEASES)
Medicines for lung Transition to adult life Bridging the gap Outcome measures
protection / between neonatal in clinical studies of
Severe BPD palliative care and preterm babies
developmental care
12:30 12:30
LUNCHEON LUNCHEON
SYMPOSIUM SYMPOSIUM
Pulse Oximetry CCHD ROP in 2017 & Beyond
Screening: focus on LUNCH BREAK - Latest Strategies
the recent EU Improving Patient
consensus towards Care
implementation
13:30 13:30
POSTER SATELLITE POSTER POSTER POSTER POSTER
SESSION 6 SYMPOSIUM SESSION 7 SESSION 8 SESSION 9 SESSION 10
Importance
LUNG 2 of Human Milk in LUNG 3 CARDIOLOGY + INFECTIOUS DISEASE NEUROLOGY 1
Preterm Nutrition MICROCIRCULATION 2
14:30 14:30
Parallel Parallel Parallel Parallel Parallel Parallel EPIDEMIOLOGY
Session 18 Session 19 Session 20 Session 21 Session 22 Session 23 SECTION MEETING
(PULMONOLOGY 3) (NUTRITION 3) Neonatal ARDS: (EFCNI 4) Oxygenation in the (BRAIN 4)
Ventilation support Nutrition of the ELBWI: recognising the exi- Digital patient care newborn and infant Biomarkers in term
Improving Nutritional stence of a syndrome the new dimension? period neonatal
Care across the age encephalopathy
16:30 16:30
COFFEE BREAK
17:00 17:00
PLENARY
SESSION 5
Will Big Data change
the future?
18:00 18:00
EXECUTIVE
SATELLITE
SYMPOSIUM
Enhancing the
Success of Respiratory
Management in nRDS
19:30 19:30
Mothers milk 08:00 - 10:00

PLENARY SESSION 4 |DARSENA ROOM
YOUNG INVESTIGATOR PRIZE SESSION
our passion Chairs: Umberto Simeoni (Switzerland);
Luc Zimmermann (The Netherlands)
08:00 - 08:15 Individualized growth trajectories for preterm infants using a

Medela exists to enhance mother and baby health through
growth trajectory calculator tool
the life-giving benefits of human milk. For more information, E. Landau-Crangle; N. Rochow; T.R. Fenton; K. Liu; H.Y. So; G. Fusch;
visit www.medela.com A. Ali; M.L. Marrin; C. Fusch (Canada)
08:15 - 08:30 Touchscreens for cognitive assessment of toddlers

D.M. Twomey 1; C. Wrigley 1; C. Ahearne 1; R. Murphy 1;
M. de Haan 2; N. Marlow 2; D.M. Murray 1
(1. Ireland; 2. United Kingdom)
08:30 - 08:45 Tracking childhood height of small for gestational age

infants in Ireland
F. Maguire; E. Loftus; D. Gibbons; N. OConnor; O. OBrien;
S. Carolan; J. Byrne; E.J. Molloy (Ireland)
08:45 - 09:00 Evaluation of effect of caffeine onset time on surfactant

synthesis of premature infants of 30 gestational weeks and
below with respiratory distress
N. Okur; M. Buyuktiryaki; H. Bezirganoglu; O. Ertekin; E.D. Alyamac;
F.E. Canpolat; S.S. Oguz (Turkey)
09:00 - 09:15 Use of specialist services until two years of age in the epice
cohort of very preterm births in Europe
A.V. Seppnen 1; F. Bodeau-Livinec 1; E.M. Boyle 2;
A.K. Edstedt-Bonamy 3; M. Cuttini 4; L. Toome 3; R.F. Maier 6;
E. Cloet 7; C. Koopman-Esseboom 8; J. Gadzinowski 9; J. Zeitlin 1
(1. France; 2. United Kigdom; 3. Sweden; 4. Italy; 5. Estonia;
6. Germany; 7. Belgium; 8. The Netherlands; 9. Poland)
09:15 - 09:30 Impact of neonatal white matter injury and brain volumes to
school-age neurodevelopment in children with congenital
heart disease
N.H.P. Claessens; S.O. Algra; T.L. Ouwehand; N.J.G. Jansen;
P. Moeskops; I. Igum; R. Schappin; I.C. van Haastert;
M.J.C. Eijsermans; F. Groenendaal; L.S. de Vries; M.J.N.L. Benders
(The Netherlands)
2nd November, 2017 53

53
09:30 - 09:45 Nanomolecular signalling in the developing brain: PARALLEL SESSION 13 (PULMONOLOGY 2)
10:30 12:30
characteristics of exosomes in the cerebrospinal fluid of
preterm infants
SEVERE BPD |DARSENA ROOM
R. Spaull; B. McPherson; A. Clayton; J. Uney; O. Cordero-Llana; Chairs: Daniele de Luca (France);
A. Heep (United Kingdom) Kerstin Jost (Switzerland)
09:45 - 10:00 Blood plasma profile of temporal microrna expression of 10:30 10:50 Ethical decision making in lung failure
inflammation in lipopolysaccharide sensitised porcine Eduard Verhagen (The Netherland)
model of hypoxic ischaemic encephalopathy
A. Avdic-Belltheus 1; I. Lingam 1; C. Meehan 1; K. Martinello 1; 10:50 11:10 BPD-associated pulmonary hypertension
S. Ragab 1; I. Tachtsidis 1; C. Tann 1; M. Hristova 1; B. Fleiss 1; Robin Steinhorn (United States)
T. Wolfs 2; B. Kramer 2; N. Klein 1; H. Hagberg 1; P. Gressens 1;
N.J. Robertson 1 (United Kingdom) 11:10 - 11:25 Physiological basis of the NICHD BPD classification:
a prospective observational study in very preterm infants
10:00 - 10:10 Cerebral monitoring during neonatal surgery for non-cardiac J. Svedenkrans 1, 2; B. Stoecklin 2; J.G. Jones 3; A.W. Gill 2;
congenital anomalies: a first step to improve outcome D. Doherty 2; J.J. Pillow 2
Lisanne Stolwijk (The Netherlands) (1. Sweden; 2. Australia; 3. United Kigdom)
11:25 - 11:40 Identification of a regulatory alveogenesis gene cluster

using a novel genetic approach
NEONATOLOGIST PERFORMED |SORRENTO ROOM
08:30 12:30 F. Gao; C. Li; R. Ramanathan; P. Minoo (United States)
ECHOCARDIOGRAPHY (NPE)
Chairs: Willem de Boode (The Netherlands); 11:40 - 11:55 Healthcare burden of bronchopulmonary dysplasia among
Afif El-Khuffash (Ireland) extremely preterm infants in the United States
M. Mowitz; S. Sarda; A. Mangili; R. Ayyagari; W. Gao;
J. Zhao; (United States)
08:30 08:35 Welcome
Afif El-Khuffash (Ireland)
11:55 - 12:10 Relationship between secretory phospholipase A2 pathway
and short term outcomes in preterm neonates with RDS
08:35 09:00 Physics of ultrasound and artefact recognition
S. Shankar-Aguilera 1; C. Fitting 1; R. Raschetti 1; M. Sminato 2;
V. DellOrto 1; L. Vedovili 1; V.P. Carnielli 2; L. Touqui 1; D. De Luca 1
09:00 09:30 Routine ultrasound views
12:10 - 12:25 Relaxation rate of the respiratory muscles and prediction of
extubation outcome in prematurely born infants
09:30 10:00 Assessment of PDA
T. Dassios; O. Kaltsogianni; A. Greenough (United Kingdom)
Patrick McNamara (Canada)
10:00 10:30 COFFEE BREAK
10:30 11:00 Assessment of PPHN

Shahab Noori (United States)
11:00 11:30 Assessment of flow and contractility

Nick Evans (Australia)
11:30 12:00 Advanced ecocardiographic technologies

Eirik Nestaas (Norway)
12:00 12:30 Panel discussion - All speakers

54
54 2nd November, 2017 2nd November, 2017 55
55
10:30 12:30 PARALLEL SESSION 14 (BRAIN 3) PARALLEL SESSION 15 (EFCNI 3)
10:30 12:30
TRANSITION TO ADULT LIFE |VENEZIA ROOM BRIDGING THE GAP BETWEEN NEONATAL
Chairs: Petteri Hovi (Finland); Neil Marlow (United Kingdom) PALLIATIVE CARE AND DEVELOPMENTAL CARE
|ROMA ROOM
10:30 10:50 Cognition and attainment Chairs: Jacques Sizun (France); Nicole Thiele (Germany)
Neil Marlow (United Kingdom)
10:30 10:50 Neonatal palliative care, developmental care:
10:50 11:10 Psychiatric outcomes
different wording for one single concept?
Chiara Nosarti (United Kingdom)
Jacques Sizun (France)
11:10 11:30 Cardiovascular health
10:50 11:10 How involved are parents in difficult life decisions
Petteri Hovi (Finland)
11:30 11:45 Cognitive functioning in adolescents born moderately
preterm at 32-26 weeks gestation: a Swedish regional 11:10 11:25 Retrospective analyses of parental counseling
population based case control study and decision making for extreme preterm birth in a tertiary
M. Adamsson; B. Hgglf; M. Bckman; A. Farooqi (Sweden) Dutch perinatal center
E. de Booij; J. de Boer; A. Eggink; I. Reiss; S.H.P. Simons; I.A. Bruss
11:45 12:00 Cognitive trajectories from infancy to early adulthood (The Netherlands)
following birth before 26 weeks of gestation
L. Linsell; S. Johnson; D. Wolke; H. OReilly; J. Morris; J. Kurinczuk; 11:25 11:40 Health care professionals and parents attitudes toward
N. Marlow (United Kingdom) parental autonomy and the best interest of the extreme
preterm infant: a national study in Switzerland
12:00 12:15 Persistent mathematics learning difficulties from childhood to M. Hendriks; H. Bucher; S. Klein; R. Baumann-Holzle; J. Streuli;
adolescence in very preterm children in mainstream school J. Fauchre (Switzerland)
S. Clayton; L. Cragg; C. Gilmore; N. Marlow; V. Simms; R. Spong;
S. Johnson (United Kingdom) 11:40 11:55 Childrens outcomes at two-year follow-up after four years of
structured multi-professional medical-ethical decision-
12:15 12:30 Inhibitory control at 20 months predicts VP/VLBW and term making in a neonatal intensive care unit
adults attention, IQ, and wealth at age 26 years J. de Boer; L. Gennissen; M. Williams; M. van Dijk; D. Tibboel; I. Reiss;
J. Jaekel 1,2; N. Baumann 2; P. Bartmann 3; D. Wolke 2 S. Naghib; J. Sol (The Netherlands)
(1. United States; 2. United Kingdom; 3. Germany)
11:55 12:10 The delivery of bad news: a one or 2-step approach?
The case for Trisomy 21
M.S. Schimmel; M.Y. kassirer; H.M. Towers (United States)
12:10 12:25 Neonatal organ donation: a potential new donor source for
cell and organ transplantation
C. Jorns; E. Henckel; G. Nowak; A. Karadagi; T. Kjellin; E. Bluhme;
. Jynge; M. Hending; A. Croon; M. Sderstrm; B. Fischler;
A. Nemeth; R. Gramignoli; S. Strom; E. Ellis; B. Hallberg (Sweden)
56
57
10:30 12:30 PARALLEL SESSION 16 (EPIDEMIOLOGY 1) 10:30 12:30 PARALLEL SESSION 17
OUTCOME MEASURES IN CLINICAL STUDIES OF INFECTIOUS DISEASES |LECCE ROOM
PRETERM BABIES |FIRENZE ROOM Chairs: Christoph Bhrer (Germany);
Chairs: Tine Brink Henriksen (Denmark); Sinno Simons (The Netherlands)
Anne-Cathrine Finnemann Viuff (Denmark)
10:30 10:50 Antimicrobial impregnated catheters and prevention of
11:00 - 11:20 Composite outcomes in clinical NICU studies - infection in newborn infants
pros and cons Sam Oddie (United Kingdom)
Keith Barrington (Canada)
10:50 11:10 Food additives for prevention of sepsis and necrotizing
11:20 - 11:40 Measuring risk of postnatal endpoints enterocolitis
Olga Basso (Canada) Christoph Bhrer (Germany)
11:40 - 11:55 Rends in mortality and major morbidity of very preterm 11:10 11:25 Colonisation with gram-negative bacteria (GNB) in
neonates in 10 national neonatal database: the international infants in a tertiary neonatal unit
network for evaluation of outcomes (INEO) experience C. Kortsalioudaki; M. Sellwood; G. Kendall; B. Shuttleworth;
K. Lui 1; S. Lee 2; S. Kusuda 3; M. Adams 4; M. Vento Torres 5; N. Shetty; C.J. Tann; P. Wilson (United Kingdom)
B. Reichman 6; B. Darlow 7; L. Lehtonen 8; N. Modi 9;
M. Norman 10; S. Hakansson 11; D. Bassler 4; F. Rusconi 12; P. Shah 2 11:25 11:40 Antimicrobial activity of copper in reducing enviromental
on behalf of the International Network for Evaluating Outcomes of burden in a neonatal intensive care unit (NICU)
Neonates C. Petropoulou; E. Kouskouni; P. Efstathiou; Helen Bouza;
(1. Australia; 2. Canada; 3. Japan; 4. Switzerland; 5. Spain; 6. Israel; Z. Manolidou; K. Karageorgou; A. Efstathiou; M. Logothetis
7. New Zealand; 8. United Kingdom; 10. Sweden; 11. Italy) (Greece)
11:55 - 12:10 Impact of major neonatal morbidities on the outcome at 6.5 11:40 11:55 The antisecretory factor in relation to preterm birth and
years of children born extremely preterm: a Swedish inflammatory response
national prospective study (express) A. Gustafsson; E. Henckel; E. Johansson; M. Oshalim; S. Lange;
A. Farooqi; K. Klln; K. Marl; F. Serenius (Sweden) A. Olin; P. Brodin; K. Bohlin (Sweden)
12:10 - 12:25 Differential susceptibility effects of maternal sensitivity at age 11:55 12:10 Can endocan predict late neonatal sepsis?
6 on small for gestational age adults attention regulation M. Buyuktiryaki; N. Okur; C. Tayman; U. Serkant; U. Cakr; H. Halil;
and wealth at age 26 M.Y. Oncel; SS. Oguz (Turkey)
T. Nichols 1; J. Jaekel 1,2; P. Bartmann 3; D. Wolke 2
(1. United States; 2. United Kingdom; 3. Germany) 12:10 12:25 Comparison of the incidence, clinical features and
outcomes of invasive candidiasis in children and neonates
12:25 - 12:40 Educational trajectories of school outcome after preterm J.F. Hsu; S.M. Chu; M.H. Tsai (Taiwan)
birth
D. Odd; D. Evans; A. Emond (United Kingdom)
12:40 - 12:55 In utero exposure to perfluoroalkyl and polyfluoroalkyl 12:30 13:30 LUNCH BREAK
substances and attention and executive function in the
offspring
C.C. Bach 1; Z. Liew 2; N.B. Matthiesen 1; T.B. Henriksen 1;
B.H. Bech 1; E.A. Nohr 1; E.C. Bonefeld-Jrgensen 1; J. Olsen 1,2
(1. Denmark; 2. United States)
58
59
Pulse Oximetry CCHD Screening:
12:30 13:30 13:30 14:30 POSTER SESSION 6 (LUNG 2)|DARSENA ROOM
focus on the recent EUconsensus towards Chairs: Roland Hentschel (Germany); Ola D. Saugstad (Norway)
implementation |DARSENA ROOM
Industry Supported session - please see page 126 13:30 - 13:35 Assessment of cardio-respiratory rates by non-invasive
(Lunch will be provided) measurement methods in hospitalized preterm neonates
Chair: Paolo Manzoni (Italy); Manuel Sanchez-Luna (Spain) L. Antognoli; P. Marchionni; L. Scalis; S. Nobile; E.P. Tomasini;
V.P. Carnielli (Italy)
12:30 - 13:00 Pulse Oximetry Screening for Critical Congenital Heart
defects: aEuropean Consensus 13:35 - 13:40 Oxygen saturation trends in late preterm infants
Andrew Ewer (United Kingdom) L.Z.J. Williams; D. McNamara; J.M. Alsweiler (New Zealand)
13:00 - 13:30 Practical aspects of Pulse Oximetry Screening for Critical 13:40 - 13:45 Reliability of manually collected cardio-pulmonary
Congenital Heart defects: any hurdles for implementation? parameters in patients charts
Paolo Manzoni (Italy) P. Marchionni; L. Scalise; L. Antognoli; S. Nobile; E.P. Tomasini;
V.P. Carnielli (Italy)
13:45 - 13:50 Correlation between body temperature and cerebral

12:30 13:30 ROP in 2017 & Beyond - Latest Strategies oxygenation in neonates during transition after birth
Improving Patient Care |LECCE ROOM L.P. Mileder; A. Richter; N. Baik-Schneditz; B. Schwaberger;
Industry Supported session - please see page 126 C. Binder-Heschl; B. Urlesberger; G. Pichler (Austria)
(Lunch will be provided)
Chair: Maximo Vento Torres (Spain) 13:50 - 13:55 Accuracy of obtaining neonatal heart rate from a novel hat
mounted, green wavelength optical device
Oxygen Targeting in the Delivery Room and International C. Henry; L. Shipley; C. Ward; S. Mirahamdi; B. Hayes-Gill;
Trends in the Management of ROP in the Neonatal Period J. Carpenter; D. McCartney; D. Sharkey (United Kingdom)
Maximo Vento Torres (Spain)
13:55 - 14:00 Drops in saturation and heart rate in healthy newborns:
Retinopathy of Prematurity: Improving Patient Safety more than we think
Preventative Strategies and Clinical Advances S.J.A. Balink; R.C.J. de Jonge; T.G. Goos; R.H.T. van Beek
Ann Hellstrm (Sweden) (The Netherlands)
Oxidative Stress and Oxygen Monitoring: 14:00 - 14:05 Sudden unexpected collapse of newborn infants: incidence,
From Theory to Practice Are We Improving Outcomes? risk factors and role of perinatal transition
Augusto Sola (United states) E. Herlenius; D. Forsberg; G. Drevin; N.J. Pejovic (Sweden)
14:05 - 14:10 Improvement of face mask ventilation technique

13:30 14:30 Importance of Human Milk in Preterm Nutrition using a live feedback system
|VENEZIA ROOM S. Bhayat; H. Gowda (United Kingdom)
14:10 - 14:15 Is APGAR score a predictor of severity in preterm infants?
13:30 - 14:00 Human Milk Oligosaccharides and Necrotizing Enterocolitis W.A. Gonalves-Ferri; P.P. Paiva; A.B. Gouvea; E. Sacramento;
Lars Bode (United States) C. Calixto; D.C. Aragon (Brazil)
14:00 - 14:30 Preterm nutrition and HM fortification

Jean-Charles Picaud (France)
60
61
14:15 - 14:20 Blood glucose level and cerebral oxygenation in neonates 13:55 - 14:00 Octreotide for chylothorax? A systematic
immediately after birth approach to answering the question
B. Urlesberger; C.H. Matterberger; N. Baik-Schneditz; G. Zuanetti; G. Cavallaro; G. Raffaeli; M. Colnaghi; F. Ciralli;
B. Schwaberger; G.M. Schmlzer; L. Mileder; G. Pichler (Austria) I. Amodeo; S. Gulden; E. Leva; L. Pugni; F. Mosca (Italy)
14:20 - 14:25 A neonatal resuscitation algorithm for mid-to-low resource 14:00 - 14:05 Prevention of hypocapnia with inhalative CO2 in neonates
settings in medecins sans frontieres programs with hypoxic-ischemic encephalopathy-the henric study
L. Umphrey 1; M. Blennow 2; M. Breindahl 2; A. Brown 3; E. Szakmar 1; K. Kovacs 1; U. Meder 1; C.S. Andorka 1; K. Kaila 2;
O.D. Saugstad 4; M. Thio Lluch 3; D. Trevisanuto 5; C.C. Roehr 6 M. Szabo 1; A. Jermendy 1
(1. France; 2. Sweden; 3. Australia; 4. Norway; 5. Italy; (1. Hungary; 2. Finland)
6. United Kingdom)
14:05 - 14:10 In vitro analyses of gastric aspirates from preterm neonates
14:25 - 14:30 Reliability and accuracy of pulse oxymetry to determine after corticosteroid therapy
SAO2 and PAO2 in preterm infants V. Milov; D. Manoylov; A. Jordanova; A. Tsanova; V. Stoyanova;
D. Wackernagel; M. Blennow; A. Hellstrm (Sweden) E. Stoimenova; D. Petrova; E. Hristova; Z. Lalchev (Bulgaria)
14:10 - 14:15 The SAFE protocol: a sonographic algorithm for

liFe-threatening emergencies in the NICU
13:30 14:30 POSTER SESSION 7 (LUNG 3) |ROMA ROOM N. Yousef; S. Shankar-Aguilera; D. De Luca (France)
Chairs: Daniel Klotz (Germany);
Luc Zimmermann (The Netherlands) 14:15 - 14:20 Changes in expression of connective tissue growth factor
(CTGF) in newborn rat lungs after ventilation
13:30 - 13:35 Evaluation of oxidative stress in neonates A. Remesal; E. Gutierrez; L. San Feliciano; M. Mateos;
M. Matyas; M. Hsmsanu; D. Leucuta; L. Blaga; G. Zaharie A. Garca-Snchez; M. Isidoro-Garca; D. Ludea (Spain)
(Romania)
14:20 - 14:25 Oxygen saturation targeting using automated versus manual
13:35 - 13:40 Simplified Australian and New Zealand neonatal network control of inspired oxygen in preterm infants:
(ANZNN) shift test accurately predicts rightward shift of the a systematic review and meta-analysis
SPO2-PIO2 curve in an extremely preterm infant population S. Mitra; B. Singh; W. El-Naggar; D. McMillan (Canada)
Y.J. Choi; B. Stoecklin; M.A. Hakeem; P. Woods; J.J. Pillow (Australia)
13:40 - 13:45 Normalisation of pulmonary gas exchange capacity in very

preterm infants following initial hospital discharge defined by
shift of the SPO2-PIO2 curve
Y.J. Choi; B. Stoecklin; J.J. Pillow (Australia)
13:45 - 13:50 Measuring oxygen diffusion at 36 weeks PMA in preterm

infants: analysis of the SATO2/FIO2 ratio and its correlation
with early respiratory patterns of disease
S. Nobile; P. Marchionni; F. Porcarelli; A. Boria; V.P. Carnielli (Italy)
13:50 - 13:55 Macrolide therapy and increased patent ductus arteriosus

treatment in ureaplasma-positive premature infants
S. Kim; E. Jung; H. Kim; W. Sun Song; J. Hye Hwang;
C. Young Kim; B.S. Lee; E. Ai-Rhan Kim; K.S. Kim (Korea)
62
63
13:30 14:30 POSTER SESSION 8 |FIRENZE ROOM 14:05 - 14:10 Experience of infants born with a diagnosis of
(CARDIOLOGY + MICRO CIRCULATION 2) down syndrome in a tertiary neonatal centre: burden
of disease and length of hospital stay
Chairs: Mayka Bravo (Spain); Colm Breatnach (Ireland) T. Martin 1; A. Smith 1; C.R. Breatnach 1; E. Kent 1; I. Shanahan 1;
M. Boyle 1; P.T. Levy 2; O. Franklin 1; A. EL-Khuffash 1
13:30 - 13:35 Resistence index (RI) of arteria cerebri anterior and cerebral (1. Ireland; 2. United States)
oxygenation in preterm infants
N. Baik-Schneditz; B. Urlesberger; B. Schwaberger; L. Mileder; 14:10 - 14:15 Influence of type of congenital heart defects on epithelial
N. Hller; G. Pichler (Austria) lining fluid composition in infants undergoing cardiac
surgery with cardiopulmonary-bypass
13:35 - 13:40 Influence of global hypoxia and remote ischemic M. Simonato; A. Baritussio; M. Salvagno; L. Vedovelli; G. Falasco;
postconditioning on natriuretic peptide expression in V.P. Carnielli; M. Padalino; P. Cogo (Italy)
newborn piglet heart chambers
H. Kierkegaard; K.J. Kyng; B.S. Kousholt; S. Kerrn-Jespersen; 14:15 - 14:20 A randomised crossover study comparing speed of heart
K. Bennedsgaard; M. Kjeldsen; N. Gregersen; R.K. Olsen; rate display in newborns using electrocardiogram plus pulse
T.B. Henriksen (Denmark) oximeter versus pulse oximeter alone
M. Murphy 1; L. De Angelis 2; E. Fitzgerald 1; L. McCarthy 1;
13:40 - 13:45 Arginase up-regulation and eNOS uncoupling contribute to C. ODonnell 1
impaired endothelium-dependent vasodilation in a rat (1. Ireland; 2. Italy)
model of intrauterine growth restriction
I. Grandvuillemin 1; C. Buffat 1; F. Boubred1; E. Lamy 1; 14:20 - 14:25 Computer analysis of infant heart sound recordings
J. Fromonot 1; A.C. Peyter 2; U. Simeoni 2; C. Yzydorczyk 2 D. Wertheim; K. Naicker; J. Chang; M. Chang; M. Rigby; A. Kumar;
(1. France; 2. Switzerland) R. Kayyali (United Kingdom)
13:45 - 13:50 Low serum cortisol levels in asphyxiated infants with 14:25 - 14:30 Simulation hemodynamics Neocardiosim -
haemodynamic instability perinatal and critical congenital heart scenarios
K. Kovacs; E. Szakmar; U. Meder; A. Cseko; M. Szabo; A. Jermendy W. Blaz; A. Eberhardt; A. Szadkowska; B. Chmielarz; B. Zych;
(Hungary) B. Andraka (Poland)
13:50 - 13:55 Changes of NT-PROBNP concentration wthin the first week of

life in preterm newborns with birth body mass 1200g
T. Talar; E. Gulczyska; B. Cyranowicz; J. Moll (Poland) 13:30 14:30 POSTER SESSION 9 (INFECTIOUS DISEASE)
|SORRENTO ROOM
13:55 - 14:00 Avoiding hypotension in preterm neonates (AHIP)
Chairs: Sam Oddie (United Kingdom); Chirstoph Bhrer (Germany)
a single-center randomised controlled study
G. Pichler; N. Hller; N. Baik-Schneditz; B. Schwaberger; L. Mileder;
A. Avian; J. Pansy; B. Urlesberger (Austria) 13:30 - 13:35 Maternal contribution to neonatal microbiota
R.S. Procianoy 1; L.F. Roesch 1; A.L. Corso 1; V. Mai 2 ; R.C. Silveira 1
14:00 - 14:05 Two year outcomes in extremely preterm infants with (1. Brazil; 2. United States)
differing blood pressure management
P. Chisholm; A. Sinha; J. Tan; S. Kempley; A. Matthew; J. Banerjee; 13:35 - 13:40 Human breast milk supplies newborn infants with high
J. Morris; N. Aladangady (United Kingdom) amounts of S100-alarmins protecting from sepsis
S. Pirr; M. Richter; J. Pagel; C. Hrtel; B. Fehlhaber; J. Roth; T. Vogl;
D. Viemann (Germany)
64
65
13:40 - 13:45 Variability in immunological response to oropharyngeal 13:30 14:30 POSTER SESSION 10 (NEUROLOGY 1)
colostrum administration in preterm newborn based on sex
|LECCE ROOM
E. Martin-Alvarez; L. Serrano-Lopez; J. Daz-Castro;
M. Pea-Caballero; M.B. Snchez-Martnez; F. Martn-Peregrina; Chairs: Luca Ramenghi (Italy); Sandra Horsch (Germany)
J.J. Ochoa; J.A. Hurtado-Suazo (Spain)
13:30 - 13:35 Longitudinal study of brain tissue volumes in preterm
13:45 - 13:50 Neonatal intestinal colonization with ESBL-producing infants and their relation with neonatal risk factors and
enterobacteriaceae a 5 year follow up study neurodevelopmental outcome
V. Nordberg; K. Jonsson; C.G. Giske; A. Iversen; O. Aspevall; L. Gui; F. Lazeyras; P.S. Hppi; C. Borradori (Switzerland)
B. Jonsson; A. Camporeale; M. Norman; L. Navr (Sweden)
13:35 - 13:40 A new evaluation index for left-right unequal
13:50 - 13:55 Characterization of resistance plasmids during a nosocomial ventriculomegaly in very low birth weight infants: association
epe-outbreak using optical DNA mapping with walking disabilities at 1.6 years of corrected age
S. Kumar Bikkarolla; V. Nordberg; M. Humaun Kabir; V. Mller; T. Ikuta; M. Mizobuchi; Y. Katayama; S. Yoshimoto; T. Ioroi;
T. Ambjrnsson; C.G. Giske; L. Navr; L. Sandegren; F. Westerlund M. Yamane; T. Morisawa; A. Takatera; M. Ueda; A. Shibata;
(Sweden) K. Maeyama; K. Fujioka; N. Nishimura; K. Iijima; I. Morioka (Japan)
13:55 - 14:00 Long term follow up of hearing disorders in patients 13:40 - 13:45 Differences between intrauterine and extrauterine growth of
with congenital cytomegalovirus infection the cerebellum
A. Giannattasio; R. Alfani; P. Di Costanzo; D. Bruzzese; L. Bucci; A.I. Toma; I. Cuzino; A. Cozinov; R.G. Olteanu (Romania)
M.R. Augurio; L. Capasso; F. Raimondi (Italy)
13:45 - 13:50 Prognostic value of early conventional proton magnetic
14:00 - 14:05 Outcomes of congenital cytomegalovirus disease following resonance spectroscopy in cooled asphyxiated newborns
maternal primary and non-primary infection H. Barta; A. Jermendy; M. Kolossvary; L. R. Kozak; A. Lakatos;
A. Giannattasio; S. Cenni; D. De Martino; T. Ferrara; L. Capasso; U. Meder; G. Rudas; M. Szabo (Hungary)
E. Capone; P. Di Costanzo; F. Raimondi (Italy)
13:50 - 13:55 Autism spectrum disorder in ex-preterms is preceded by
14:05 - 14:10 The frequency of mannan-binding lectin (MBL) deficiency altered neonatal brain volumes in multimodal association
in premature babies and the effect on long term morbidities areas and altered patterns of brain asymmetry
H. Ozkan; P.Dogan; N. Koksal; B. Oral; O. Bagc; I. Varal (Turkey) N. Padilla; E. Eklf; G. Mrtensson; S. Blte; H. Lagercrantz;
U. den (Sweden)
14:10 - 14:15 The early onset risk calculator to evaluate early-onset sepsis
in infants born 35 weeks gestation 35 weeks gestation 13:55 - 14:00 Characterisation of the neonatal corpus callosum (CC) using
S. Stokes; R. Cuzzilla; A.J. Daley; S.E. Jacobs (Australia) MRI and cranial ultrasound (US)
M. Mills; V. Pelling; L. Harris; J. Smith; H. Rabe; J.R. Fernandez Alvarez
14:15 - 14:20 HeRO as a tool for predicting morbidity and mortality in (United Kingdom)
preterm infants with late onset sepsis admitted to tertiary
level neonatal unit 14:00 - 14:05 Brain growth and relationships with illnesses and
E. Hoyle; C. Dewhurst (United Kingdom) neurodevelopment outcome
R. DAscenzo 1; B. Pieroni 1; A. Pianesi 1; A. Peretti 1 ; L. Regnicolo 1;
14:20 - 14:25 S100-alarmin-induced innate immune G. Polonara 1; M.J.N.L. Benders 2; V.P. Carnielli 1
programming protects newborn infants from sepsis (1. Italy; 2. The Netherlands)
S. Pirr; T. Ulas; B. Fehlhaber; M.S. Bickes; T.G. Loof; T. Vogl;
L. Mellinger; A.S. Heinemann; J. Burgmann; J. Schning; S. Schreek; 14:05 - 14:10 Predicting the development of cerebral palsy: a comparison
S. Pfeifer; F. Reuner; L. Vllger; M. Stanulla; between DTI-MRI and early hand assessment in infants with
M. von Kckritz-Blickwede; S. Glander; K. Barczyk-Kahlert; unilateral perinatal brain injury
C.S. von Kaisenberg; J. Friesenhagen; L. Fischer-Riepe; S. Zenker; B. van Gasselt; N. Wagenaar; C. Verhage; M.J.N.L. Benders;
J.L. Schultze; J. Roth; D. Viemann (Germany) F. Groenendaal; L. de Vries; N. van der Aa (The Netherlands)
66
67
14:10 - 14:15 Low-grade IVH and low-grade CBH: which influence on 14:30 - 16:30 PARALLEL SESSION 19 (NUTRITION 3)
Griffiths score at 2 years of age?
A. Parodi; M. Malova; S. Uccella; L. Boeri; E. De Grandis; A. Sannia;
NUTRITION OF THE ELBWI:
M. Severino; G. Morana; D. Tortora; A. Rossi; E. Veneselli; IMPROVING NUTRITIONAL CARE |VENEZIA ROOM
L.A. Ramenghi (Italy) Chairs: Alexandre Lapillonne (France);
Mark Jonhson (United Kingdom)
14:15 - 14:20 Long-term effects of neonatal complications on
brain growth at 10 years of age in children born 14:30 - 14:50 Electrolyte needs and balance in the EBLW, how to avoid
extremely preterm disturbances
Silvia Iacobelli (France)
N. Padilla; C. Jimenez-Espinoza; H. Kvanta; U. Adn (Sweden)
14:20 - 14:25 Music effects in preterm infants brain: a structural 14:50 - 15:10 How to integrate enteral intake when administering
neuroimaging investigation parenteral nutrition in ELBW infants?
Sissel Moltu (Norway)
J.R. Alves S de Almeida; N. Kunz; L. Lordier; A. Darque; F. Lazeyras;
P. Hppi (Switzerland)
15:10 - 15:30 Feeding strategies in neonates: the SIFT feeding trial
Jon Dorling (United Kingdom)
14:25 - 14:30 Noise in the NICU Unit: Introducing a noise reduction policy
to Southmead Neonatal Intensive Care Unit: primary results
from a 3 month service improvement project 15:30 - 15:45 The Norwegian preterm infant gut (PINGU) study: a
J. Hawksley; E. Helliwell; F. Emery (United Kingdom) metagenomic approach to gut microbiota composition and
resistome in infants supplemented with probiotics
E. Esaiassen; E. Hjerde; P. Cavanagh; T. Pedersen; J. Andresen;
S. Rettedal; R. Sten; B. Nakstad; N.P. Willassen; C. Klingenberg
14:30 - 16:30 PARALLEL SESSION 18 (PULMONOLOGY 2) (Norway)
VENTILATION SUPPORT |DARSENA ROOM
15:45 - 16:00 Assessment of enzymotherapy efficacy in case of lactase
Chairs: Manuel Sanchez-Luna (Spain); Christian Poets (Germany) insufficiency in preterm infants
O. Vlasova; L. Koliubakina (Ukraine)
14:30 15:00 Update on NIVM
Corrado Moretti (Italy) 16:00 - 16:15 Detrimental mucosal effect of ibuprofen in the immature
human intestine
15:00 15:30 Closed loop FiO2 controle E. Tremblay; E. Ferretti; M.P. Thibault; D. Grynspan; K.M. Burghardt;
Nelson Claure (United States) M. Bettolli; C. Babakissa; E. Levy; J.F. Beaulieu (Canada)
15:30 16:00 Automated oxygen control in the NICU 16:15 - 16:30 Patched skin bilirubin assay to monitor extremely preterm
Peter Dargaville (Australia) neonates undergoing phototherapy
16:00 16:15 Volume controlled or volume guarantee ventilation in D. De Luca; V. DellOrto (France)
preterm infants: a randomised controlled trial
H. Chitty; W. Tin; D. Stocken; R. Agbeko; J Vormoor; S. Sinha
(United Kingdom)
16:15 16:30 Volume-targeted versus pressure-limited

ventilation in neonates - a cochrane systematic
review and meta-analysis updated 2017
C. Klingenberg 1; K.I. Wheeler 2; N. McCallion 3; C.J. Morley 4;
P.G. Davis 2 (1. Norway; 2. Australia; 3. Irelands; 4. United Kingdom)
68
69
14:30 - 16:30 PARALLEL SESSION 20 |ROMA ROOM 16:00 - 16:15 Development and evaluation of e learning
education to support breastfeeding in NICU
NEONATAL ARDS: RECOGNISING THE
W. Higman; L. Wallace; A. Turner; S. Law; K. Blake
EXISTENCE OF A SYNDROME ACROSS THE AGE (United Kingdom)
Scientific session endorsed by ESPR and ESPNIC
Chairs: Luc Zimmerman (The Netherlands); Virgilio P. Carnielli (Italy)
14:30 - 16:30 PARALLEL SESSION 22 |SORRENTO ROOM
14:30 15:00 Physiopathology of ARDS across the ages
OXYGENATION IN THE NEWBORN AND INFANT
Peter Rimensberger (Switzerland)
PERIOD
15:00 15:30 Biology of ARDS across the ages Chairs: Ola D. Saugstad (Norway); Robin Steinhorn (United States)
Daniele De Luca (France)
14:30 15:00 Embryonic and fetal oxygenation and oxygen control
15:30 16:00 The Montreux definition of neonatal ARDS Satyan Lakshminrusimha (United States)
Martin K. Kneyber (The Netherlands)
15:00 15:30 Oxygenation in the transition from fetal to newborn life
16:00 16:20 The fate of neonates with ARDS: the second phase of Maximo Vento Torres (Spain)
neonatal ARDS project
Anton van Kaam (The Netherlands) 15:30 16:00 Oxygen targets beyond the delivery room
Ola D. Saugstad (Norway)
16:00 16:30 Oxygenation and growth in BPD

14:30 - 16:30 PARALLEL SESSION 21 (EFCNI 4) |FIRENZE ROOM
Robin Steinhorn (United States)
DIGITAL PATIENT CARE THE NEW DIMENSION?
Chairs: Silke Mader (Germany);
Agnes Van Den Hoogen (Netherland); 14:30 - 16:30 PARALLEL SESSION 23 (BRAIN)
BIOMARKERS IN TERM NEONATAL
14:30 - 14:50 Digital information support or challenge? ENCEPHALOPATHY |LECCE ROOM
Silke Mader (Germany) Chairs: Deirdre Murray (Ireland); Bobbi Fleiss (France)
14:50 - 15:10 Web camera use in the neonatal intensive care unit: 14:30 - 14:50 Biomarkers in neonatal brak injury: can a systems biology
impact on nursing workflow approach lead us to the Holy Grail?
Gillian Kennedy (United Kingdom) Deidre Murray (Ireland)
15:10 - 15:30 Using technology to continue Family Centred 14:50 - 15:10 Metabolic phenotyping to understand neonatal
Care post discharge encephalopathy
Alison McNulty (Ireland) Bobbi Fleiss (France)
15:30 - 15:45 Development and implementation of an integrated family 15:10 - 15:25 Depression during pregnancy and DNA methylation
delivered neonatal care model including a parent support changes in cord blood
mobile app A.C. Viuff 1; G. Sharp 2.; D. Raj 2; K.J. Kyng 1; L.H. Pedersen 1;
J. Banerjee; A. Aloysius; K. Platonos; A. Deierl (United Kingdom) T.B. Henriksen 1; C.L. Relton 2
(1. Denmark; 2. United Kingdom)
15:45 - 16:00 Tablet based parental feedback in neonatal transport
P. Bhat; C. Garland; A. Frame; G. Bullimore; L. Watts; C. Leach;
C. Lawn (United Kingdom)
70
71
15:25 - 15:40 A novel cerebral ultrasound scoring system is 18:00 - 19:30 Enhancing the Success of Respiratory
associated with neurological outcome in neonates
with hypoxic-ischemic encephalopathy
Management in nRDS|VENEZIA ROOM
K. Annink; F. Groenendaal; M. Lequin; D. Vijlbrief; L. de Vries; Industry Supported session - please see page 126
M.J.N.L. Benders; J. Dudink (The Netherlands) Chair: Anton Van Kaam (The Netherlands)

15:40 - 15:55 Placental histology findings as possible risk factors for
MRI-detected brain lesions in VLBW infants 18:00 - 18:30 BPD: from trials to clinical practice
Wolfgang Gpel (Germany)
A. Parodi; M. Re; D. Brignole; MP Brisigotti; M.G. Calevo; M. Malova;
A. Sannia; M. Severino; G. Morana; D. Tortora; A. Rossi; E. Fulcheri;
L.A. Ramenghi (Italy) 18:30 - 19:00 Less Invasive Surfactant Administration (LISA), a new chapter
in neonatal management
15:55 - 16:10 MicroRNA panel validation in hypoxic schemic Peter Dargaville (Australia)
encephalopathy
M.P. OSullivan 1; A.M. Looney 1; G. Moloney 1; B. Hallberg 2; 19:00 - 19:30 Success of intervention: the importance of Training with LISA
G. Clarke 1; G.B. Boylan 1; D.M. Murray 1 Maximo Vento Torres (Spain)
(1. Ireland; 2. Sweden)
16:10 - 16:25 Phospholipid synthesis related biomarkers in plasma from

newborns with hypoxic-ischemic encephalopathy
M. Vento Torres; J. Kuligowski; . Snchez-Illana; J.D. Pieiro-Ramos;
A. Nez-Ramiro; M. Cernada; A. Parra; E. Valverde; D. Blanco;
M.T. Moral-Pumarega; F. Cabaas; H. Boix; A. Pavon; M. Chaffanel;
I. Benavente-Fernndez; I. Tofe; B. Loureir (Spain)
17:00 - 18:00 PLENARY SESSION 5 |DARSENA ROOM

WILL BIG DATA CHANGE THE FUTURE?
Chairs: Manon Benders (The Netherlands); Pierre Gressens (France)
17:00 17:30 Using big data for cognitive computing approaches to

personalised medicine for neonatal care
Carolyn McGregor (Canada)
17:30 18:00 Big data and genetic encephalopathic epilepsy

Michael Johnson (United Kingdom)
72
73
08:00 08:00
POSTER WALK EBN Business Meeting POSTER WALK
09:00 09:00
Parallel Parallel Parallel Parallel Parallel PULMONOLOGY
Session 24 Session 25 Session 26 Session 27 Session 28 SECTION MEETING
Stress and (BRAIN 5) (PHARMA 2) (CIRCULATION 3) (EFCNI 4)
development Neuroprotection New insights in future Training guidelines Measuring quality of
EPO trial neonatal care for Neonatologist care in neonatal care
Performed Echo-
11:00 cardiography (NPE) 11:00
COFFEE BREAK - an intercontinental COFFEE BREAK
11:30 debate
11:30
IPRF PLENARY
SESSION 6
12:30 12:30
LUNCH BREAK
13:30 13:30
POSTER SYMPOSIUM POSTER POSTER POSTER POSTER
SESSION 11 Human Milk SESSION 12 SESSION 13 SESSION 14 SESSION 15
NEUROLOGY 2 Fortification: benefits EPIDEMIOLOGY NUTRITION 2 LUNG 4 ETHICS + PERINATAL
of an exclusive human
PRACTICE
milk diet for premature
infants
15:00 15:00
Parallel Parallel Parallel Parallel Parallel Parallel CIRCULATION
Session 29 Session 30 Session 31 Session 32 Session 33 Session 34 SECTION MEETING
(BRAIN 6) (PULMONOLOGY 4) (EPIDEMIOLOGY 2) Children Born Preterm IUGR across COINN Global
Congenital brain Pharmacology of lung Perinatal perspcetives in
SPECIALITIES
infections protection epidemiology neonatal care
17:00 17:00
COFFEE BREAK
17:30 17:30
PLENARY ESPR
Business Meeting
SESSION 7
The Need of
multidisciplinary
18:30 approaches in 18:30
research
19:30 19:30
Up to 35%
Special Congress Discount 08:00 09:00

POSTER WALK | GROUND FLOOR
Neonatal Hematology and Bilirubin
Chairs: Elsa Kermorvant (France)
World Review of Nutrition and Dietetics
Editor: B. Koletzko
Vol. 110
Nutritional Care of
Editor
Z. Hochberg
Preterm Infants ID 020 PROLONGED JAUNDICE SCREENING: FBC OR NO FBC!
N. Storring; R. Doherty; V. Ponnusamy (United Kingdom)
Practical
Scientific Basis and Practical Guidelines
Editors
B. Koletzko
Algorithms in B. Poindexter
R. Uauy
dexter
ID 042 LABORATORY FINDINGS; DIAGNOSIS AND TREATMENT OF THE
Pediatric NEWBORN ADMITTED DUE TO HEMATEMESIS OR BLOODY STOOL IN
11 YEARS
Endocrinology
3rd, revised edition
I. Hokuto; Y. Ito; T. Mori; S. Komachi (Japan)
ID 154 AN UNUSUAL CAUSE OF CYANOSIS: SEVERE METHEMOGLOBINEMIA

Practical Algorithms in Pediatrics
Series Editor: Z. Hochberg
IN A PRETERM INFANT WITH SEPSIS

Editor: Z. Hochberg (Haifa) Editors: Koletzko, B. (Munich); Poindexter, B.
List price: CHF 53.00 / EUR 50.00 / USD 62.00 (Indianapolis, Ind.); Uauy, R. (Santiago de Chile)
F. Bakar; M. Berber (Turkey)
Special offer: CHF 42.00 / EUR 40.00 / USD 50.00 List price: CHF 148.00 / EUR 138.00 / USD 174.00
ISBN 9783318059175 Special offer: CHF 96.00 / EUR 90.00 / USD 113.00 ID 171 THE INFLUENCE OF INTRAUTERINE TRANSFUSION ON THE OUTCOMES
ISBN 9783318026405 (hard cover) OF NEWBORNS WITH SEVERE HEMOLYTIC DISEASE
Order at:
www.karger.com/pape Order at: E. Balashova; O. Bystrykh; T. Fedorova; O. Ionov; A. Kirtbaya;
and use the promotional code: DPAPE17 www.karger.com/wrund D. Sharafutdinova; V. Zubkov; D. Degtyarev; O. Horoshkeeva; N. Fedorova;
and use the promotional code: DJENS17 N. Tetruashvili; K. Kostukov; N. Karetnikova (Russia)
Pediatric and Adolescent Medicine

ID 491 IV FLUID SUPPLEMENTATION IN SEVERE NEONATAL
SickKids Handbook
Editor: W. Kiess
HYPERBILIRUBINEMIA: YES or NO
Vol. 18
of Pediatric Thrombosis
and Hemostasis
Neonatal M.T. Saleh; S. El Doory; S. Saleh; M.E.l. Halik (Saudi Arabia)
Pharmacology and
Editors
Nutrition Update
ID 543 RIGHT SUBCLAVIAN ARTERY THROMBOSIS. A CASE REPORT
Victor S. Blanchette
Leonardo R. Brando
Vicky R. Breakey
G. Ucls; T. Fuentes; R. Villarino; M. Gonzlez-Valcrcel; A. Martnez (Spain)

Editors
Shoshana Revel-Vilk 2nd, revised and extended edition
F.B. Mimouni
BMA Med J.N. van den Anker
ical Book
Awards 20
17
highly co
in Paedia
mmende
d ID 555 RISK FACTORS FOR PORTAL VENOUS THROMBOSIS IN NEWBORNS:
trics
A RETROSPECTIVE STUDY
A. Zanin; M. Colella; C. Farnoux; S. Soudee; M. Leport; R. Stern; O. Bequet;
M. Alison; V. Biran; O. Baud (France)
Editors: V.S. Blanchette (Toronto, Ont.); L.R. Brando Editors: Mimouni, F.B. (Tel Aviv); van den Anker, J.N. ID 611 RELATIONSHIP BETWEEN LEUKOCYTES AND PLATELETS AND
(Toronto, Ont.); V.R. Breakey (Hamilton, Ont.); (Washington, D.C./Basel/Rotterdam) PREMATURE RETINOPATHY
S. Revel-Vilk (Jerusalem) List price: CHF 126.00 / EUR 118.00 / USD 148.00 V. Filip; C. Lazar (Romania)
List price: CHF 127.00 / EUR 119.00 / USD 149.00 Special offer: CHF 82.00 / EUR 77.00 / USD 96.00
Special offer: CHF 83.00 /EUR 77.00 / USD 97.00 ISBN 9783318027358 (hard cover)
ISBN 9783318030266 ID 692 CONGENITAL HEPATOCELLULAR CARCINOMA ASSOCIATED WITH
Order at: NEONATAL HEMOCHROMATOSIS
Order at: www.karger.com/pamed P. Francalanci; C. Grimaldi; M.C. Saffioti; R. Angelico; R. Boldrini; F. Callea
www.karger.com/sickkids and use the promotional code: DJENS17
and use the promotional code: DJENS17 (Italy)
Special offers include the digital version.
Prices subject to change, VAT not included.
EUR price for eurozone countries, USD price for USA and Latin America only
ID 740 OUTCOME OF BABIES WITH SERUM BILIRUBIN LEVEL OF GREATER THAN
400mmol/L
R. Prasad; S.V. Rasiah (United Kingdom)
Karger Medical and Scientific Publishers
CH4009 Basel, Switzerland
KI17451
orders@karger.com, f: +41 61 306 12 34

Medical and Scientific Publishers www.karger.com
74
74 3rd November, 2017 75
75
Neurology
ID 094 NEONATAL ADMISSIONS FOR HYPOXIC ISCHEMIC
Chairs: Nicola Roberston (United Kingdom) ENCEPHALOPATHY: WEEKEND AND OUT OF HOURS EFFECT
F. Ceroni; M. Parmar; S. Narayanan; N. Merchant (United Kingdom)
ID 003 PRETERM BIRTH AND THE TIMING OF PUBERTY
E. James; C. Wood; H. Nair; T. Williams (United Kigdom)
ID 100 WHICH PARTS OF GROWTH SHOULD BE MONITORED FOR
NEURODEVELOPMENT OF PRETERM INFANTS
ID 036 PREVENTION OF CEREBRAL PALSY: FEASIBILITY OF UMBILICAL CORD I.G. Song; H.R. Yoon; Y.M. Yoon; J.S. Shin; S.H. Shin; E.K. Kim; H.S. Kim (Korea)
BLOOD STEM CELLS AND UMBILICAL CORD MESENCHYMAL STROMAL
CELLS ID 103 TARGETED METHYLATION TESTING OF A 154 PATIENTS COHORT WITH
H. Shintaku; M. Nabetani; T. Hamazaki; S. Kusuda; M. Tamura; S. Watabe; CLINICAL FEATURES OF IMPRINTING DISORDERS: EVIDENCE OF
M. Hayakawa; Y. Sato; M. Tsuji; A. Taguchi; H. Ichiba; O. Akira; R. Mori;
MULTILOCUS METHYLATION DEFECTS
A. Taki; T. Mukai; T. Nagamura-Inoue (Japan)
A. Touati; S. Nouri; F. Chioukh; M. Haddaji Mastouri; N. Ben Salah; S. Trabelsi;
S. Hammami; S. Mougou; M. Gribaa; N. Guedich; H. Seboui; A. Nouri;
ID 039 NO GENDER-RELATED DIFFERENCES IN FETAL CORPUS CALLOSUM K. Monastiri; A. Saad; D. Hmida-Ben Brahim (Tunisia)
THICKNESS: IN-UTERO MRI STUDY
R. Bercovitz; R. Achiron; C. Hoffmann; A. Achiron (Israel) ID 105 STEINERT MYOTONIC DYSTROPHY (DM1): WHAT ABOUT CARDIAC
INVOLVEMENT?
ID 040 NEUROMOTOR PROFILE OF HIGH-RISK INFANTS AT TERM OR NEAR H. Hadj Abdallah; Y. Halleb; N. Ben Salah; F.Z. Chioukh; K. Ben Ameur;
TERM F. Kallel; L. Ben Slamia; S. Hidar; M. Bellallah; S. Nouri; S. Ben Amor; A. Hsin;
I. Ereno; W.Y. Teh (Singapore) M. Grira; H. Ajmi; S. Zardi; S. Abroug; N. Mahdhaoui; H. Sboui; S. Ben Ammou;
K. Mestiri; A. Saad; D. Hmida (Tunisia)
ID 043 THE PREDICTIVE VALUE OF SEVERE BRONCHOPULMONARY DYSPLASIA
FOR NEUROLOGICAL IMPAIRMENT IN 2-YEARS-OLD VERY PRETERM ID 150 HEAD MIDLINE POSITION FOR THE PREVENTION OF GERMINAL
INFANTS IS HIGHER WHEN DIAGNOSED AT 40 THAN AT 36 WEEKS MATRIX-INTRAVENTRICULAR HEMORRHAGE IN PRETERM INFANTS:
POSTMENSTRUAL WEEKS A SYSTEMATIC REVIEW AND META-ANALYSIS
A.M. Malavolti 1; D. Bassler 1; R. Arlettaz-Mieth 1; G. Faldella 2; B. Latal 1
O. Romantsik 1; M.G. Calevo 2; M. Bruschettini 1
G. Natalucci 1
(1. Sweden; 2. Italy)
(1. Switzerland; 2. Italy)
ID 157 MOTOR FUNCTION AT EARLY SHCOOL-AGE IN EXTREMELY PRETERM
ID 055 PSYCHOSOCIAL OUTCOME OF INFANTS WITH CONGENITAL BORN CHILDREN WITHOUT MAJOR IMPAIRMETNS IN RELATION TO
MALFORMATIONS AFTER POSTNATAL SURGICAL REPAIR PERINATAL FACTORS: NATIONAL POPULATION-BASED STUDY
N. Doberschuetz; A. Allendorf; R. Dewitz; B. Wittekindt; U. Rolle; R. Schloesser
(EXPRESS)
(Germany)
J. Bolk; A. Farooqi; M. Hafstrm; U. den; F. Serenius (Sweden)
ID 060 THERAPEUTIC HYPOTHERMIA AND HEARING IMPAIRMENT: INCIDENCE ID 169 EARLY RISK FACTORS FOR ADVERSE NEUROMOTOR DEVELOPMENT IN
AND ASSOCIATED FACTORS TERM INFANTS AFTER MODERATE HYPOXIC-ISCHAEMIC
M. PFitzgerald; G. Norman; C. Mc Garvey; A. Reynolds; M. King; B. Hayes ENCEPHALOPATHY
(Ireland)
A. Matic (Serbia)
ID 070 PRETERM INFANTS 33-35 WEEKS GESTATION WITH SEVERE HYPOXIC- ID 175 THERAPEUTIC HYPOTHERMIA IN BABIES WITH HYPOXIC-ISCHAEMIC
ISCHEMIC ENCEPHALOPATHY TREATED WITH HYPOTHERMIA DO NOT ENCEPHALOPATHY: EVIDENCE AND CLINICAL PRACTICE
PRESENT MORE ORGAN DYSFUNCTION THAN TERM NEWBORNS K. Ghazal; A. Panickar; S. Garg (United Kingdom)
M. Alsina; A. Martin-Ancel; M. Leon; G . Arca; E. Perez; A. Garca-Alix (Spain)
ID 196 SECRETONEURIN SERUM CONCENTRATIONS CORRELATE WITH
ID 080 IMPACT OF ENVIRONMENTAL FACTORS ON MOTOR AND COGNITIVE ABNORMAL NEURODEVELOPMENTAL OUTCOME AT THE AGE OF 24
PERFORMANCE OF LATE PRETERM INFANTS. MONTHS IN TERM NEONATES WITH ASPHYXIA
M.M. Santos; C. Corsi; A.C. Campos; N.A.C.F. Rocha (Brazil) K. Wechselberger; A. Schmid; M. Hck; A. Posod; M. Urbanek (Austria)

ID 206 SCREENING C677T POLYMORPHISM IN
METHYLENETETRAHYDROFOLATE REDUCTASE GENE IN TAIWAN
POPULATION
C.Y. Chuang; C.C. Hung; Y.N. Su; P.N. Tsao (Taiwan)
76
76 3rd November, 2017 3rd November, 2017 77
77
ID 230 COGNITIVE OUTCOME IN ADULTS BORN WITH VERY LOW BIRTH ID 484 EARLY CRANIAL ULTRASOUND AND MRI AT TERM IN VERY
WEIGHT OR SMALL FOR GESTATIONAL AGE PRETERM INFANTS: DIAGNOSIS OF BRAIN INJURY VERSUS
S. Weider; A.M.W. Lrum; K. AI Evensen; S. Lydersen; A.M. Brubakk; NEURODEVELOPMENTAL OUTCOME AT 12 AND 24 MONTHS
M.S. Indredavik (Norway) CORRECTED GESTATIONAL AGE
K. Chatzidimitriou; A. Chebsey; D. Odd; M. El Brookle; M. Likeman; A. Heep
ID 281 REACHING SKILLS OF INFANTS BORN VERY PRETERM PREDICT (United Kingdom)
NEURODEVELOPMENT AT 3 YEARS
Y. Fredriksson Kaul; K. Rosander; H. Grnqvist; K. Strand Brodd; ID 485 CRANIAL ULTRASOUND AT DAY 7 AND CLINICAL MRI AT
L. Hellstrm-Westas; C. von Hofsten (Sweden) TERM IN VERY PRETERM INFANTS BORN AT LESS THAN 28 WEEKS:
VENTRICULOMEGALY IS RELATED TO SUBTLE BRAIN PATHOLOGY AND
ID 315 UNDERSTANDING ADHD AND ASD IN VERY PRETERM CHILDREN FROM UNFAVORABLE DEVELOPMENTAL OUTCOME AT 24 MONTH
A SENSORY PROCESSING PERSPECTIVE: A CONTROLLED K. Chatzidimitriou; A Chebsey; D. Odd; M. El Brookle; M. Likeman; A. Heep
NEUROPSYCHOLOGICAL STUDY (United Kingdom)
T. Brring; K. Oostrom; M. Knigs; E. van Dijk-Lokkart; H. Lafeber; A. Brugman;
J. Oosterlaan (The Netherlands) ID 502 VALIDITY OF THE KOREAN DEVELOPMENTAL SCREENING TEST FOR
VERY LOW BIRTH WEIGHT INFANTS
ID 319 SOCIAL-EMOTIONAL DEVELOPMENT IN VERY PRETERM INFANTS C.Y. Kim; J.H. Hwang; E. Jung; B.S. Lee; K.S. Kim; A.R. Kim (Korea)
DURING EARLY INFANCY
P.H. Gray; D.M. Edwards; M. Pritchard (Australia) ID 547 CYTOKINES TRAJECTORIES IN NEWBORNS WITH HYPOXIC-ISCHEMIC
ENCEPHALOPATHY: THE ROLE OF HYPOTHERMIA
ID 323 NEUROPROTECTIVE INTERVENTION AFTER HYPOXIA-ISCHEMIA MAY S. Perrone 1; S. Cornacchione 1; M.D. Weiss 2; R. Candace 2; M. Longini 1;
CHANGE INTRACEREBRAL METABOLIC MEASURES IN A NEWBORN F. Proietti 1; M. Calderisi 1; G. Buonocore 1
PIGLET MODEL (1. Italy; 2. United States)
T.C. Andelius; N. Bgh; M.V. Pedersen; C. Omann; V.E. Hjortdal;
M. Pedersen; T.B. Henriksen; K.J. Kyng (Denmark) ID 563 COLD-INDUCIBLE RBM3 AUGMENTS IGF2 EXPRESSION IN NEURAL
STEM CELLS BY INTERACTING WITH IMP2 IN AN RNA-DEPENDENT
ID 353 BRAIN VOLUMES BY CEREBRAL MRI AND CORRELATIONS WITH MANNER
PSYCHIATRIC SYMPTOMS IN LOW BIRTHWEIGHT ADULTS J. Yan; X. Zhu; Z. Andrea; J. Kapfhammer; S. Wellmann (Switzerland)
A.M.W. Lrum; L.M. Rimol; S.K. Reitan; A. Brubakk; K.A.I. Evensen;
K.J. Bjuland; S. Lydersen; J. Skranes; M.S. Indredavik (Norway) ID 591 CHILDREN BORN VERY PRETERM WITH AUTISM EXPERIENCE
INCREASED RISK OF PARENTING RELATIONSHIP PROBLEMS
ID 371 POSTURE AND MOBILITY INFLUENCE ON ATTENTION ABILITIES IN H. Haydon; M. Pritchard; L. Johnston; J. Paynter (Canada)
HEALTHY 7 YEARS OLD CHILDREN
H. Ceyte; J. Rosenbaum; S. Caudron; J-M. Hascoet (France) ID 596 STABILITY of AUTISM DIAGNOSIS IN CHILDREN BORN VERY-PRETERM
FROM AGE 2 TO 4 YEARS
ID 424 SURGICAL DECISION MANAGEMENT IN CHIARI TYPE 2 M. Pritchard; H. Haydon; T. de Dassel; E. Beller; F. Bogossian; L. Johnston;
MALFORMATION: SINGLE CENTER EXPERIENCE J. Paynter; S. Russo; J.G. Scott (Canada)
S. Alkan Ozdemir; N. Ozdemir; A. Karadag; E. Arun Ozer (Turkey)
ID 620 OUTBORN PRETERM INFANTS WITH POST-HAEMORRHAGIC
ID 427 EFFECTS OF NEURAL STEM CELL MEDIA ON HYPOXIC INJURY IN RAT VENTRICULAR DILATATION: ARE THEY TRANSFERRED TOO LATE?
HIPPOCAMPAL SLICE CULTURES A. Parodi; M. Malova; A. Sannia; A. Cama; M. Ravegnani; C. Bellini;
N.M. Lee; S.A. Chae; H.J. Lee (Turkey) L.A. Ramenghi (Italy)
ID 438 CEREBROSPINAL FLUID LACTATE IN NEW-BORN AND PRETERM ID 631 GENETIC CASUSES IN NEWBORNS WITH EPILEPTIC ENCEPHALOPATHIES
INFANTS. PILOT DATA A. Soltirovska Salamon; D. Paro-Panjan (Slovenia)
G. Ucls; D. Arjona; R. Borrego; R. Daz; M.D. Snchez-Redondo; A. Escobar
(Spain) ID 643 OUTCOME AT FIVE YEARS OLD IN A SWISS NATIONAL COHORT OF
VERY PRETERM INFANTS BORN IN 2006
M.P. Pittet; M. Adams; M. Bickle-Graz; S. Grunt; I. Mrner-Lavanchy;
R.E. Pfister; G. Natalucci; C. Borradori Tolsa (Switzerland)
78
79
ID 680 OUTCOME PREDICTION IN HIE GRADE II NICU Quality Improvement,
K. Goeral; B. Urlesberger; V. Giordano; G. Kasprian; M. Wagner; L. Schmidt;
A. Berger; K. Klebermass-Schrehof; M. Olischar (Austria) Family Centre Care
Chairs: Hugo Lagercrantz (Sweden)
ID 696 COMPARISON OF 1-DIMENSIONAL AND 2-DIMENSIONAL
SONOGRAPHIC (US) AND MRI MEASUREMENTS OF THE CEREBELLUM ID 026 PRETERM INFANTS WITH MEDICAL COMPLEXITY: IMPATC ON HEALTH
IN TERM NEWBORNS CARE RESSOURCE USE; FAMILY EMPLOYMENT AND
B. Reulecke; R. Fernandez; M. Mills; V. Pelling; H. Rabe; L. Harris NEURODEVELOPMENTAL OUTCOMES
(United Kingdom) D. Nassel 1,2; C. Chartrand 2 ; M-J. Dor-Bergeron2; M. Ballantyne 2;
F. Lefebvre 2; T.M. Luu 2
ID 713 MILD HYPOXIC ISCHAEMIC ENCEPHALOPATHY AND LONG TERM (1. Belgium; 2. Canada)
NEURODEVELOPMENTAL OUTCOME- A SYSTEMATIC REVIEW
J. Conway 1,2; B.H. Walsh 3; M. Dozier 2; G.B. Boylan 1; D.M. Murray 1 ID 046 BREAST MILK DONATION IN THE MUSLIM POPULATION
(1. Ireland; 2. United Kingdom; 3. United States) S. Jebali; E. Ayachi; R. Terki Hassaine; A. Giuseppi; D. Vaiman; S. Brunet;
V. Rigourd (France)
ID 722 NEURODEVELOPMENTAL AND SENSORY OUTCOME AT TWO YEARS IN
VLBW BABIES: CORRELATIONS WITH BRAIN LESIONS DETECTED AT ID 065 TO DETERMINE HOW MANYMOTHERS OF PRETERM BABIES WHO WERE
TERM MRI DELIVERED BETWEEN 24 AND 34 WEEK GESTATION AND WERE
M. Malova; L. Ceschi; C. Traggiai; S. Uccella; A. Parodi; A. Sannia; L. Boeri; ADMITTED TO NEONATAL UNIT AT ST.MARYS HOSPITAL; DID NOT
E. De Grandis; M. Severino; G. Morana; D. Tortora; M.G. Calevo; A. Rossi; RECEIVE ANTENATAL STERIOD
E. Veneselli; C. Bellini; L.A. Ramenghi (Italy) Arunoday; A. Manou; I. Sadasivam (United Kingdom)
ID 818 PERSISTENT MONOCYTE AND NEUTROPHIL ACTIVATION IN SCHOOL ID 085 MOVING BABIES: A CALENDAR YEAR OF TRANSPORT TO AND FROM
AGE CHILDREN POST NEONATAL ENCEPHALOPATHY A REGIONAL NEONATAL CENTRE
Z. Zareen; V. Mc Eneaney; N.A. Taher; L. Kelly; D. Sweetman; D. Doherty; C.M. Moore; M. Cassidy; M. Byrne; A. Bowden; J. Franta; I. Farombi;
E.J. Molloy (Ireland) J.J. Fitzsimons (Ireland)
ID 831 ARE THE 2 YEAR GRIFFITHS SCORES OF BABIES WITH CBH AND IVH ID 144 REDUCING THE WASTAGE OF PAEDIATRIC RED CELLS
SIGNIFICANTLY DIFFERENT COMPARED TO THOSE OF BABIES C.C. Roehr; J. Staves; S. Hemmatpour; N. Mohanraj; S. Pavord
SUFFERING FROM ISOLATED IVH? (United Kingdom)
S. Uccella; A. Parodi; M. Malova; L. Boeri; E. De Grandis; C. Traggiai;
A. Sannia; M. Severino; G. Morana; D. Tortora; A. Rossi; E. Veneselli; ID 155 ACCURATE DETECTION OF CEREBROSPINAL FLUID FROM THE TIP OF
L.A. Ramenghi (Italy) INJEQ IQ-NEEDLE(TM) IN PEDIATRIC LUMBAR PUNCTURE
PRELIMINARY RESULTS OF CLINICAL STUDY
ID 836 INCIDENCE AND CHARACTERISTICS OF INFANTS WITH RETINOPATHY S. Halonen; J. Kari; O. Tammela; K. Kronstrm; V. Eskola (Finland)
OF PREMATURITY IN CROATIA
M. Vucinovic; L.J. Znaor; A. Vucinovic (Croatia) ID 235 CONSERVATIVE TREATMENT OF IATROGENIC PERFORATIONS
CAUSED BY GASTRIC TUBES IN EXTREMELY LOW BIRTH WEIGHT
ID 873 NEUROPROTECTIVE DRUGS IN INFANTS WITH A CONGENITAL HEART INFANTS EXPERIENCE OF A SINGLE CENTER
DISEASE REQUIRING CARDIAC SURGERY WITH CARDIOPULMONARY M. Thanhaeuser; A. Repa; A. Berger; N. Haiden (Austria)
BYPASS: A SYSTEMATIC REVIEW
R. Stegeman; K.D. Lamur; A. van den Hoogen; J. (H.) M.P.J. Breur; ID 270 SCARRED FOR LIFE?
F. Groenendaal; N.J.G. Jansen; M.J.N.L. Benders (The Netherlands) M. Kristiansen; C-A. Olsson Mgi (sweden)
ID 884 NEUROPHYSIOLOGICAL; NEURORADIOLOGICAL AND ID 272 HOW CAN NEONATAL NURSES ENHANCE PARENT-INFANT BOND BY
NEUROPATHOLOGICAL FINDINGS IN LETHAL NEONATAL RIGIDITY EMPOWERING PARENTS
AND MULTIFOCAL SEIZURES SYNDROME ASSOCIATED WITH BRAT1 M.J. Ravn; J.B. Wigdel (Norway)
MUTATIONS
M-C. Cornet; R. Schubert; E. Huang; J. Shimotake; O. Danhaive; J. McGuire; ID 348 THE EFFECT OF BATHING AT TWO DIFFERENT TIMES ON BODY
M-R. Cilio (United States) TEMPERATURE AND SKIN MOISTURE LEVEL IN NEWBORNS
D. Gzen; S. Yalnzolu aka; S. Ate Beirik; Y. Perk (Turkey)
80
81
ID 370 THE FIRST MINUTES WHEN MY EXTREMLY PRETERM INFANT WAS BORN ID 742 SHORT AND LONG TERM OUTCOMES RELATED TO
C. Israelsson; F. Thorolfson (Sweden) UMBILICAL VENOUS CATHETER PLACEMENT IN PRETERM INFANTS
L. Arques; R. del Rio; C. Balcells; E. Inarejos; V. Aldecoa-Bilbao;
ID 386 NEUROPROTECTIVE DEVELOPMENTAL CARE: STATE OF KNOWLEDGE I. Iglesias-Platas (Spain)
AND IMPLICATIONS FOR PRACTICE
A. Lavalle; G. De Clifford-Faugre; A. N. Fernandez Oviedo; C. Garcia; ID 756 ACHIEVING NORMOTHERMIA IN INFANTS ADMITTED TO THE
M. Hon; M. Aita (Canada) NEONATOLOGY DEPARTMENT-A QUALITY IMPROVEMENT PROJECT AT
THE KAROLINSKA UNIVERSITY HOSPITAL
ID 446 EVALUATION OF PROLONGED PAIN IN PRETERM INFANTS WITH K. Jonsson; A. Gudmundsdottir; A. Chakhunashvili; A-S. Ingman;
PNEUMOTHORAX USING HRV ANALYSIS AND EDIN SCORES C. Branvik-Ingelsson; E. Wilson; I. Edqvist; M. Viberg; B. Hallberg; M. Breindahl
M. Buyuktiryaki; N. Uras; N. Okur; M.Y. Oncel; G. Kadioglu Simsek; S. Isik; (Sweden)
S.S. Oguz (Turkey)
ID 776 PERSONALITY TRAITS AND STYLES OF COPING WITH STRESS AMONG
ID 487 COST-EFFECTIVENESS OF TRANSCUTANEOUS BILIRUBIN (TcB) MIDWIVES
MONITORING IN A GROWING HEALTH ECONOMY B. Zych; W. Blaz; M. Muster; M. Mazur-Magoa; G. Raba (Poland)
L. Mohammed; B.N. Ofoegbu (Saudi Arabia)
ID 784 EVALUATING MATERNAL CLOSSENESS AND SEPARATION IN NICU.
ID 495 IMPROVING THE QUALITY OF DISCHARGE IN BABIES WITH DOWN GUIDELINES FOR THE CREATION OF PERINATAL CENTERS
SYNDROME A. Karkani; K. Kwnstadinidi; M. Theodoraki; S. Gancheva; M. Papadopoulou
C.M. Moore; S.M. Eldaw; M. McCormack; J.J. Fitzsimons (Ireland) (Greece)
ID 582 NOT A MONITORING PROBE LESION ID 823 ENHANCING NEONATAL AND PARENTAL OUTCOMES THROUGH THE
A. Olariu; S.Nallagonda; J. Egyepong (United Kingdom) OPTIMIZATION OF EVIDENCE-BASED NURSING PRACTICES
M. Aita; S. Semenic; N. Feeley; L. Haiek; M. Hon; A. Larone Juneau;
ID 605 QUALITY IMPROVEMENT PROJECT: TOWARDS NEONATAL K. Levasseur; G. Roch; L. Talbot (Canada)
MANAGEMENT OF PREGNANCIES COMPLICATED BY
POLYHYDRAMNIOS ID 856 WHAT DOES THE PREMATURE BABYS PARENTS FEEL AND HOW DOES
R. Mardare; A. Olariu; M. Noureldein; J. Egyepong (United Kingdom) THEY SEE THE STAFF TAKING CARE OF THEIR CHILD?
A. Bialas (Poland)
ID 632 SITUATIONAL FAMILY INTERACTION
N. Betzelos; J. Nilsson; J. Hgstrm; M. Corrias; S. Lillieskld; M. Norman; ID 861 CROSS-CULTURAL ADAPTATION AND VALIDATION OF THE NEONATAL
K. Bohlin (Sweden) INFANT PAIN SCALE (NIPS) FOR BRAZILIAN PORTUGUESE
G. de Cssia Pinheiro da Motta; M.L. Chollopetz da Cunha (Brazil)
ID 695 MILK ANALYSIS USING MILK ANALYZERS IN A STANDARDIZED SETTING
(MAMAS) STUDY ID 864 EARLY OUTCOME OF NEONATES AFTER CONTINUOUS
G. Fusch 1; C. Kwan 1; N. Rochow 1; M. Belfort 2; J. Festival 1; A. Hair 2; AMNIOINFUSION VIA A SUBCUTANEOUSLY IMPLANTED PORT SYSTEM
J-M. Hascoet 3; T. Kuehn 4; MIRIS 5; M. Nelle 6; D. OConnor 1; G. Pelligra 1; WITH PPROM AND ANHYDRAMNIOS <28 + 0 WEEKS OF GESTATION
B. Poindexter 2; B. Urlesberger 7; A. Wesolowska 8; C. Fusch 1,4 (FIRST EXPERIENCES IN RUSSIA)
(1. Canada; 2. United States; 3. France; 4. Germany; 5. Sweden; Y. Naberezhnev 1; M. Beluga 2; O. Golovchenko 2; E. Golosovsky 2;
6. Switzerland; 7. Austria; 8. Poland) M. Tchirikov 1
(1. Germany; 2. Russia)
ID 705 A SYSTEMATIC REVIEW OF THE EFFECTIVENESS OF INTERVENTIONS
DURING NICU HOSPITALIZATION ON THE SHORT-TERM ID 865 EVALUATION OF DYNAMIC THIOL-DISULFIDE HOMEOSTASIS IN
NEURODEVELOPMENT OF PRETERM INFANTS HEALTHY VERY LOW BIRTH WEIGHTED PRETERMS
M. Aita; R. Stremler; N. Feeley; A. Lavalle; G. De Clifford-Faugre (Canada) S. Unal; D. Ulubas Isik; A. Yagmur Bas; S. Erol; . Arifoglu; M. Alisik; O. Erel;
N. Demirel (Turkey)
ID 731 SAFETY CULTURE ASSESSMENT IN A NEONATAL UNIT FOLLOWING A
PLAN TO IMPROVE PATIENT SAFETY ID 867 THE EFFECT OF THE MODE OF DELIVERY ON THE MATERNAL AND
M. Arriaga-Redondo; A. Rodriguez-Sanchez de la Blanca; E. Sanz-Lopez; NEONATAL DYNAMIC THIOL-DISULFIDE HOMEOSTASIS
A. Diaz-Redondo; R. Gregorio-Hernandez; P. Chimenti-Camacho; D. Ulubas Isik; Y. Akda Reis; A. Yagmur Bas; S. Unal; B. zcan;
M. Sanchez-Luna (Spain) L. Mollamahmutoglu; S. Neelioglu; O. Erel4; N. Demirel (Turkey)
82
83
ID 870 READMISSION RATES IN THE FIRST MONTH FOLLOWING DISCHARGE ID 355 INFANTS AND MATERNAL OUTCOME OF PREGNANCIES
AMONG BABIES DISCHARGED FROM THE NEONATAL SERVICE: COMPLICATED BY H1N1 INFECTION NEEDING ECMO THERAPY:
A SINGLE CENTRE EXPERIENCE A UK ECMO CENTRE EXPERIENCE
R. Calthorpe; A.M. Mustafa Kamal; D. Jayasinghe (United Kingdom) N. Singh; J. Behrsin; F. Siddiqui; R. Porter; M. Charlton; A. Akuma; S. Mittal
(United Kingdom)
ID 871 SOUNDS MEASUREMENTS IN A WARD TO IMPROVE THE NICU
ENVIRONMENT ID 447 THE ASSOCIATION OF NEONATAL MORBIDITIES AND MORTALITY OF
A-A. Vinaixa Vergs; J. Romeu Garb; M. Nicolau Manzano; PRETERM INFANTS WITH DIFFERENT COURSES OF ANTENATAL STEROIDS
P. Morales De Mata; R. Puigarnau Vallhonrat; E. Quintana Rio; M. Buyuktiryaki; F.N. Sari; H. Bezirganoglu; N. Okur; E. Alyamac Dizdar;
A. Mirada Vives (Spain) N. Uras; F.E. Canpolat; S.S. Oguz (Turkey)
ID 872 REFERRAL REASONS AND OUTCOMES OF NEWBORN INFANT ID 475 REFERRAL CASE OF NEONATAL ADMISSION AND OUTCOME AT
PHYSICAL EXAMINATION HIP REFERRALS NEONATAL UNIT IN TERTIARY HOSPITAL IN LOW-MIDDLE INCOME
J. Hussain (United Kingdom) COUNTRY
P.M.T. Marsubrin; E. Ameliana; R. Sari; R. Rohsiswatmo (Indonesia)
ID 883 EFFICACY OF INTRAVENOUS; ENDOTRACHEAL OR NASAL
ADRENALINE ADMINISTRATION DURING RESUSCITATION OF ID 479 MONITORING AND ASSESMENT OF NEONATAL CARE IN KYRGYZSTAN
NEAR-TERM ASPHYXIATED LAMBS S.Abduvalieva; C.Rakmanova; G.Jumagulova; E. Jumalieva (Kyrgyzstan)
N.T. Songstad 1; C. Klingenberg 1; K.J. Crossley 2; E.V. McGillick 2;
G.R. Polglase 2; P.G. Davis 2; S.B. Hooper 2 ID 561 EVOLUTION OF PERINATAL MANAGEMENT AT THE LIMIT OF VIABILITY
(1. Norway; 2. Australia) IN THE LAST DECADE
S. Zeballos Sarrato; C. Ramos Navarro; G. Zeballos Sarrato; N. Navarro;
M. Snchez-Luna (Spain)
Perinatal Practices
Chairs: Pierre Kuhn (France); Shoo Lee (Canada) ID 649 EARLY ONSET INTRAUTERINE GROWTH RESTRICTION: AN INDEPENDENT
RISK FACTOR FOR POOR PERINATAL OUTCOME IN VERY PRETERM
ID 054 VACUUM EXTRACTION AND RISK OF NEONATAL COMPLICATIONS: INFANTS?
A POPULATION-BASED COHORT STUDY T.D. Nguyen; D. Bassler; N. Ochsenbein-Klble; G. Natalucci (Switzerland)
D. Rossetti; AS Lagan; G. Valenti; B. Chiofalo; S. Buttic; G. Sanpietro;
A.M.C. Rapisarda; F. Sapia; M. Noventa; A. Vitagliano; S.G. Vitale (Italy) ID 651 THE EFFECT OF GENDER ON NEONATAL MORBIDITIES AND MORTALITY
ON TWIN PAIRS
ID 109 ELECTIVE CAESAREAN SECTION AND RESPIRATORY MORBIDITIES IN B. Ozer Bekmez; H. G. Kanmaz Kutman; C. Tayman; M. Buyuktiryaki (Turkey)
TERM INFANTS
P. Mallya; S. Garg (United Kingdom) ID 679 IS FETAL ARTERIAL AND VENOUS DOPPLER VELOCIMETRY
MANDATORY IN THE CASE OF THE IUGR RISK PREGNANCIES?
ID 124 CESAREAN DELIVERY AMONG FOREIGN-BORN CHINESE AND US M. Tunescu; G. Olariu; A. Ratiu; D. Bujorescu (Romania)
BORN-CHINESE WOMEN IN THE U.S
T.A. Yen 1; M. Lahiff 2; N. Hosang 2; E. Brenda 2 ID 710 IN VITRO FERTILIZATION - NEONATAL OUTCOME
(1. Taiwan; 2. United States) M.L. Ognean; R. Chicea; R. Dumitra; O. Boant; M. Codru (Romania)
ID 170 RISK FACTORS AND OUTCOME IN PREVIABLE PPROM AND CURRENT ID 732 NEONATAL JAUNDICE AND PHOTOTHERAPY: ARE WE DOING IT
TREATMENT PRACTICE RIGHT? - A RETROSPECTIVE STUDY
A. van Gennip; E.E.M. Mulder; R.M. Brohet; J. van Eyck; R.A. van Lingen M. Nogueira; C. Teles Silva; A. Reis e Melo; M. Rosrio; J. Santos Silva;
(The Netherlands) G. Silva; H. Guimares (Portugal)
ID 303 ASSESSMENT OF FUNCTIONAL STATUS IN PRETERM INFANTS: ONLINE ID 768 REVIEW OF OUTCOMES OF BABIES WITH BIRTH WEIGHT LESS THAN 500
SURVEY TO INFORM SCORING OF A CLINICIAN-REPORTED GRAMS IN A NEONATAL INTENSIVE CARE UNIT
OUTCOMES (CLINRO) TOOL N. Gulati; N. Mahalingam; S. Vishna Rasiah; A. Singh (United Kingdom)
M. Turner 1; I. Hansen-Pupp 2; J. Higginson 3; R. Ward 3; M. Vanya 3;
E. Flood 3; E. Schwartz 3; H. Doll 3; A. Tocoian 4; A. Mangili 3; N. Barton 3;
S. Sarda 3 (1. United Kingdom; 2. Sweden; 3. United States; 4. Switzerland)
84
85
9:00 - 11:00 PARALLEL SESSION 24 |DARSENA ROOM 9:00 - 11:00 PARALLEL SESSION 25 (BRAIN 5)
STRESS AND DEVELOPMENT NEUROPROTECTION, EPO TRIAL |VENEZIA ROOM
Chairs: Petra Hppi (Switzerland); Aijaz Farooqi (Sweden) Chairs: Nicola Robertson (United Kingdom); Ivo Bendix (Germany)
09:00 - 09:20 Prenatal stress and its effects on the fetus and the child 09:00 - 09:20 Current global issues for optimising brain protection of the
Francesca Cirulli (Italy) term infant
Nicola Robertson (United Kingdom)
09:20 - 09:40 Stress in health and disease; stress, learning and plasticity
Marian Joels (The Netherland) 09:20 - 09:40 Preterm Epo Neuroprotection: the PENUT Trial
Sandra Juul (United States)
09:40 - 09:55 Differentiating the preterm phenotype: distinct profiles of
development after late and moderately preterm birth 09:40 - 09:55 A mixed lipid emulsion rich in docosahexaenoic acid
S. Johnson; G. Waheed; B. N. Manktelow; D. Field; N. Marlow; (DHA)- and its effect on brain maturation in extremely low
E.S. Draper; E.M. Boyle (United Kingdom) birth weight infants
C. Binder 1; A. Repa 1; V. Giordano 1; M. Thanhaeuser 1; A. Kreissl 1;
09:55 - 10:10 Prenatal methadone exposure and neurodevelopmental N. Haiden 1; A. Berger 1; N. Longford 2; K. Klebermass-Schrehof 1
and neuroimaging outcomes: a systematic review (1. Austria; 2. United Kingdom)
V. Monnelly; R. Hamilton; F. Chappell; H. Mactier; J. Boardman
(United Kingdom) 09: 55 - 10:10 Thrombocytopenia is associated with severe retinopathy of
prematurity clinically; in mice platelet transfusion suppresses
10:10 - 10:25 Atypical brain development associated with prenatal retinopathy
methadone exposure P. Lundgren 1; R. Liegl 2; S. Klevebro 3; G. Hellgren 1; C. Lfqvist 1;
V. Monnelly; D. Anblagan; A. Quigley; E. Cooper; H. Mactier; C. Mannheimer 1; Y. Sun 2; Z-J. Liu 2; M.C. Sola-Visner 2;
S. Semple; M. Bastin; J. Boardman (United Kingdom) B. Hallberg 1; L.E.H. Smith 2; A. Hellstrm 1
(1. Sweden; 2. United States)
10:25 - 10:40 Epigenetic differences in cord blood of newborns exposed
to antidepressant medication during pregnancy a study in 10:10 - 10:25 Peripheral T-cell depletion by fingolimod is associated with
the Aarhus birth cohort exacerbated hypoxic-ischemic brain injury in neonatal
A-C. Viuff 1; G.C. Sharp 1; L.H. Pedersen 1,2; N.H. Staunstrup 2; mice
K.J. Kyng2; D. Rai 3; C.L. Relton 1; T.B. Henriksen 1,2 I. Bendix; M. Crasmller; C. Kster; M. Serdar; U. Felderhoff-Mser;
(1. United Kingdom; 2. Denmark) J. Herz (Germany)
10:40 - 10:55 Mental health in adolescents born at 23-25 weeks of 10:25 - 10:40 Intranasally applied mesenchymal stem cells migrate to
gestation injured brain regions of newborn non-human primates
A. Farooqi; M. Samuelsson; A. Holsti; M. Adamsson; F. Serenius; N. Wagenaar 1; F. van Bel 1; M.J.N.L. Benders 1; C. Blanco 2;
B. Hgglf (Sweden) D. McCurmin 2; S. Mustafa 2; F. Groenendaal 1; L. de Vries 1;
C. Heijnen 2; C. Nijboer 1
(1. The Netherlands; 2. United States)
10:40 - 10:55 Maternal swimming during pregnancy protects the neonatal

rat brain from hypoxic-ischemic injury
E.F. Sanches; Y. van de Looij; A. Silva; J. Romero; S.V. Sizonenko
(Switzerland)
86
87
9:00 - 11:00 PARALLEL SESSION 26 (PHARMA 2)|ROMA ROOM 9:00 - 11:00 PARALLEL SESSION 27 (CIRCULATION 3)
NEW INSIGHTS IN FUTURE NEONATAL CARE TRAINING GUIDELINES FOR NEONATOLOGIST PERFORMED
Chairs: Sinno Simons (The Netherlands); Eugene Dempsey (Ireland) ECHOCARDIOGRAPHY (NPE) - AN INTERCONTINENTAL DEBATE
|SORRENTO ROOM
09:00 - 09:20 Tick-tock pharmacotherapy and our body clock Chairs: Willem de Boode (The Netherlands);
Bert van der Horst (The Netherlands) Colm Breatnach (Ireland)
09:20 - 09:40 Chronobiology in neonatology 09:00 - 09:20 The North-American perspective

Irwin Reiss (The Netherlands) Patrick McNamara (Canada)
09:40 - 09:55 Late cord clamping trial
09:20 - 09:40 The Australian perspective
William Tarnow-Mordi (Australia)
Nick Evans (Australia)
09:55 - 10:10 Pharmacokinetic and pharmacodynamic studies aiming for
09:40 - 10:00 The United Kingdom perspective
rational drug dosing in preterm neonates: the DINO study
Yogen Singh (United Kingdom)
R.B. Flint; S. Vller; R. de Groot; D. Liem; P. Andriessen;
P. Degrauewe; I. Reiss; D. Burger; D. Tibboel; C.A.J. Knibbe;
S.H.P. Simons; DINO Research group (The Netherlands)
10:00 - 10:20 The European perspective
10:10 - 10:25 Fentanyl for procedural pain in preterm newborn infants
a pharmacokinetic and pharmacodynamic study 10:20 - 10:35 Incidental findings on routine targeted neonatal
E. Norman 1; J.M. Kindblom 1; A-C. Berg 1; C. Halzius 1; G. Printz 1; echocardiography performed in preterm infants less
A. Rane 1; H. Lagercrantz 1; B. Hallberg 1; V. Fellman 2 than 29 weeks gestation
(1. Sweden; 2. Finland) A. Smith; C.R. Breatnach; A.T. James; O. Franklin; A. El-Khuffash
(Ireland)
10:25 - 10:40 Big data analyses for continuous evaluation of
pharmacotherapy: a proof of principle with doxapram for 10:35 - 10:50 Emerging quantitative echocardiographic markers of
preterm infants pulmonary vasculae disease and right ventricular
R.B. Flint; W. van Weteringen; S. Vller; J. Poppe; B. Koch; dysfunction in extreme preterm infants with late pulmonary
R. de Groot; D. Tibboel; C. Knibbe; I. Reiss; S.H.P. Simons; hypertension
DINO Research group (The Netherlands) P. Levy 1; C. Brennan 1; M. Patel; S. Choudhry 1; A.A. Sanchez 1;
A. EL-Khuffash 2; C. Breatnach 2; O. Franklin 2; A. Hamvas 1;
10:40 - 10:55 Ibuprofen pharmacogenetic study in human milk Samples S. Gautam 1
V. Rigourd; C. Verstyuft; J.F. Mritet; P. Seraissol; B. De Villepin; (1. United States; 2. Ireland)
A. Amirouche; R. Serreau (France)
10:50 - 11:00 Novel methods to characterize right ventricular -
pulmonary arterial coupling in extreme preterm infants with
late onset pulmonary hypertension
P. Levy; M. Patel; S. Choudhry; M. Holland; T. Sekarski; A. Hamvas;
G. Singh (United States)
88
89
9:00 - 11:00 PARALLEL SESSION 28 (EFCNI 4) |LECCE ROOM 11:30 12:30 IPRF PLENARY SESSION 6 |DARSENA ROOM
MEASURING QUALITY OF CARE IN NEONATAL CARE Chairs: Heike Rabe (United Kingdom);
Chairs: Boubou Hallberg (Sweden); Silke Mader (Germany); Topun Austin (United Kingdom)

09:00 - 09:20 Value based health care and improvement of health in the 11:30 12:00 Human cerebral organoids as a new tool to study human
very youngest infants neocortex development
Boubou Hallberg (Sweden) Wieland Huttner (Germany)
09:20 - 09:40 Nature and nurture improving quality of care in a genetic 12:00 12:30 From Population and Personalized Genomics to Personalized
cohort study Medicine
Wolfgang Gpel (Germany) Manolis Dermitzakis (Switzerland)
09:40 - 09:55 The implementation of the close collaboration with parents

training program in 5 neonatal units - a qualitative study
M. Toivonen; L. Lehtonen; S. Ahlqvist-Bjrkroth; A. Axelin (Finland) 12:30 12:45 ESPR AWARDS SESSION |DARSENA ROOM
Chairs: Charles C. Roehr (United Kingdom);
09:55 - 10:10 A pilot study assessing the effectiveness of a family- Luc Zimmermann (The Netherlands)
centered care intervention in preterm infants in China
R. Zhang 1; R. Huang 1; X. Gao 1; X. Peng 1; L. Zhu 1; Young Investigator Awards
R. Ramanathan 2; J. Latour 1,3 ESPR Research Grants 2017
(1. China; 2. United States; 3. United Kingdom)
10:10 - 10:25 Core outcomes in neonatology: preliminary results

J.W.H. Webbe; N. Modi; C. Gale On behalf of the
COIN Steering Group (United Kingdom)
10:25 - 10:40 Close collaboration with parents intervention prevents Human Milk Fortification: Benefits of an
13:30 - 15:00
prolonged maternal postpartum depressive symptoms
S. Ahlqvist-Bjrkroth; A. Axelin; R. Korja; M. Huhtala; L. Lehtonen Exclusive Human Milk Diet for Premature
(Finland) Infants |VENEZIA ROOM
Industry supported session - please see page 125
10:40 - 10:55 Reducing medication errors on NICU - Chairs: Victoria Niklas (United States); Enrico Bertino (Italy)
a quality improvement project
D.A. Al Masri; B. Ofoegbu; L. Yahya; K. Catroon; A. Saliba; 13:30 - 13:40 Introduction to human milk in the NICU - use and challenges
H. Ibrahim (United Arab Emirates) Enrico Bertino (Italy)
13:40 - 14:10 Science and clinical impact of human breast milk feeding
for premature infants
11:00 - 11:30 COFFEE BREAK Alan Lucas (United Kingdom)
14:10 - 14:40 Clinical benefits of an exclusive human milk diet in

premature infants
Sergio Golombek (United States)
14:40 - 15:00 Conclusion and discussion

Victoria Niklas (United States)
90
91
13:30 - 15:00 POSTER SESSION 11 (NEUROLOGY 2) |FIRENZE ROOM 14:10 - 14:15 Reduced prevalence of severe intraventricular
hemorrhage in very preterm infants delivered after
Chairs: Pierre Gressens (France); Ola D. Saugstad (Norway)
maternal pre-eclampsia
E. Morsing; K. Marl; D. Ley (Sweden)
13:30 - 13:35 Impact of parturition on maternal neuronal integrity
K.S. Evers 1; S. Fouzas 2; C. Barro 1; J. Kuhle 1; U. Fisch 1; 14:15 - 14:20 Neurodevelopment in 7-year old children born with
O. Lapaire 1; S. Wellmann 1 marginally low birth weight
(1. Switzerland; 2. Greece) J. Starnberg; M. Norman; B. Westrup; M. Domellf; S.K. Berglund
(Sweden)
13:35 - 13:40 Mild germinal matrix-intraventricular hemorrhage in preterm
infants: anatomical insights provided by SWI-venography
D. Tortora 1; M. Malova 1; M. Severino 1; A Parodi 1; G. Morana 1; 14:20 - 14:25 Performance of the German version of the PARCA-R
P. Govaert 2; J.J. Volpe 3; A. Rossi 1; L.A. Ramenghi 1 questionnaire as a cognitive screening tool in very preterm
(1. Italy; 2. Belgium; 3. United States) infants at 2 years of corrected age
G. Natalucci; N. Bechtel; C. Borradori-Tolsa; M. Bickle-Graz;
13:40 - 13:45 Association between transient neonatal hypoglycemia and M. Adams; S. Grunt for the Swiss Neonatal Network & Follow-Up
adverse neurological development at 2-6 years of age Group (Switzerland)
R. Wickstrm 1; B. Skild 1; G. Petersson 2; O. Stephansson 1;
M. Altman 1,2 (1. Sweden; 2. Italy) 14:25 - 14:30 Cold-inducible RBM3 promotes neurogenesis after brain
hypoxic-ischemia/reperfusion injury
13:45 - 13:50 Neurofilament serum levels as biomarker of neuronal injury X. Zhu; C. Brgre; J. Yan; U. Fisch; J. Kapfhammer; R. Guzman;
in very preterm born infants S. Wellmann (Switzerland)
A. Depoorter; C. Barro; R. Neumann; J. Kuhle; S. Wellmann
(Switzerland) 14:30 - 14:35 Monitoring the energy metabolism in plasma from
newborns with hypoxic-ischemic encephalopathy (HIE)
13:50 - 13:55 Effect of dehydroepiandrosterone and its sulfate ester on during therapeutic hypothermia
neonatal hypoxic-ischemic brain injury preliminary data . Snchez-Illana; A. Nez-Ramiro; M. Cernada; A. Parra;
A. Posod; M. Lachinger; B. Vejnoska; E. Huber; M. Urbanek; E. Valverde; D. Blanco; M.T. Moral-Pumarega; F. Cabaas; H. Boix;
U. Kiechl-Kohlendorfer; E. Griesmaier (Austria) A. Pavon; M. Chaffanel; I. Benavente-Fernndez; I. Tofe;
B. Loureiro; JR. Fernndez-Lorenzo; B. Fernndez-Colomer;
13:55 - 14:00 Long-term neurodevelopmental outcomes among young J. Kuligowski; M. Vento Torres and the HYPOTOP Study Group
adults born preterm (Spain)
M. Tei; S. Negro; M.C. Muraca; M.G. Gatti; D. Urilli; G. Buonocore;
S. Perrone (Italy) 14:35 - 14:40 Decreased impact of poor weight gain as a predictor for
ROP after implementation of higher oxygen saturation
14:00 - 14:05 Genetic contributions to the development of intraventricular targets
hemorrhage in preterm newborns P. Lundgren 1; AL. Hrd 1; . Wilde1; C. Lfqvist 1; L.E.H. Smith 3;
D. Szpecht; J. Gadzinowski; A. Seremak-Mrozikiewicz; A. Hellstrm 1
G. Kurzawiska; K. Drews; M. Szymankiewicz (Poland) (1. Sweden; 2. United States)
14:05 - 14:10 Neurodevelopment follow-up for high-risk babies in

liverpool: a qualitative study. foundation study follow-up for
neurodevelopmentally at risk infants of neonatal care
A. Komoriyama; F. Paize; C. Dewhurst; M. Gladstone
(United Kingdom)
92
93
13:30 - 15:00 POSTER SESSION 12 (EPIDEMIOLOGY 2) 14:10 - 14:15 Femoral pulse examinations ability to predict
coarctation of the aorta
|SORRENTO ROOM
F. Khammari Nystroem; S. Johansson; O. Stephansson;
Chairs: Thomas Williams (United Kingdom) M. Altman (Sweden)
Anne-Cathrine Finnemann Viuff (Denmark)
14:15 - 14:20 Variations in initial oxygen concentration at resuscitation
13:30 - 13:35 Incidence of bronchopulmonary dysplasia and of preterm neonates <29 weeks gestation: an international
intraventricular haemorrhage among extremely preterm survey
infants in Europe: a systematic literature review K. Lui 1; M. Vento Torres 2; A. Noguchi 3; S. Hakannson 4;
C. Siffel; K. Kistler; J. Lewis; S. Sarda (United States) B. Reichman 5; P. Shah 6; G. Sjrs 4; F. Rusconi 7; M. Adams 8;
S. Lee 6; L. Lehtonen 9; S. Kusuda 10; T. Isayama 6; N. Modi 11;
13:35 - 13:40 Chronic conditions and health care needs of adolescents D. Bassler 6; M. Beltempo 6; K. Helenius 9; N. Morisaki 10 ;
born moderately preterm at 32-26 weeks gestation: B.A. Darlow 12 (1. Australia; 2. Spain; 3. United States; 4. Sweden;
a Swedish regional population based case control study 5. Israel; 6. Canada; 7. Italy; 8. Switzerland; 9. Finland; 10. Japan;
A. Farooqi; A. Sjstrm; M. Adamsson; M. Bckman; B. Hgglf 11. United Kingdom; 12. New Zealand)
(Sweden)
14:20 - 14:25 Morbidity, mortality and 2-year outcome of babies born with
13:40 - 13:45 A registry-based descriptive analysis of end stage renal birth weight 500g over 11 years in a tertiary neonatal unit
disease and renal replacement therapy in Swedish neonates M. Noureldein; A. Olariu; J. Egyepong (United Kingdom)
S. Nolbrant; O. Andersson; B. Hallberg; L. Sartz (Sweden)
14:25 - 14:30 Trends in mortality rates at the limit of viability in the last
13:45 - 13:50 Preterm childrens social inhibition before school entry decade
predicts their friendships in 2nd grade A. Rodriguez Snchez de la Blanca; S. Zeballos Sarrato;
J. Jaekel 1,2; K. Heuser 3; L. Miranda 1; D. Wolke 2 G. Zeballos Sarrato; I. Pescador Chamorro; A. Rodriguez;
(1. United States; 2. United Kingdom; 3. Germany) S. Villar Castro; M. Snchez-Luna (Spain)
13:50 - 13:55 Children with cerebral palsy (non-post-neonatal) born at 14:30 - 14:35 Applying data mining techniques to predict
term, non-admitted to neonatal intensive care, from the bronchopulmonary dysplasia in very-low-birth-weight
Portuguese national register (VLBW) infants- a population-based study
D. Virella; T. Folha; M.G. Andrada; A. Cadete; R. Gouveia; T. Gaia; Y.J. Lin; C.H. Lin; Y.C. Lin; Y.S. Chang; C.C. Huang; K.I. Tsou (Taiwan)
J.J. Alvarelho; E. Calado (Portugal)
14:35 - 14:40 Caregiver burden associated with extremely preterm birth
13:55 - 14:00 Risk factors associated with mortality at the limit of viability S. Sarda; W. Lenderking; R. Pokrzywinski; S. Stringer; A. Mangili
S. Zeballos Sarrato; N. Gonzlez Pacheco; I. Pescador Chamorro; (United States)
A. Rodriguez Snchez de la Blanca; M. Snchez-Luna (Spain)
14:40 - 14:45 The gestation study deep machine learning algorithm for
14:00 - 14:05 Epidemiology of esbl-producing multidrug-resistant accurate postnatal gestational age assessment
gram-negative bacilli in three NICUs in Italy C. Henry; C. Ward; M. Torres Torres; M. Valstar; D. Sharkey
D. Vecchio; L. Saporito; C. Achille; D.M. Geraci; S. Giampietro; (United Kingdom)
M. Trancassini; C. Tzialla; C.M. Maida; M. Mario (Italy)
14:45 - 14:50 A systematic review of incidence of neonatal necrotising
14:05 - 14:10 Temporal trends in preterm infant mortality over the last 15 enterocolitis in high income countries
years (2001-2015), with particular reference to 23 week C. Battersby; T. Santhalingam; K. Costeloe; N. Modi
gestation infants. Results from a UK single centre case series (United Kingdom)
with comparison to the Vermont Oxford network
A. Doerr; D. Odd (United Kingdom) 14:50 - 14:55 Impact of elective caesarian section on neonatal retrieval
in Western Australia during a 12 year period
A. Tho; S. Resnick; J.W. Davis (Australia)
94
95
13:30 - 15:00 POSTER SESSION 13 (NUTRITION 2) |FIRENZE ROOM 14:15 - 14:20 Use of pasteurised human donor milk in England
C. Battersby; R. Marciano Alves Mousinho; N. Longford;
Chairs: Umberto Simeoni (Switzerland); Petteri Hovi (Finland)
N. Modi for the UK Neonatal Collaborative Necrotising
Enterocolitis (UKNC-NEC) Study Group (United Kingdom)
13:30 - 13:35 Individualized fortification of human milk improves nutritional
supplies and growth in preterm infants 14:20 - 14:25 Neonatal body composition of infants born to mothers with
V. de Halleux; C. Pieltain; T. Senterre; F. Studzinski; J. Rigo (Belgium) gestational diabetes mellitus
FA.M. Pavel; M. ORiordan; L. Culliney; T. Nabialek;
13:35 - 13:40 Birth weight percentiles based on maternal height are J. De Meulemeester; F. Caulfield; A. Stanescu; Z. Coffrey; D. Coffey;
universally applicable and valid for different ethnic groups A. Doolan (Ireland)
D. Olbertz 1; N. Rochow 2; M. Al Samnan 2; J. Dbritz 1;
R. Hentschel 1; U. Wittwer-Backofen 1; M. Voigt 1 14:25 - 14:30 Current practice and beliefs: survey of breast milk handling
(1. Germany; 2. Canada) routines in German, Swiss and Austrian neonatal units reveals
large centre specific differences
13:40 - 13:45 Comparison of the postnatal catch up growth according to D. Klotz; S. Jansen; H. Schneider; C. Gebauer; H. Fuchs (Germany)
the definition of small for gestational age infants
J. Huh; J.Y. Kwon; E.H. Lee; H.R. Kim; K.H. Lee (Korea) 14:30 - 14:35 Variability in the protein and fat content of the donor
human milk supply revealed by mid-infrared spectrometer
13:45 - 13:50 Measuring postnatal growth: a comparison of neonatal analysis: a fist step towards preventing disruption of
growth using international intergrowth-21st standards and per natal programming
established UK charts V. Rigourd; Z. Assaf; A. Lapillonne; J.F. Magny (France)
O.M. Bendor-Samuel; S. Zivanovic; C.C. Roehr (United Kingdom)
14:35 - 14:40 Decreasing extrauterine growth restriction in very low birth
13:50 - 13:55 Human milk and human milk derived products: how weight (VLBW) infants after implementation of a nutritional
bioactive component analysis may inform clinical outcomes protocol
in the NICU J.A. Asaro; R. Snyder; C. Aikey; I. Griffin; A. Herdt; M. Rogido
V. Niklas; D. Rechtman; M. Lee; A. Lebouedec; A. Sun (United States)
(United States)
13:55 - 14:00 Effect of a nationwide program for promoting breastfeeding

in-hospital in China 13:30 - 15:00 POSTER SESSION 14 (LUNG 4)|SORRENTO ROOM
Y. Zhang; H.S. Wang; X. Jin; B. Cao; D.H. Wang; M. Jiang; L.X. Wang; Chairs: Kajsa Bohlin (Sweden); Kerstin Jost (Switzerland)
S.M. Wang; W.W. Feng; L.M. Yao (China)
13:30 - 13:35 Perinatal inflammation and intrauterine growth retardation
14:00 - 14:05 Association between maternal knowledge on breastfeeding are both associated with lung function impairment at 12
and the assessment of the newborns latch in a maternity years of age in very preterm infants
center in the university hospital of the south region of Brazil C. Hagman; L.J. Bjrklund; E. Tufvesson; I. Hansen Pupp (Sweden)
S.S. Nader; P.J.H. Nader; N.T. Canabarro (Brazil)
13:35 - 13:40 Early predictive factors for insure failure in the management
14:05 - 14:10 Prevalence of breastfeeding at 6th months in sick neonates of preterm infants with neonatal respiratory distress
S. Kositamongkol; K. Moungsuwan (Thailand) syndrome: a systematic review
B. De Bisschop; F. Derriks; F. Cools (Belgium)
14:10 - 14:15 Is there any association between lamellar body counts and
cord blood vitamin d levels of term and late preterm infants
N.Okur; H.G. Kanmaz; M. Buyuktiryaki; H. Bezirganoglu;
G. Kadioglu Simsek; F.E. Canpolat; N. Uras; S.S. Oguz (Turkey)
96
97
13:40 - 13:45 Outcomes of postnatal hydrocortsone therapy n preterm 14:30 - 14:35 Protocolized weaning in mechanical ventilation
infants wth bronchopulmonary dysplasa: experence n a B. Bol 1; H. van Zanten 1; J. Wielenga 1; A. vd Hoogen 1;
tertary center P. Mansvelt 1; B. Blackwood 2; O.K. Helder 1
M. Buyuktiryaki; E. Alyamac Dizdar; N. Okur; H. Bezirganoglu; (1. The Netherlands; 2. United Kingdom)
F.N. Sari; N. Uras; F.E. Canpolat; S.S. Oguz (Turkey)
14:35 - 14:40 NEO (Neonatal Esophageal Observation) Tube -
13:45 - 13:50 Maternal preeclampsia and the risk of respiratory distress a feeding tube with monitoring function
syndrome in VLBW infants P. Simmen; B. Jesacher; P-A. Tran; L. Suter; A. Haeberlin;
T.A. Yen; Y.H. Wen; H.I. Yang; W.S. Hsieh; H.C. Chou; C.Y. Chen; S.M. Schulzke; T. Niederhauser; K. Jost (Switzerland)
K.I. Tsou; P.N. Tsao (Taiwan)
14:40 - 14:45 Helping babies breathe, second edition: strengthening the
13:50 - 13:55 Comparison of RSV hospitalisation in preterm infants with program to increase global newborn survival
chronic lung disease who do not qualify for palivizumab B. Kamath-Rayne 1; M. Visick 1; W. Keenan 1; G. Little 1;
prophylaxis with those who qualify in Nottingham, UK N. Singhal 2; S. Niermeyer 1
S. Tsilika; D. Batra (United Kingdom) (1. United States; 2. Canada)
13:55 - 14:00 The effect of antenatal steroid on different gestational age of 14:45 - 14:50 Ventfirst: a multicenter RCT of assested ventilation during
VLBW infant - a population study delayed cord clamping for extremely preterm infants
Y-T. Chen; S-Y. Liu; H-I Yang; C-Y. Chen; H-C. Chou; W-S. Hsieh; K. Fairchild; S. Niermeyer; J. Winter; C. Chisholm; J. Kattwinkel;
K-I. Tsou; P-N. Tsao (Taiwan) on behalf of the VentFirst Steering Committee (J. Fang,
C. Colby; J. Barry; M. Al-Hosni; M. Strand; T. Gorman; L. van Marter;
14:00 - 14:05 Effects of passive smoking on lung function tests in preschool R. Schelonka; J. Warren; S. Thomas; G. Schmolzer; A. Camblos;
children born late-preterm S. Fowler; M. Haynes; G. Petroni; M. Thielen) (United States)
A. Gnlemez; I. Er; C. Baydemir; A.E. Arsoy; A.S. Gkalp (Turkey)
14:50 - 14:55 Inhaled nitric oxide improves survival in preterm infants
14:05 - 14:10 Transfusion-related acute lung injury in (pre)term infants in diagnosed with pulmonary hypoplasia
the neonatal intensive care K.R. Ellsworth; M. Ellsworth; L. Sangaralingham; R. Clark; G. Asay;
M. van Tuyl; L. Snoek; R.M. Wsten-van Asperen; C. Colby; W.A. Carey (United States)
A.H.L.C. van Kaam; W. Onland (The Netherlands)
14:55 - 15:00 Inhaled nitric oxide in congenital diaphragmatic
hernia results from the European inhaled nitric oxide
14:15 - 14:20 Lung ultrasound for the diagnosis of pulmonary registr
consolidations in patients with bronchopulmonary dysplasia R. Kettle; N.V. Subhedar (United Kingdom)
I. Koltunov; M. Degtyareva; A. Mazaev; A. Gorbunov; A. Erokhina
(Russia)
14:20 - 14:25 Bedside lung ultrasonography for the diagnosis of neonatal

respiratory distress in the first 24 hours of life
I. Corsini; N. Parri; E. Gozzini; C. Coviello; V. Leonardi; C. Poggi;
M. Giacalone; T. Bianconi; L. Tofani; C. Dani (Italy)
14:25 - 14:30 Is the double lung point an accurate diagnostic marker for
TTN? A prospective, international study
F. Migliaro; N. Yousef; J. Rodriguez Fanjul; D. De Luca; I. Corsini;
C. Dani; V. Di Guardo; M. Giampietri; L. Capasso; A. Sodano;
F. Raimondi (Italy)
98
99
13:30 - 15:00 POSTER SESSION 15 (ETHICS + PERINATAL PRACTICE) 15:40 - 15:55 Neonatal neuroimaging in symptomatic
congenital CMV (cCMV) and its correlation with
|LECCE ROOM
outcome: emphasis on white matter disease
Chairs: Sandra Horsch (Germany); Gorm Greisen (Denmark) A. Alarcon 1,2; A. Garcia-Alix 2; M. Martinez-Biarge 3;
I. van Straaten 3; F. Cabaas 2; J. Quero 2; L. de Vries 3
13:30 - 13:35 Changing parental perceptions in trisomies a potential (1. United Kingdom; 2. Spain; 3. The Netherlands)
ethical dilemma for neonatologists?
E.A. Simons; P. Nath; P. Parthasarathy (United Kingdom) 15:55 - 16:10 Postnatal MR-imaging and ADC measures in congential
cytomegalovirus infection provide an added diagnostic
13:35 - 13:40 Evaluation of parental informed consent procedure in value on cerebral ultrasound in characterizing white matter
neonatal intensive care unit disease
E.(P.G.) van t Verlaat; E. de Kort; I. Reiss; M. van Weissenbruch; C. Martins 1; J. Schneider 2; M. Bickle Graz 1; M. Kobas 1; S. Asner 1;
S.H.P. Simons (The Netherlands) A.C. Truttmann 1
(1. Switzerland; 2. Canada)
13:40 - 13:45 Alarm visibility and infusion continuity: environmental
change and technology assistance 16:10 - 16:25 Hyperechogenicity of the lenticulostriate arteries: incidense
M. Bastanie; H. Blom; L. Mahieu; M. Meeus; S. Laroche; and clinical impact in a tertiary NICU
D. Van Laere; M. Voeten; V. Demeulemeester; R. Vermeulen; P. Triantafyllidou; M. Papadopoulou; S. Gantseva-Patsoura;
A. Mulder (Belgium) F. Kokkori; E. Varxalama; M. Theodoraki; A. Gounaris (Greece)
13:45 - 13:50 Fast and meticulous: improving quality of neonatal 16:25 - 16:40 Systemic alterations in Hypoxia-inducible factor 1 expression
resuscitation documentation and the NLRP3 inflammasome in post neonatal
M. Karam; N. Merchant; A. Sierra; S. Narayanan (The Netherlands) encephalopathy in school age children and response to
melatonin in vitro
13:50 - 13:55 Early discharge of premature infants <36 weeks gestational L. Russo; V. Mc Eneaney; Z. Zareen; L.A Kelly; E.J. Molloy (Ireland)
age with nasogastric tube feeding, new standard of care?
F.S. van Kampen; A.C. de Mol; J.P. Korstanje; F. Maingay-de Groof; 16:40 - 16:55 Systemic inflammasome activation in neonatal
L. van Meurs-Asseler; H.G. Stas; R. Willemsen; G.M.S.J. Stoelhorst encephalopathy
(The Netherlands) M. ODea; L. Kelly; J.J. OLeary; E.J. Molloy (Ireland)
13:55 - 14:00 Incidence of hypothermia associated with birth and

intrahospital transport of newborn infants requiring admission
to a NICU - a quantitative observational study 15:00 - 17:00 PARALLEL SESSION 30 (PULMONOLOGY 4)
V. Hansson; M. Hedin; A. rtenstrand; M. Viberg (Sweden) PHARMACOLOGY OF LUNG PROTECTION
|VENEZIA ROOM
Chairs: Daniele De Luca (France)
15:00 - 17:00 PARALLEL SESSION 29 (BRAIN 6) |DARSENA ROOM
CONGENITAL BRAIN INFECTIONS 15:00 - 15:20 Antenatal corticosteroids current controversies
Lex Doyle (Australia)
Chairs: Pierre Gressens (France); Steven Miller (Canada)
15:20 - 15:40 Update on postnatal systemic and inhaled corticosteroids
15:00 - 15:20 CMV cellular and molecular mechanisms Olivier Baud (Switzerland)
Pierre Szepetowski (France)
15:40 - 16:00 Update on respiratory stimulants and diuretics in BPD
15:20 - 15:40 ZIKA congenital encephalopathies prevention
Ferdinando Di Cunto (Italy) Christian Poets (Germany)
100
101
16:00 - 16:15 Using the combination of surfactant and budesonide the 16:10 - 16:25 Perinatal infections and cerebral palsy: are
prevention of chronic lung disease in preterm infants with prolonged ruptures of membranes a risk factor in
RDS children born at term?
O. Sapun; E. Kleshchenko; O. Shishkina; T. Senyuk; N. Petrukhina; M. Mynarek; S. Bjellmo; S. Lydersen; J. Afset; G. Andersen; T. Vik
D. Kryuchko (Russia) (Norway)
16:15 - 16:30 Antenatal glucocorticoids attenuate changes by ventilation 16:25 - 16:40 Congenital heart defects and the risk of spontaneous
in expression of connective tissue growth factor (CTGF) in preterm birth: a nationwide study of 924,422 liveborn infants
newborn rat lung N.B. Matthiesen; J.R. stergaard; C.C. Bach; V. Hjortdal;
M. Mateos; E. Gutierrez; L. San Feliciano; A. Remesal; T.B. Henriksen (Denmark)
M. Isidoro-Garca; A. Garca-Snchez; D. Ludea (Spain)
16:40 - 16:55 The dose-effect relationship between gestational age and
16:30 - 16:45 Effect of commercially available surfactants on mortality and severe school difficulties - a Danish population-based
respiratory outcomes in preterm neonates with RDS: register study
systematic reviews and meta-analysis R. Wiingreen; G. Greisen; J. Svensson; BM. Hansen (Denmark)
L. De Martino; D. De Luca (France)
16:45 - 17:00 Secretory phospholipase A2 and inflammation profile in

preterm babies with RDS receiving one or multiple surfactant 15:00 - 17:00 PARALLEL SESSION 32 |FIRENZE ROOM
doses CHILDREN BORN PRETERM
S. Shankar-Aguilera 1; C. Fitting 1; L. Vedovelli 2; V. DellOrto 1;
V.P. Carnielli 2; L. Touqui 1; D. De Luca 1; M. Simonato 2 Chairs: Neil Marlow (United Kingdom); Hugo Lagercrantz (Sweden)
15:00 - 15:20 RECAP, a EU Horizon2020 collaborative effort to harmonize
existing and new follow-up data on preterm survivor
children, adolsecents and adults
15:00 - 17:00 PARALLEL SESSION 31 (EPIDEMIOLOGY 2) Dieter Wolke (United Kingdom)
PERINATAL EPIDEMIOLOGY |ROMA ROOM 15:20 15:40 Psychiatric outcomes following very preterm birth
Chairs: Tine Brink Henriksen (Denmark); Peter Anderson (Australia)
Thomas Williams (United Kingdom)
15:40 16:00 The brain and neuropsychiatric disorders in children born
15:00 - 15:40 Registry based perinatal epidemiology: the importance of preterm
sibling and generation data Nelly Padilla (Sweden)
Rolv Skjaerven (Norway)
16:00 - 16:15 Two-year outcome of extremely preterm infants < 26 weeks
15:40 - 15:55 Association between maternal body mass index in early of gestation born in Switzerland: is intensity of perinatal care
pregnancy and incidence of cerebral palsy associated with increased neurodevelopmental
S. Johansson; E. Villamor; K. Tedroff; M. Peterson; M. Neovius; impairment?
G. Petersson; S. Cnattingius (Sweden) G. Natalucci; T.M. Berger; C. Borradori-Tolsa; M. Bickle-Graz;
S. Grunt; R. Gerull; D. Bassler; M. Adams (Switzerland)
15:55 - 16:10 Prevalence of long-term neurodevelopmental impairment
following extremely preterm birth in Europe: a systematic 16:15 - 16:30 Cognitive and behavioral aspects of executive functioning
literature review at age 6.5 years in children born extremely preterm:
S. Sarda 1; G. Sarri 2; S. Abogunrin 2; C. Siffel 1 a Swedish national prospective study (EXPRESS)
(1. United States; 2. United Kingdom) A. Farooqi; F. Serenius; M. Adamsson; M. Hafstrm; U. den;
K. Stjernqvist (Sweden)
102
103
15:00 17:00 PARALLEL SESSION 34 |LECCE ROOM
16:30 - 16:45 Delineating the behavioural phenotype among children
born extremely preterm COINN Global perspectives in neonatal care
J. Trickett; D. Wolke; C. Hollis; N. Marlow; S. Johnson Chairs: Agnes van den Hoogen (The Netherlands);
(United Kingdom) Karen Walker (Australia)
16:45 - 17:00 Prevalence of autism in extreme preterm children born in 15:00 15:30 COINNs leadership and partnerships to decrease mortality
Stockholm 2004-2007 and morbidity and improve neonatal care global
E. Eklf; A. Hedfors Moretti; H. Lagercrantz; S. Bolte; U. Aden perspective
Karen New (Australia)
(Sweden)
15:30 16:00 Using parent experiences for learning - exploring the use of
parent narratives to inform education in neonatal care
15:00 - 17:00 PARALLEL SESSION 33 |SORRENTO ROOM Julia Petty (United Kingdom)
IUGR across SPECIALITIES 16:00 16:30 Global neonatal nursing - opportunities and challanges
Chairs: Chiara Mand (Italy); Luca Ramenghi (Italy) Carole Kenner (United States)
15:00 15:20 Metabolic and oxidative phenotype of IUGR 16:30 17:00 Developmental Surveillance in children born very preterm
Chiara Mand (Italy) Margo Pritchard (Australia)
15.20 15:40 Cardiovascular assessment and outcome of the early IUGR

Tiziana Frusca (Italy)
15:40 16:00 The very preterm IUGR between lung and nutrition
Virgilio P. Carnielli (Italy)
16:00 16:20 1The premature brain and the IUGR brain developmental
trajectories THE NEED OF MULTIDISCIPLINARY APPROACHES
Petra Hppi (Switzerland) IN RESEARCH
Chairs: Silke Mader (Germany); Neil Marlow (United Kingdom)
16:20 16:40 IVH and IUGR: thoughts for improving neonatal care?
Luca Ramenghi (Italy) 17:30 18:00 The benefit of an equal partnership with parents in research
Mark Turner (United Kingdom)
16:40 17:00 Discussion
18:00 18:30 How to involve and empower parents in research projects
Nicole Thiele (Germany)
18:30 19:00 The benefit of an active partnership with nurses in research

104
105
08:00 08:00
POSTER WALK
09:00 09:00
Sensory outcomes (BRAIN 5) (PULMONOLOGY 5) (NUTRITION 4) Nurse specialist and (EFCNI 5)
and pain Autophagy in Fetal growth Programming by early Nurse practioner roles Bridging the gap
developing brain size matters nutrition in preterm and practices between hospital and
out-patient care for
hospitalised newborns
11:00 11:00
COFFEE BREAK
11:30 11:30
CLOSING
SESSION
Personalized medicine
13:00 13:00
08:00 09:00 POSTER WALK | GROUND FLOOR

Cardiac Physiology Pathology
Chairs: Daria Kryuchko (Russia); Lizelle Van Wyk (South Africa)
ID 106 DIAGNOSIS OF DIGEORGE SYNDROME: THE CONTRIBUTION OF
MOLECULAR GENETICS
Y. Halleb; H. Hadj-Abdallah; S. Nouri; A. Touati; M. Bellallah; J. Mathlouthi;
N. Mahdhaoui; H. Sboui; A. Saad; D. Hmida (Tunisia)
ID 168 EFFICACY OF MEDICAL TREATMENT IN CLOSING PATENT DUCTUS

ARTERIOSUS IN ELBW INFANTS
S. Bellis; Y. Singh (United Kingdom)
ID 178 ACETAMINOPHEN FOR CLOSING PDA. SHOULD IT BE A FIRST LINE

THERAPEUTIC OPTION?
I. Tof; M.D. Ruiz; M.P. Jaraba; M.V. Rodriguez; R.L. Rueda; M.D. Ordoez;
M.J. Parraga (Spain)
ID 190 PATENT DUCTUS ARTERIOSUS WITH HEMODYNAMIC REPERCUSSION IN

VERY LOW WEIGHT PRETERM INFANTS TREATED WITH ORAL IBUPROFEN
PRESENT A HIGH RATE OF BRONCHOPULMONARY DYSPLASIA
M.M. Loureno; E. Sacramento; F. Carmona; C. Calixto; F. Martin-Celini;
G.H. Seribelli; W.A. Gonalves-Ferri (Brazil)
ID 231 PRENATAL DIAGNOSIS OF THE SYSTEMIC BLOOD FLOW RESTRICTION

DEFECTS IMPROVES HEMODYNAMIC STABILITY OF THE NEONATES
WITH CONGENITAL CARDIAC DEFECT AT THE ADMITTANCE IN
NEONATAL INTENSIVE CARE UNIT
M. Cucerea; M. Simon; M. Ungureanu; R. Marian; E. Moldovan; M. Rusneac;
C. Gliga; L. Suciu (Romania)
ID 247 ASSOCIATION BETWEEN ASYMPTOMATIC PATENT DUCTUS

ARTERIOSUS BEYOND THE EARLY POSTNATAL PERIOD AND 3-YEAR
NEUROLOGICAL OUTCOME
K. Inomata; S. Taniguchi; T. Inoue; A. Kawase; Y. Kondo (Japan)
ID 380 THE SUDDEN CHANGE IN CARDIAC FUNCTION AFTER PATENT DUCTUS

ARTERIOSUS LIGATION MEASURED BY ELECTRICAL CARDIOMETRY IN
AN EXTREME LOW BIRTH WEIGHT INFANT
Y.H. Chien; K.Y. Chao; Y.L. Chen; L.Y. Tsai; C.E. Chiang; S.C. Mu (Taiwan)
ID 509 PULSE OXIMETRY SCREENING IN THE ASYMPTOMATIC NEWBORNS

S. Chaudhry; Y. Singh (United Kingdom)
ID 513 CHANGES IN THE MANAGEMENT OF PATENT DUCTUS ARTERIOSUS

OVER 10 YEARS IN A TERTIARY NEONATAL CENTRE
D. Panjwani; S. Mittal (United Kingdom)
106
106 4th November, 2017 107
107
ID 515 COARCTATION OF THE AORTA - THE CONGENITAL HEART DEFECT ID 273 HEMODYNAMIC RELEVANCE OF PATENT DUCTUS
WITH A MILLION FACES ARTERIOSUS IN PRETERM INFANTS ASSESSED BY CEREBRAL
M. Simon; R. Snta; L.M. Suciu; Z.S. Gll; R. Marian; M. Rusneac; C. Gliga; OXYGENATION OF FREQUENCY DOMAIN NEAR-INFRARED
M.C. Cucerea (Romania) SPECTROSCOPY; ECHOCARDIOGRAPHIC AND
DOPPLER-ULTRASOUND PARAMETERS AND NT-PROBNP: A
ID 550 RARE CONGENITAL MITRAL VALVE MALFORMATION PROSPECTIVE OBSERVATIONAL STUDY
R. Stroescu; A. Popoiu; M. Gafencu; O. Marginean; G. Doros (Romania) C.E. Schwarz; A. Preusche; M. Wolf; C.F. Poets; A.R. Franz (Germany)
ID 628 ASSESSMENT OF NEONATAL HEART RATE IMMEDIATELY AFTER BIRTH ID 417 ULTRASONOGRAPHIC MONITORING FOR POSTNATAL ADAPTATION IN
USING DIGITAL STETHOSCOPE; HAND HELD ULTRASOUND AND PRETERM INFANTS
ELECTROCARDIOGRAPHY V. Nardi 1; M.L. Tataranno 2; S. Di Fabio 1
B. Treston; J. Semberova; R. Kernan; E. Crothers; A. Branagan; N. OCathain; (1. Italy; 2. The Netherlands)
J. Miletin (Ireland)
ID 464 RETROSPECTIVE ANALYSIS OF CATHETER RELATED VEIN THROMBOSIS
ID 639 COINCIDENTAL LEFT ATRIAL THROMBUS AMONG NEWBORNS IN THE NICU SETTINGS.
I. Mungan Akin; P. Canizci; S. Sevuk Ozumut; S. Arslanoglu (Turkey) K. Chojnacka; Z. Krasinski; K. Wrblewska-Seniuk; J. Mazela (Poland)
ID 683 PERICARDIAL EFFUSION: SEVERE COMPLICATION OF CENTRAL ID 676 TREATMENT FOR PATENT DUCTUS ARTERIOSUS AND NEUROCOGNITIVE
VENOUS CATHETERIZATION IN THE NEWBORN (REPORT OF 12 OUTCOME AT 6.5 YEARS OF AGE IN CHILDREN BORN EXTREMELY
SURVIVORS) PRETERM
S. Nouri Merchaoui; J. Methlouthi; H. Ayache; M. Bellalah; I. Kacem; A. Gudmundsdottir; L. Brostrm; B. Skild; K. Klln; M. Norman; U. dn;
H. Barbouche; A. Ghith; N. Mahdhaoui; H. Seboui (Tunisia) A-K. Edstedt Bonamy (Sweden)

ID 694 GENETIC ABNORMALITIES AND CONGENITAL HEART DISEASE ID 715 SYSTEMIC HYPOPERFUSION AND REGIONAL OXYGENATION IN PDA:
S. Nouri Merchaoui; J. Methlouthi; H. Ayech; M. Bellaleh; I. Kacem; A CASE REPORT
H. Barbouche; A. Ghith; S. Mougou; D. Hmida; N. Mahdhaoui; H. Seboui V. Comito; A. Falcone; L. Bruno; E. Paviglianiti; I. Mondello; A. Rossi (Italy)
(Tunisia)
ID 724 LONG-TERM OUTCOME AFTER PATENT DUCTUS ARTERIOSUS
ID 704 USE OF PROSTIN IN A TERTIARY NEONATAL UNIT TREATMENT IN EXTREMELY PRETERM INFANTS
R. Prasad; H. Wood; O. Nolan; S.V. Rasiah (United Kingdom) M.S. Veldhuis; L.M.L. Dix; J.M.P. Breur; W.B. de Vries; I.C. van Haastert;
P.M.A. Lemmers; D.C. Vijlbrief (The Netherlands)
ID 769 THE USABILITY OF ICON FOR NEONATOLOGY
W.P. de Boode; B.M. Wulterkens; B.A.M. Nieuweweme (The Netherlands) ID 794 PROGNOSTIC VALUE OF THE VALUE OF SUPERIOR VENA CAVA FLOW
DURING THE FIRST DAY IN PRETERM INFANTS 32 WEEKS GESTATION
ID 810 WHAT IS THAT PULSATING ON THE ANTERIOR ABDOMINAL WALL? G.C. Zaharie; T. Drugan; D. Muresan; M. Matyas;
O. Nolan; R. Prasad; P. Miller; M. Singh; SV. Rasiah (United Kingdom) H. Rabe; Behalf of the NEO-Circ; M. Hasmasanu (Romania)
ID 796 COMPARISON OF CARDIAC OUTPUT MEASURED BY BIOREACTANCE

WITH ECHOCARDIOGRAPHY MEASUREMENTS IN INFANTS WITH BIRTH
Circulation Macro Microcirculation WEIGHT BELOW 1250G.
J. Miletin 1,2; J. Semberova 1,2; Z. Stranak 1,2
Chairs: Willem de Boode (The Netherlands) (1. Ireland; 2. Czech Republic)
ID 236 THE INFLUENCE OF MATERNAL MEDICATION ON CLOSURE OF THE ID 807 SPONTANEOUS NEONATAL ARTERIAL THROMBOSIS: A REPORT OF 6
DUCTUS ARTERIOSUS IN THE PREMATURE NEWBORN NEONATES
W.P. de Boode; J. van Drongelen; M.J.A. Raaymakers (The Netherlands) J. Mathlouthi; S. Nouri; H. Ayech; M. Bellaleh; I. Kacem; H. Barbouch;
N. Mahdhaoui (Tunisia)
ID 263 CHRONOLOGICAL EX-UTERINE ADAPTATION OF HEMODYNAMIC
PERFORMANCE IN VERY LOW BIRTH WEIGHT (VLBW) PRETERM INFANTS ID 859 THE USE OF ETCO2 (CAPNOGRAPHY) IN NEONATAL INTUBATION
R. Lien; S. Hsu; D. Mok; W.M. Chen; L.C. See (Taiwan) A. Davies; A. Walker; L. Elsaadany; P. Shires; D. Batra (United Kingdom)
108
108 4th November, 2017 4th November, 2017 109
109
ID 877 COMPARISON BETWEEN NIRS AND THE TRADITIONAL AND NOVEL ID 202 PROACTIVE USE OF BREAST MILK FORTIFIER AND
APPROACH OF SVC FLOW ASSESSMENT IN VLBW INFANTS BREASTMILK AT DISCHARGE: IS THERE A LINK? A NATIONAL
B. Ficial; A. Boschetti; E. Bonafiglia; A. Pietrobelli; P. Biban (Italy) SURVEY OF PRACTICE
S. Stiles; L. de Rooy (United Kingdom)
ID 220 SODIUM SUPPLY BUT NOT HYPERNATREMIA IS ASSOCIATED

Neonatal Fetal Nutrition and Metabolism WITH SEVERE INTRAVENTRICULAR HEMORRHAGE IN EXTREMELY
PRETERM INFANTS
Chairs: Colin Morgan (United Kingdom); Sissel Moltu (Norway); C. Spth; E. Stoltz Sjstrm; J. gren; F. Ahlsson; M. Domellf (Sweden)
Mark Johnson (United Kingdom)
ID 245 RELATION OF CORD SERUM LEVELS OF INSULIN-LIKE GROWTH
ID 033 GUIDE LINES FOR MULTIVITAMINS ADMINISTRATION IN FORTIFIED FACTOR-I; INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-3;
HUMAN MILK PREPARE FOR PRETERM INFANT GLUCAGON AND LEPTIN ON BIRTH INDICES BETWEEN KOREAN
V. Rigourd; I. Dridi Brahim; H. Razafimahefa; F. Quetin; E. Leroy; C. Pichon; PRETERM AND TERM INFANTS
A. Giuseppi; L. Berthie (France) J.H. Park; S.J. Kang; L.H. Lee; S.Y. Shin; C.S. Kim; S.L. Lee; J.G. Bae; S. Kim
(Korea)
ID 077 EFFECTS OF EXCLUSIVE DONOR HUMAN MILK FEEDING IN A SHORT
PERIOD AFTER BIRTH ON MORBIDITY AND GROWTH OF PRETERM ID 264 USE OF DONOR BREAST MILK IN A TERTIARY NEONATAL UNIT
INFANTS DURING HOSPITALIZATION COMPLIANCE WITH A GUIDELINE
S.H. Chung; E.J. Kim (Korea) C. Apsey; K; Williams; K. Johnson; H. Shore (United Kingdom)
ID 130 ASSAY OF IRISIN CONCENTRATION IN INFANT FORMULAS AND ID 265 COPPER AND ZINC CONTENT OF BREASTMILK FROM WOMEN
BREAST MILK SUFFERING FROM WILSONS DISEASE
N. Ml; P. Tomasik; M. Zasada; P. Kwinta (Poland) T. Reicherzer; G. Schtze; M. Vogeser; A. Schulze; A.W. Flemmer (Germany)
ID 140 ENTERAL FEEDING STRATEGIES FOR VERY LOW BIRTH WEIGHT INFANTS: ID 276 EARLY ENERGY AND PROTEIN INTAKE AFFECTS GROWTH AND
A NATIONWIDE SURVEY IN JAPAN MORBIDITY IN EXTREMELY PRETERM INFANTS
M. Ashina; K. Fujioka; S. Totsu; H. Shoji; T. Miyazawa; K. Wada; K. Iijima; S. Klevebro; V. Westin; E. Stoltz Sjstrm; M. Norman; M Domellf;
I. Morioka (Japan) A-K Edstedt Bonamy; B Hallberg (Sweden)
ID 160 DONOR HUMAN MILK MACRONUTRIENT CONTENT: THE EFFECT OF ID 293 USE OF PROBIOTICS IN PRETERM NEWBORNS. DOES FEEDING
HOLDER PASTEURIZATION TOLERANCE IMPROVE?
P. Piemontese; D. Mallardi; N. Liotto; C. Menis; C. Tabasso; M. Perrone; M.I. Huescar; M.G. Espinosa; T. Sanchez; E. Salguero (Spain)
M.L. Giann; P. Roggero; F. Mosca (Italy)
ID 339 EXTRAUTERINE GROWTH RESTRICTION ASSOCIATED FACTORS IN
ID 161 NEW PARENTERAL NUTRITION AND ACIDOSIS IN PRETERM INFANTS SMALL AND APPROPRIATE FOR GESTATIONAL AGE INFANTS:
F. Bonsante; JB. Gouyon; S. Iacobelli (France) A COHORT STUDY
C. Morcelli-Tovar; A.A.Vieira (Brazil)
ID 172 IMPACT ON BREASTFEEDING RATES OF PRETERM INFANTS WITH LESS
THAN 29 WEEKS WITH RESTRICTION OF RAW HUMAN MILK IN THE FIRST ID 362 NEONATAL INTESTINAL FAILURE IN THE UK WHO CARES?
EIGHT WEEKS OF LIFE DUE TO THE RISK OF PERINATAL R. Jones; P. Cairns (United Kingdom)
CYTOMEGALOVIRUS INFECTION
F.P. Martins-Celini; W.A. Gonalves-Ferri; B.B. Lima; D.C. Aragon; M.M. Mussi ID 398 HYPOARGININAEMIA AND SEPSIS IN VERY PRETERM INFANTS
(Brazil) RECEIVING PARENTERAL NUTRITION
C. Morgan; L. Burgess (United Kingdom)
ID 179 VITAMIN D STATUS AMONG PRETERM INFANTS AS A HIGH RISK
MORBIDITY MARKER ID 399 TARGET PARENTERAL PROTEIN ATTAINMENT IN PARENTERALLY FED
I. Tofe; M.D. Caete M.J. de la Torre; J.L. Perez-Navero; PRETERM INFANTS FOLLOWING THE IMPLEMENTATION OF THE
J. Caballero-Villarraso (Spain) CONCENTRATED MACRONUTRIENTS IN PARENTERAL STANDARDISED
SOLUTIONS (CoMPaSS) PROGRAMME
F. Callaghan; C. Morgan (United Kingdom)
110
111
ID 435 LEVELS OF GLUCOSE IN CORD BLOOD SAMPLES (LOGICS) ID 721 TYPE OF FEEDING IN BABIES FROM THE NEONATAL
N. Cathin 1; A. Stanzelova 1; B. Treston 1; R. OKelly 2; A. Killalea 2; INTENSIVE THERAPY UNIT OF A BABY FRIENDLY HOSPITAL AT
J. Kelly 2; J. Semberova 1; J. Miletin 1,2 THE TIME OF HOSPITAL DISCHARGE
(1. Ireland; 2. Czech Republic) A.M. Miranda; A.L.L. Ledesma; G.M. Fernandes; I.C.L. Firmino;
G. Berretim-Felix (Brazil)
ID 455 SANJAD SAKATI SYNDROME: ABOUT NEW TUNISIAN CASES
A. Touati 1; S. Nouri 1 ;Y. Hallab 1; J. mathlouthi 1; N. Ben Salah 1; ID 725 DONOR HUMAN MILK IMPACT ON NUTRITIONAL STATUS
M. Mastouri Haddeji 1; Y. El Abed 1; A. Ben Ahmed 1; A. Saad 1; OF VERY PRETERM INFANTS
C. Ben Singor 2; D. Hmida Ben Brahim 1 S. Salas; D. Caizo; M. Izquierdo; I. Iglesias (Spain)
(1. Tunisia; 2. France)
ID 730 INFLUENCE OF THE USE OF DONOR HUMAN MILK IN THE CLINICAL
ID 466 THE EFFECT OF DRESSING AFTER TUB BATHING ON MOISTURE LOSS IN COURSE OF TWO COHORTS OF VERY PRETERM INFANTS
PRETERM INFANTS D. Caizo; S. Salas; M. Izquierdo; I.Iglesias (Spain)
Z. Kan Onturk; D. Gozen (Turkey)
ID 770 GROWTH AND BODY COMPOSITION ASSESSMENT AT FOLLOW-UP OF
ID 508 THE IMPACT OF EARLY VERSUS LATE NUTRITIONAL SUPPORT ON VERY PRETERM INFANTS
GROWTH AND NEURODEVELOPMENTAL OUTCOME IN VERY LOW B. del Rey Hurtado de Mendoza; C. Balcells; M. Izquierdo-Renau;
BIRTH WEIGHT INFANTS I. Iglesias-Platas (Spain)
C.Y. Kim; J.H. Hwang; E. Jung; B.S. Lee; A.R. Kim; K.S. Kim (Korea)
ID 782 GROWTH OF VERY PRETERM INFANTS (<32 WEEKS) WITHIN 3 YEARS
ID 574 INSULIN INFUSION FOR HYPERGLYCEMIA IN EXTREMELY PRETERM - AFTER BIRTH
A PILOT STUDY K. Suzuki; Y Murayama; H Masaki (Japan)
W. Hellstrm; S. Najm; K. Svman; I. Pupp Hansen; D. Ley; G. Hellgren;
A. Hellstrm; C. Lfqvist (Sweden) ID 786 THE ASSOCATON BETWEEN 25 OH-D VTAMN LEVELS AND
AORTC; CAROTD NTMA MEDA THCKNESS N HEALTY NEWBORN
ID 600 PONDERAL INDEX IN SGA NEONATES: IS IT RELIABLE INDEX? NFANTS
S. Erin; T. Gursoy (Turkey) D. Arman; Z. Cetiner; A. Erdil; E.Yurdakul (Turkey)
ID 609 POSTNATAL GROWTH VELOCITY CALCULATION: ACCURACY OF ID 828 GROWTH PARAMETERS AT BIRTH IN INFANTS WITH CONGENITAL ZIKA
DIFFERENT METHODS VIRUS SYNDROME AND MICROCEPHALY
A. Ali 1; N. Rochow 1; A; Alkhoraidly 2; R. Iskander 1; G. Fusch 1; C. Fusch 1,3 I. Garca-Garca; L. Gely; J. Negrn; L. Garca-Fragoso (Puerto Rico)
(1. Canada; 2. Saudi Arabia; Germany)
ID 848 MICROBIOA AND SCFA OF TERM INFANTS
ID 640 NEONATAL HYPOGLYCEMIA DETECTED BY A GLUCOSE METER: A. Bartnicka; M. Szewc; K. Mielnik; M. Gacka; J. Mazela (Poland)
IS IT RELIABLE?
K. Ben Ameur; K. Msalbi; T. Khemis; H. Ben Hamida; F.Z. Chioukh; K. Monastiri ID 857 URINARY METABOLIC PROFILE OF NEONATES IN WESTERN GREECE:
(Tunisia) PRELIMINARY DATA
I. Giannakopoulos; A. Tsintoni; I. Christopoulou; L. Vitsa; N. Malic;
ID 688 CLINICAL EFFECTS OF OROPHARYNGEAL COLOSTRUM M.M. Pogka; S. E. Bariamis; I. Georgakopoulou; S.A. Chasapi;
ADMINISTRATION IN VERY LOW BIRTH WEIGHT INFANTS IN THE FIRST G.A. Spyroulias; A. Varvarigou (Greece)
MONTH OF LIFE
E. Martin-Alvarez; M. Pea-Caballero; L. Serrano-Lopez; ID 858 DIETARY MANIPULATION OF MOTHERS OF PRETERM INFANTS: EFFECT
M.B. Snchez-Martnez; M. Alonso-Moya; J.J. Ochoa; J. Maldonado; ON BREASTMILK COMPOSITION AND MEETING MACRONUTRIENT
J.A. Hurtado-Suazo (Spain) REQUIREMENTS
K. Megaw (South Africa)
ID 719 MACRONUTRIENT PROFILE OF DONATED BREAST MILK:
DOES LONG TIME BREASTFEEDING MODIFY IT? ID 866 THE CONSEQUENCE OF PHOTOTHERAPY EXPOSURE ON OXIDATIVE
N. Sarmiento-Carrera; N. Gonzalez-Freiria; A. Concheiro-Guisan; STRESS STATUS OF EXPRESSED HUMAN MILK
M. Suarez-Albo; S. Alonso-Clemente; Jr Fernandez-Lorenzo (Spain) S. Unal; N. Demirel; D. Yaprak Sul; D. Ulubas Isik; S. Erol; S. Neselioglu; O. Erel;
A. Yagmur Bas (Turkey)
112
113
ID 869 MONITORING THE GUT MICROBIOTA ESTABLISHMENT IN VERY ID 352 C-REACTIVE PROTEIN: AN ADJUNCT OR DILEMMA
LOW-WEIGHT PRETERM INFANTS FOR DIAGNOSIS OF NEONATAL MENINGITIS
E. Escribano; C. Saralegui; R. del Campo; S. del Pozo; L. Moles; F. Yasin; S.F. Virupachi; R.A. Khan (Ireland)
J.M. Rodrguez; M. Saenz de Pipaon (Spain)
ID 408 DNA VIRUSES: THEIR ROLE IN ACUTE RESPIRATORY
ID 876 BABIES WITH FEEDING DIFFICULTIES HAVE HIGHER CONCENTRATIONS INFECTIONS IN NEONATAL UNIT IN TUNISIA
OF BETA-HYDROXYBUTYRATE I. Brini 1,2; N. Hannachi 1; A. Guerrero 2; B. Hetzer 2; W. Borena 2;
D.L. Harris; P.J. Weston; J.E.Harding (New Zealand) S. Nouri Merchaoui 1; H. Sboui 1; D. Von Laer 2; J. Boukadida 1; H. Stoiber 2
(1. Tunisia; 2. Austria)
Neonatal Infections Diseases / Immunology ID 429 REVIEW OF ADVERSE VACCINE REACTIONS IN AN IRISH NEONATAL
UNIT
Chairs: Charles C. Roehr (United Kingdom) C. Fox; E. Gordon (Ireland)
ID 019 UPTAKE OF PERTUSSIS AND INFLUENZA VACCINES IN PREGNANCY ID 445 DOES DURATION OF BLOOD CULTURE REPORTING IMPACT ON THE
A. Saso; B. Donaldson; B. Kampmann (United Kingdom) CARE OF NEONATES AT RISK OF EARLY ONSET NEONATAL SEPSIS?
L. Woodgate; C. Chetcuti Ganado (United Kingdom)
ID 034 SEVERE COMBINED IMMUNE DEFICIENCY AND CONTINUED
BREASTFEEDING: REPORT OF 5 OWN MOTHERS MILK DONATION ID 459 A CANDIDA TROPICALIS OUTBREAK DURING EL NINO IN A NEONATAL
(OMM) AT THE REGIONAL ILE DE FRANCE MILK BANK INTENSIVE CARE UNIT IN SOUTHERN PHILIPPINES
V. Rigourd; D. Moshous; J.F. Mritet; M. Nicloux; C. Hovhannisyan; M. Dorsi; C. Masilungan; R. Aunal; J. Peralta (Philippines)
T. Hachem; P. Frange; A. Lapillonne; J.F. Magny (France)
ID 483 CONGENITAL CYTOMEGALOVIRUS INFECTION- NEONATOLOGICAL
ID 251 ANTIBIOTIC EXPOSURE IN NEONATES AND IMPACT ON GUT ASPECT
MICROBIOTA AND ANTIBIOTIC RESISTANCE DEVELOPMENT: S. Stefanovic; V. Stefanovic; V. Stefanovic (Serbia)
A SYSTEMATIC REVIEW
J. Fjalstad 1; E. Esaiassen 1; L. Juvet 1; J. van den Anker 2; C. Klingenberg 3 ID 548 DIAGNOSTIC VALUE OF SERUM AMYLOID A IN NEONATAL BACTERIAL
(1. Norway; 2. Switzerland; 3. United States) INFECTIONS AND ASSOCIATIONS WITH CIRCULATING HDL AND
CYTOKINE LEVELS
ID 252 EFFECT OF CATHETER DWELL TIME ON RISK OF CENTRAL LINE V. Bourika; E. Hantzi; A. Margeli; I. Papassotiriou; T. Siahanidou (Greece)
ASSOCIATED BLOOD STREAM INFECTION IN NEONATES IN A
DEVELOPING HEALTHCARE SYSTEM ID 558 CONGENITAL TUBERCULOSIS AS A RESUL OF DISSEMINATED
S.B. Chaaya; R. Durmush; C.P.H. Ibrahim (United Arab Emirates) MATERNAL DISEASE. IS CORRECT THE ACTUAL MANAGEMENT?
A.B. Escobar Izquierdo; G. Ucls Lpez; M.J. Cobas Pazos; Y. Lopez Lozano;
ID 258 20 YEARS OF EARLY NEONATAL SEPSIS DUE TO ESCHERICHIA COLI: M.D. Sanchez-Redondo Sanchez-Gabriel; A. Martinez Gimeno (Spain)
SHOULD WE CHANGE EMPIRICAL ANTIBIOTIC THERAPY?
M.C. Cspedes; N. Mendoza; M. Balasch; S. Gonzalez; A. Andreu; M.A. Frick; ID 562 NEONATAL SEPSIS: FREQUENCY; RISK FACTORS AND OUTCOME IN A
MA. Linde; J.J. Gonzalez; P. Soler (Spain) LEVEL II NICU UNIT
L. Blaga; M. Matyas; C. Vidra; M. Hasmasanu; G. Abrudan; G. Zaharie
ID 288 HAND HYGIENE COMPILENCE IN NICU; A OBSERVATIONAL STUDY (Romania)
A. Grol; K.. Tekgndz; S. Polat; S.E. Tekgndz; S. Ejder Apay (Turkey)
ID 567 LUMBAR PUNCTURE SUCCESS & FAILURE IN A TERTIARY NEONATAL
ID 296 NEONATAL SEPTIC ARTHRITIS IN NICU UNIT - A PROSPECTIVE COHORT STUDY
F. Krasniqi; I. Krasniqi; X. Gojnovci; H. Jashari (Kosovo) A. Marshall 1; M. Sadarangani 1; C.C. Roehr 1,2; M. Anthony 1
(1. United Kingdom; 2. Germany)
ID 301 CURRENT PRACTICE AND NEONATAL STAFFS KNOWLEDGE ON
ANTIBIOTIC USE AND ANTIBIOTIC STEWARDSHIP PROGRAMMES ID 614 HOSPITALISATION FOR RESPIRATORY SYNCYTIAL VIRUS (RSV)
ACROSS TWO NEONATAL NETWORKS INFECTION IN PREMATURE INFANTS BORN IN MULTIPLE BIRTHS
M. Scott; M. Carpenter; P. Satodia; P. Nath (United Kingdom) R. Thwaites; S. Buchan; C. Morris; B. Rodgers-Gray; J. Fullarton; J. Coutts
(United Kingdom)
ID 333 PREDICTORS OF MORTALITY IN NEONATAL SEPSIS
G. Irawan Sarosa; R. Rahim (Indonesia)
114
115
ID 619 ANTIBIOTICS FOR EARLY ONSET NEONATAL SEPSIS: AUDITING ID 750 NEONATAL INFECTIONS AT PREMATURE AND AT TERM
PRACTICE AND ANALYSING COST NEWBORN
O. Kazeem; M. Saunders; R. Roy; C. Tremlett (United Kingdom) M. Dima; I. Petre; A Baros; E.R. Iacob; D. Iacob (Romania)
ID 630 DYSFUNCTIONAL INFLAMMATION; THE SIGNIFICANCE OF TLR2 ID 752 PROSTAGLANDIN E2 URINARY METABOLITE IN PRETERM
SIGNALING IN HYPOXIC NEONATES PREDISPOSED TO NEURAL INFANTS A BIOMARKER FOR INFLAMMATION?
ENCEPHALOPATHY V. Siljehav; L. Gerbaulet; G. Aquilano; A. Honore; S. Psyllidou; M. Vanpe;
B. Wright; K. Lynne; M. Eleanor; M. Omer; N. A Taher; M. ODea; A. Melorz; E. Herlenius (Sweden)
A. Moreno (Ireland)
ID 755 APPLICATION OF EVIDENCE-BASED MEDICINE METHODS TO
ID 658 NEONATAL THYMIC CHARACTERISTICS IN A RAT MODEL OF DIAGNOSE EARLY NEONATAL SEPSIS
INTRAUTERINE GROWTH RESTRICTION O.Vlasova; L. Koliubakina; L. Bezrukov (Ukraine)
J.B. Armengaud; K. Nardou; F. Pre-Curto; F. Candotti; F. Angelini; M. Hofer;
U. Simeoni; C. Yzydorczyk (Switzerland) ID 787 NEONATAL BRONCHIOLITIS: CLINICAL PRESENTATION; MANAGEMENT
AND PREVENTION
ID 682 IMPACT OF MICROBIAL-ASSOCIATED INTRA-AMNIOTIC H. Ben Salem; M.T. Lamouchi; M. Sellami; I. Kasraoui; N. Kasdallah; S. Blibech;
INFLAMMATION AND STERILE INTRA-AMNIOTIC INFLAMMATION M. Doagi (Tunisia)
ON SHORT-TERM NEONATAL OUTCOME IN WOMEN WITH PRETERM
LABOR AND INTACT MEMBRANES ID 801 SHOULD WE LUMBAR PUNCTURE TERM BABIES BASED ON CRP
A. Herranz Barbero; R. Amoedo Blanco; M. Izquierdo Renau; C. Murillo; CRITERIA SET BY NICE?
C. Rueda; J. Ponce; T. Cobo (Spain) H. Wood; S. Steadman; J. Gray; V. Rasiah (United Kingdom)
ID 685 PCT; IL-6 AND IL-8; BUT NOT HA ARE USEFUL FOR DIAGNOSTIC UTILITY ID 840 MENB (BEXSERO) IMMUNISATION IN NICU: EXPERIENCE IN A UK
IN NEONATES AT RISK THAT FULFILL THE NORWEGIAN CONSENSUS TERTIARY NEONATAL UNIT POST INTRODUCTION OF VACCINE
DEFINITION OF NEONATAL SEPSIS A. Mukherjee; S. Senthil; A. Razai; D. Mukherjee (United Kingdom)
B. Nakstad; H.C.D. sterholt; A.L. Solevg (Norway)
ID 699 NEONATAL INVASIVE CANDIDIASIS: STUDY OF 108 CASES COLLECTED

IN NEONATOLOGY DEPARTMENT OF SOUSSE (TUNISIA)
S. Nouri Merchaoui; N. Mahdhaoui ; H. Ayache; F. Saghrouni; M. Bellalah;
I. Kacem; H. Barbouche; A. Ghith; J. Methlouthi; H. Seboui (Tunisia)
ID 706 NEWBORN SCREENING TESTS IN INFANTS WITH CONGENITAL ZIKA

VIRUS SYNDROME AND MICROCEPHALY
L. Garca-Fragoso; L. Gely; S. Rivera-Snchez; I. Garca-Garca (Puerto Rico)
ID 716 PREVENTIVE EFFECT OF LACTATIONAL MASTITIS BY ADMINISTRATION

OF LACTOBACILLUS FERMENTUM CECT5716. A RANDOMIZED
CONTROLLED TRIAL.
L. Serrano Lpez; E. Martn lvarez; M. Pea Caballero; J. Fonoll Joya;
J.A. Hurtado Suazo (Spain)
ID 728 UMBILICAL CORD CARE AND OMPHALITIS IN NEWBORNS OF

NORTHERN PORTUGAL: A MULTICENTRIC RETROSPECTIVE STUDY
C. Teles Silva; M. Nogueira; I. Falco; A.L. Santos; M. Rodrigues;
G. Silva; H. Guimares (Portugal)
ID 743 CENTRAL LINE ASSOCIATED INFECTION IN NEWBORNS ADMITTED TO A

PORTUGUESE NEONATAL INTENSIVE CARE UNIT
T. Lopes; M. Branco; A. Freitas; I. Falco; C. Carvalho; E. Proena;
A. Almeida (Portugal)
116
117
9:00 - 11:00 PARALLEL SESSION 35 09:00 11:00 PARALLEL SESSION 36 (BRAIN 5)
SENSORY OUTCOMES AND PAIN |DARSENA ROOM AUTOPHAGY IN DEVELOPING BRAIN |VENEZIA ROOM
Chairs: Jurgen C. de Graaff (The Netherlands); Chairs: Anita Truttmann (Switzerland);
Ola D. Saugstad (Norway) Ingran Lingam (United Kingdom)
09:00 09:20 Long term effects of neonatal pain 09:00 09:20 Role of mitochondria and autophagy in perinatal brain
Suellen Walker (United Kingdom) damage
Henrik Hagberg (United Kingdom)
09:20 09:40 Anaesthetic toxicity in children
Jurgen C. de Graaff (The Netherlands) 09:20 09:40 Autophagic cell death in perinatal brain injury:
does it matter?
09:40 - 09:55 Neonatal pain, opioid and anaesthetic exposure; what Anita Truttmann (Switzerland)
remains in the human brain after the wheels of time?
G.E. van den Bosch; D. Tibboel; J.C. de Graaff; H. El Marroun; 09:40 - 09:55 Blood based proteins that differentiate inflammation-
A. van der Lugt; T. White; M. van Dijk (The Netherlands) sensitized hypoxia versus hypoxia alone within the 6h
therapeutic window in a piglet model
09:55 - 10:10 Mode of delivery influences nociceptive sensitivity in I. Lingam 1; A. Avdic-Belltheus 1; K. Martinello 1; C. Meehan 1;
newborn infants the NociCop trial S. Ragab 1; I. Tachtsidis 1; C. Tann 1; M. Hristova 1; B. Fleiss 1;
N. Klarer 1; S. Kasser 1; H. Rickenbacher 1; C. Hartley 2; T. Wolfs 2; B. Kramer 2; N. Klein 1; H. Hagberg 1; P. Gressens 1;
A. Depoorter 1; A.N. Datta 1; W. Magerl 3; E.A. Huhn 1; G. Green 2; N.J. Robertson 1
R. Slater 2; Wellmann 1 (1. United Kingdom; 2. The Netherlands)
(1. Switzerland; 2. United Kingdom; 3. Germany)
09:55 - 10:10 Autophagy inhibition protects in a preterm rat model of
10:10 - 10:25 Can differences in early functional connectivity in healthy excitotoxic brain injury
newborns exposed to olfactory stimulation help us C. Descloux; V. Ginet; J. Puyal; A.C. Truttmann (Switzerland)
understand crying behaviour at 6 weeks of life?
L. Freitas; A. Adam-Darque; F. Grouiller; J. Sauser; F. Lazeyras; 10:10 - 10:25 Interaction between acute therapeutic hypothermia and a
A. Merglen; P. Pollien; C.L. Garcia-Rodenas; delayed mesenchymal stem cell therapy in neonatal
G. Bergonzelli Degonda; D. Van De Ville; P. Hppi; hypoxia-ischemia
R. Ha-Vinh Leuchter (Switzerland) J. Herz; C. Kster; B. S. Reinboth; M. Dzietko; I. Bendix;
U. Felderhoff-Mser (Germany)
10:25 - 10:40 The effect of morphine on early brain activity in extremely
preterm infants: an observational multi-center study 10:25 - 10:40 A comparison of the effects of short term whole body
M.L. Tataranno1; L.S. deVries 1; L. Hellstrm-Westas 1; vibration, as experienced during neonatal ambulance
O. Dammann 2; M. Toet 1; F. Groenendaal 1; N.H.P. Claessens 1; transportation, on the developing brain
V. Fellman 3; K. Svman 3; M.J.N.L. Benders 1 L. Shipley; I. Bloor; D. Sharkey (United Kingdom)
(1. The Netherlands; 2. Germany; 3. Sweden)
10:40 - 10:55 CEACAM1 expression in the cerebellum
10:40 - 10:55 Self-reported widespread pain in adults born early and late S. Prager; B.B. Singer; I. Bendix; J. Herz; U. Felderhoff-Mser
preterm (Germany)
K.A.I. Evensen 1; M. Tikanmki 2; K. Heinonen 2; H-M. Matinolli 2;
M. Sipola-Leppnen 2; A. Lano 2; D. Wolke 3; M. Vrsmki 2;
J.G. Eriksson 2; S. Andersson 2,3; M-R. Jrvelin 1; P. Hovi 2;
K. Rikknen 1; E. Kajantie 2
(1. Norway; 2. Finland; 3. United Kingdom)
118
119
09:00 11:00 PARALLEL SESSION 37 (PULMONOLOGY 6) 09:00 11:00 PARALLEL SESSION 38 (NUTRITION 5)
FETAL GROWTH SIZE MATTERS |ROMA ROOM PROGRAMMING BY EARLY NUTRITION IN PRETERM
Chairs: Olivier Danhaive (Belgium) INFANTS: WHAT IS KNOWN, WHAT IS HYPOTHESIZED?
|FIRENZE ROOM
09:00 09:30 A database on fetal growth Chairs: Umberto Simeoni (Switzerland);
Stephen Kennedy (United KIngdom)
09:00 09:20 Early nutrition and long term cardiovascular health
09:30 - 09:45 Can we assess the severity of neonatal respiratory distress by Umberto Simeoni (Switzerland)
ultrasound? A comparison of three methods
F. Raimondi; F. Migliaro; L. Verdoliva; D. Gragnaniello; G. Poggi; 09:20 09:40 Decisions in early nutrition and later metabolic
C. Sansone; R. Kosova; L. Capasso (Italy) consequences
Petteri Hovi (Finland)
09:45 - 10:00 PCO2 levels and clinical and neurodevelopmental
outcomes of extremely low birthweight infants 09:40 - 09:55 Early-life protein intake in infants born extremely preterm is
T.H. Ulrich 1; J. Dreyhaupt 1; O. Genzel-Boroviczeny 1; associated with higher blood pressure at school-age - Itay
B. Bohnhorst 1; M. Schmid 2; H. Fuchs 1; O. Rohde 1; S. Avenarius 1; I. Zamir; E. Stoltz Sjstrm; A.K. Edstedt Bonamy;
H-G. Topf 1; A. Zimmermann 1; D. Faas 1; K. Timme 1; B. Kleinlein 1; L.A. Mohlkert; M. Norman; M. Domellf (Sweden)
H. Buxmann 1; W. Schenk 1; H. Segerer 1; N. Teig 1; F. Pulzer 1;
R. Hentschel 1; M. Heckmann 1; R. Schlsser 1; J. Peters 1; R. Rossi 1; 09:55 - 10:10 Prevalence of prediabetes and type 2 diabetes in young
W. Rascher 1; R. Bttger 1; J. Seidenberg 1; G. Hansen 1; adults born with very low birth weight
M. Zernickel 1; R. Muche 1; H.D. Hummler 1; for the PHELBI Study M. Talman; P. Nixon; E. Jensen; L. Washburn (United States)
Group
(1. Germany; 2. Switzerland) 10:10 - 10:25 Transient postnatal overfeeding in mice leads to metabolic
and hepatic disorders at adulthood
10:00 - 10:15 Alveolar surfactant composition in preterm infants with C. Yzydorczyk 1; N. Li 2; D. Mosig1; M. Bidho 1; B. Keshavjee 1;
respiratory distress syndrome before exogenous surfactant J.B. Armengaud 1; C. Vergely 2; U. Simeoni 1
administration: effect of gestational age and inflammation (1. Switzerland; 2.France)
G. Verlato; M. Simonato; E. Bassi; M. Fantinato; A. Correani; I. Giretti;
E. Baraldi; P. Cogo; V.P. Carnielli (Italy) 10:25 - 10:40 Effect of infant formula with protein content of 1.6g/100kcal
fed between 3-12 months on body composition and
10:15 - 10:30 TGF signaling is critical for regulating a proximal adiposity at age 5 years
differentiation program and lung branching morphogenesis E.E. Ziegler 1; D.A. Fields 1; S.D. Chernausek 1; D. Grathwohl 3;
through activating notch signaling J.M. Jeter 1; S.E. Nelson 1; M. Chen 1; N.P. Hays 1; F. Haschke 3
P.N. Tsao 1; H.K. Chen 1; T.Y. Ling 1; W.V. Cardoso 2 (1. United States; 2. Switzerland; 3. Austria)
(1. Taiwan; 2. United States)
10:40 - 10:55 Newborn bone health is affected by maternal bariatric
10:30 - 10:45 A randomised controlled trial of needle aspiration or surgery
chest drain insertion for pneumothorax in newborns E. Malchau Carlsen; K. Martha Renault; B. KanijoMller;
(The NORD Trial), ISRCTN65161530 K. Nrgaard; L. Nilas; J-E. Bech Jensen; J. Lauenborg; D. Cortes;
M. Murphy 1; C. Heiring 2; N. Doglioni 3; D. Trevisanuto 3; O. Pryds (Denmark)
M. Blennow 4; K. Bohlin 4; G. Lista 3; I. Stucchi 3; C. ODonnell 1
(1. Ireland; 2. Denmark; 3. Italy; 4. Sweden)
120
121
09:00 - 11:00 PARALLEL SESSION 39 09:55 - 10:10 Supporting the peer supporter
G. Thomson; M-C. Balaam (United Kingdom)
NURSE SPECIALIST AND NURSE PRACTIONER ROLES
AND PRACTICES |SORRENTO ROOM 10:10 - 10:25 Postpartum depression, bonding and coping strategies in
Chairs: Karen New (Australia); Carol Kenner (United States) mothers of newborns admitted to the neonatal unit
R. Porta; G. Lasheras; E. Capdevila; B. Farr-Sender ; J.M. Farr
09:00 - 09:30 New professional role in neonatology, challenges and (Spain)
regulations
Odile Frauenfelder (The Netherlands) 10:25 - 10:40 Two year neurodevelopmental follow up data:
meeting metrics vs delivering quality assessments
09:30 - 10:00 Neonatal nursing, where we are and where we are going M. Parmar; F. Ceroni; S. Narayanan; N. Merchant
the evolving role of NPs (United Kingdom)
Karen Walker (Australia)
10:40 11:00 Discussion
10:00 - 10:30 Case presentation: a neonate who suddenly collapses-
deciphering the differential diagnoses
Karen Walker (Australia)
11:00 11:30 COFFEE BREAK
10:30 - 11:00 Not just neonatal survival the effects of cerebral palsy and
long term morbidity & long term outcomes in terms of autism
etc
Margo Pritchard (Australia) 11:30 - 13:00 CLOSING SESSION |DARSENA ROOM
PERSONALIZED MEDICINE
Chairs: Charles C. Roehr (United Kingdom); Corrado Moretti (Italy)
09:00 - 11:00 PARALLEL SESSION 40 (EFCNI 5) 11:30 12:10 Epigenetics: an evolutionary perspective on chronic disease
BRIDGING THE GAP BETWEEN HOSPITAL AND Jonathan Wells (United Kigdom)
OUT-PATIENT CARE FOR HOSPITALISED NEWBORNS
12:10 12:50 The impact of early life experiences in neurodevelopmental
|LECCE ROOM disorders
Chairs: Silke Mader (Germany) Pierre Gressens (France)
09:00 - 09:20 Being a neonatal nurse practitioner working with parents is:
12:50 13:00 Closing Words
transferring, supporting and accompanying towards
parenthood
George Damhuis (The Netherlands)
09:20 09:40 Graduating from the NICU and transition to the outpatient
setting - what the primary care physician likes to know
Kai Knig (Switzerland)
09:40 - 09:55 Mother-infant closeness supports the breastfeeding

of preterm infants at discharge
S. Raiskila 1; A. Axelin 1; L. Toome 2; S. Caballero 3; B. Tandberg 4;
R. Montirosso 5; E. Normann 6; B. Hallberg 6; B. Westrup 6; U. Ewald
6; L. Lehtonen 1
(1. Finland; 2. Estonia; 3. Spain; 4. Norway; 5. Italy; 6. Sweden)
122
123
SPONSORED SESSIONS
30/10/2017
09:00 - 17:30 PRE-CONGRESS COURSE | CAPRI ROOM (PALAZZO DEL CASIN)

ESN COURSE 1 - Neonatal Infections
Supported by an unrestricted educational grant from
31/10/2017
09:00 - 17:00 PRE-CONGRESS COURSE |CAPRI ROOM (PALAZZO DEL CASIN)

ESN COURSE 2 - Neonatal Haemodynamics
01/11/2017
12:30 - 13:30 WORKSHOP |SORRENTO ROOM (MOSAICI 1)

Respiratory Support in Neonates: How to
ventilate term and preterm infants
Insights into new possibilities and neonatal
ventilation strategies
Supported by
12:30 - 13:30 LUNCHEON SYMPOSIUM |SORRENTO ROOM (MOSAICI 1)

Early optimal nutrition in the NICU
Supported by
12:30 - 13:30 LUNCHEON SYMPOSIUM |LECCE ROOM (MOSAICI 2)

Strategies and modern technologies of
continuous noninvasive blood gas monitoring
Supported by
13:30 - 15:00 ROUND TABLE |FIRENZE ROOM

Interactive clinical session: are babies with
serious hypoxemic conditions still being
missed?
Supported by
13:30 - 15:00 SATELLITE SYMPOSIUM |LECCE ROOM (MOSAICI 2)

Respiratory syncytial virus: should we identify
paediatric patients at risk for severe
disease?
Peer Voice (This activity is supported by an educational
grant from Abbvie)
15:00 - 17:00 PARALLEL SESSION 7 (PULMONOLOGY 1) |DARSENA ROOM

Pulmonary Symposium
124
124 125
125
SPONSORED SESSIONS
Despeena. 6 Years.
When I was born at 24 weeks of gestation, I couldnt
01/11/2017 breathe by myself. Thanks to your neonatal care, I can now
discover the world just like my friends do and live the
Bengt Robertson Award happy life of a six years old girl.
02/11/2017
12:30 - 13:30 LUNCHEON SYMPOSIUM |DARSENA ROOM

Pulse Oximetry CCHD Screening: focus on
the recent EU consensus towards
implementation
Supported by
12:30 - 13:30 LUNCHEON SYMPOSIUM |LECCE ROOM (MOSAICI 2)

ROP in 2017 & beyond - Present and future of
the prevention and treatment of retinopathy
of prematurity
Supported by
13:30 - 14:30 SATELLITE SYMPOSIUM |VENEZIA ROOM

Importance of human milk in preterm
nutrition
Supported by
18:00 - 19:30 EXECUTIVE SATELLITE SYMPOSIUM |VENEZIA ROOM

Enhancing the success of respiratory
management in nRDS
Supported by
03/11/2017
13:30 - 15:00 EXECUTIVE SATELLITE SYMPOSIUM |VENEZIA ROOM

Human milk fortification: benefits of an The European Foundation for the Care of Newborn
exclusive human milk diet for premature Infants (EFCNI) is the first pan-European organisation
infants and network to represent the interests of preterm and
Supported by Become a newborn infants and their families.
supporter for the
best start in life.
www.efcni.org/
126
126 donate the care of newborn infants
Chiesi Satellite Symposium
Thursday, November 2nd 2017
h. 18:00 - 19:30 | Hall Venezia, ground floor
ENHANCING THE SUCCESS OF

RESPIRATORY MANAGEMENT IN nRDS
Chair Prof. A. Van Kaam, The Netherlands
BPD: from trials to clinical practice

Prof. W. Gpel, Germany
Less Invasive Surfactant Administration (LISA),

a new chapter in Neonatal Management
Prof. P. Dargaville, Australia
Success of intervention: the importance of Training with LISA

Prof. M. Vento, Spain
LISA Training with LISAcath

Prof. P. Dargaville, Australia
Wednesday, November 1st
Thursday, November 2nd
Friday, November 3rd
h. 11:00 - 11:30 I Chiesi booth, Stand nb.1, Exhibitory Area, third floor
During morning coffee breaks*
*Please verify in the official congress agenda the definitive slots of morning coffee breaks
SPONSORS & EXHIBITORS
130
130 131
131
EXHIBITORS FLOOR PLAN
THIRD FLOOR - PALAZZO DEL CASIN
platform
1 7 12 FUTURE
CONGRESSES 17 23 33
2 8 13 18 24 34
3&5 9 14 19 25
4 10 15 20 26
platform
6 11 16 21 32
&22
132
132 133
133
ACUTRONIC Medical Systems AG CHIESI FARMACEUTICI S.p.A.

Address: Fabrik im Schiffli, CH-8816 Hirzel, Switzerland Address: Via Palermo 26/A 43122 Parma - Italy
Website: www.acutronic-medical.ch Website: www.chiesi.com
Email: info@acutronic-medical.ch Email: info@chiesi.com
Telephone number: +41 44 729 70 80 Telephone number: +39 0521 2791
Booth N. : 10 Booth N. : 1
ACUTRONIC is a swiss company developing, manufacturing and di- Based in Parma, Italy, Chiesi Farmaceutici is an international rese-
stributing high tech ventilation solutions for worldwide NICUs/PICUs, arch-focused Healthcare Group, with over 80 years of experience,
ICUs and Intensive Care Transportation. We are the leading partner present in 26 countries. Chiesi researches, develops and markets in-
for hospitals when it comes to the most critical areas of respiratory novative drugs in respiratory therapeutics, specialist medicine and
care: Neonatalogy/Pediatrics, Jet Ventilation and Difficult Airway rare disease areas. Its R&D organisation is headquartered in Parma
Management. and integrated with 6 other R&D groups.
Our innovative products simplify the busy clinical routine for caregi- Curosurf is the leading surfactant for the treatment of RDS in pre-
vers and increase the safety of patients. We challenge ourselves to matures, launched 25 years ago. Curosurf is now available in 94
continuously improve and set standards like the fabian, the most countries. The Less Invasive Surfactant Administration (LISA) was ap-
silent neo-ventilator in the marketplace today. And we strive every- proved in 2016, while in 2011 Chiesi launched Peyona, a pharma-
day to provide the technologically best solutions that are needed for ceutical standard caffeine citrate for the treatment of AoP.
the most medically challenging patients.
ACUTRONIC. Ventilation Beyond Limits.
BAXTER Drgerwerk AG & Co. KGaA - Medical Division
Address: Thurgauerstrasse 130, CH-8152 Glattpark Address: Moislinger Allee 53/55, 23558 Lbeck, Germany
Opfikon, Switzerland Website: www.draeger.com
Website: www.baxterhealthcare.ie Email: info@draeger.com
Booth N. : 9 Telephone number: +49 451 882- 0
Booth N. : 7
Baxter assisted clinicians in treating patients diverse nutrient needs
since the 1940s, when the company first introduced liquid proteins. Technology for Life: Drger is an international leader in the fields of
Since then, Baxter has continued to advance parenteral nutrition (PN) medical and safety technology. Drger products protect, support
therapy. For example, Baxter pioneered the worlds first triple-cham- and save lives. The current product range of the medical division
ber system internationally for IV nutrition, which provides many of the includes anaesthesia workstations, medical ventilation, patient
essential ingredients of balanced nutrition protein, carbohydrates, monitoring as well as neonatal care for premature babies and
lipids and electrolytes in a single container simplifying the prepara- newborns. With ceiling supply units, IT solutions for the OR, and gas
tion of PN. Today, Baxter provides one of the broadest PN portfolios management systems the company is at the customers side throu-
globally, which includes premix IV solutions, vitamins and lipids, as well ghout the entire hospital. Drger has more than 13,000 employees
as pharmacy workflow management, labeling, compounding tech- worldwide and is currently present in more than 190 countries.
nology and enteral nutrition syringes and accessories.
134
134 135
135
EMERGENCY NGO Fritz Stephan GmbH
Address: Via Santa Croce 19 20122 Milan, Italy Address: Kirchstr. 19, 56412 Gackenbach, Germany
Website: www.emergency.it Website: www.stephan-gmbh.com
Email: fo.recruitingmergency.it Email: info@stephan-gmbh.com
Telephone number: +39 02 86316316 Telephone number: +49 6439-9125-0
EMERGENCY is an independent Italian organization that provides Fritz Stephan GmbH, Germany has been providing innovative me-
free, high quality medical and surgical treatment to the victims of dicai technology and constantly setting new standards in artificial
war, landmines and poverty. It promotes a culture of peace, solidarity respiration, anesthesia and oxygen supply systems since 1978.
and respect for human rights. Particular emphasis is placed on manufacturing respirators for pre-
Since 1994 over 8 million people have received free, high quality he- mature infants and newborns. Requirements of medicai devices in
alth care by EMERGENCY. neonata! care are fundamentally different from those for adults;
artificial respiration needs to be as gentle as possible and must take
physiological differences into account. Recent development and
integration of a module for automatic contro! of oxygen saturation
in respirators, thus improving treatment of premature infants, is just
one recent example how Stephan innovations result in advanced
lifesaving technology.
Foundation Acta Paediatrica GE Healthcare
Address: Tomtebodavgen 9, 171 65 Solna, Sweden Website: www.gehealthcare.com

Website: www.actapaediatrica.com Booth N. : 21/22
Email: mail@actapaediatrica.se
Telephone number: +46 730 202 44 47 GE Healthcare provides transformational medical technologies
Booth N. : 25 and services to meet the demand for increased access, enhan-
ced quality and more affordable healthcare around the world. GE
Acta Paediatrica is a monthly peer-reviewed journal at the forefront (NYSE: GE) works on things that matter - great people and techno-
of international paediatric research. Our latest impact factor rose logies taking on tough challenges. From medical imaging, software
by 25% this year, making us one of the top three general paediatric & IT, patient monitoring and diagnostics to drug discovery, biophar-
journals in Europe. Editor-in-chief Professor Hugo Lagercrantz welco- maceutical manufacturing technologies and performance impro-
mes original clinical and experimental research papers, reviews and vement solutions, GE Healthcare helps medical professionals deli-
commentaries on a wide range of established and emerging pae- ver great healthcare to their patients. For more information about
diatric subjects. Our particular areas of interest include non-invasive GE Healthcare, visit our website at www.gehealthcare.com.
neonatology, such as CPAP, breastfeeding and Kangaroo care, and
sudden infant death syndrome. We also focus on lifestyles and health,
including how modern technology affects childhood development
and the growing paediatric obesity crisis.
136
136 137
137
GINEVRI srl Injeq Oy (Ltd)

Address: Via Cancelliera 25/B 00041 Address: Hermiankatu 22, FI-33720 Tampere, Finland
Albano Laziale (RM), Italy Website: www.injeq.com
Website: www.ginevri.com Email: rami.lehtinen@injeq.com
Email: export@ginevri.com Telephone number: +358 50 528 70 12
Telephone number: +39 0693459330 Booth N. : 15
Booth N. : 32
Injeq Ltd is a medical device company based in Tampere, Finland.
GINEVRI srl is a State of the Art leading Italian manufacturer of ad- The company is devoted to developing real time bioimpedance
vanced electromedical solutions regarding the neonatal/paediatric guided tissue identification technologies. The technologies can be
field since 1953. applied for multiple clinical applications, for example regional ane-
Being internationally recognized the Company strives for perfection in sthesia, lumbar punctures, and more.
reliability, quality and innovation. Injeq IQ-Needle knows where its tip is during the lumbar puncture.
A comprehensive range is available on the following website: www. Bioimpedance guidance functionality was developed to avoid too
ginevri.com deep punctures and unnecessary tissue damage to improve the
Each step of the production process is entirely monitored with our pro- success rate of lumbar punctures. The Injeq IQ-Needle products
ducts being 100% MADE IN ITALY and fully customizable to meet the are expected to benefit the patients by improving diagnosis, redu-
most demanding international medical standards. cing complications and enabling new type of treatments.
Hamamatsu Photonics Deutschland GmbH Inspiration Healthcare Group plc

Address: Arzbergerstrae 10, D-82211, Herrsching, Address: 2 Satellite Business Village, Fleming Way,
Germany Crawley, West Sussex, RH10 9NE, UK
Website: www.hamamatsu.de Website: www.inspiration-healthcare.com
Email: info@hamamatsu.de Email: info@inspiration-healthcare.com
Telephone number: +49 8152-375-200 Telephone number: +44 (0) 1455 840555
Booth N. : 34
Hamamatsu Photonics is a world leader in the manufacture of op-
toelectronic devices, including many for the medical market. The Inspiration Healthcare Group plc is a global supplier of medical te-
new NIRO-200NX Monitor enables the monitoring of the cerebral or chnology for critical care, operating theatre and home healthcare
systemic oxygenation. As it provides not only the oxygenation data applications. Our mission is to provide high quality innovative pro-
but also can detect the haemodynamic functions in the tissue it is a ducts to patients and caregivers around the world that help to im-
perfect tool for monitoring and improvement of the patient manage- prove patient outcomes and efficiencies of healthcare organisa-
ment during cardiac surgery. Our NIRO monitors are routinely used in tions with patient focused customer service and technical support.
many hospitals. Our own brand of critical care solutions span non-invasive respi-
ratory management, thermoregulation and patient warming for
newborns through to adults in intensive care and the operating
theatre, whilst our distribution business in the UK and Ireland sup-
plies solutions to support specialised surgical procedures and infu-
sion therapies.
Inspiration Healthcare products are available in over 50 countries
worldwide, our success has been built on continuous innovation,
excellent customer service and an inherent commitment to impro-
ving the quality of life of patients.
138
138 139
139
Masimo Corporation Medtronic
Website: www.masimo.co.uk Website: www.medtronic.eu

Booth N. : 2 Email: anastazja.walz@medtronic.com
Telephone number: +420 739 249 515
Masimo Corporation is one of the worlds most admired medical te- Booth N. : 13
chnology companies credited with revolutionizing pulse oximetry and
noninvasive patient monitoring. A global medical technology innova- As a global leader in medical technology, services and solutions,
tor, Masimo has been on the forefront of patient safety and a beacon Medtronic improves the lives and health of millions of people each
of innovation in healthcare for more than 25 years. As the inventor of year. We use our deep clinical, therapeutic and economic experti-
Measure-Through Motion and Low Perfusion Masimo SET pulse oxi- se to address the complex challenges faced by healthcare systems
metrythe market-leading pulse oximetry technology solutionand today. Lets take healthcare Further, Together.
Masimo rainbow Pulse CO-Oximetrya breakthrough noninvasi-
ve blood-constituent monitoring platform, Masimo has a portfolio of
clinically proven products that lead the way in innovation, perfor-
mance and patient safety by giving health care providers the infor-
mation they need to optimize clinical decision-making. In addition,
with technology license and OEM agreements with leading patient
monitoring manufacturers spanning the globe, Masimos advanced
oximetry technologies can be found inside of todays top multipa-
rameter brands, such as Atom, Datascope, GE Medical, Medtronic,
Philips, Spacelabs and Zoll, among others.
Medela Monivent AB
Website: www.medela.com Address: Arvid Wallgrens backe 20, 413 46

Booth N. : 8 Gothenburg, Sweden
Website: www.monivent.se
Founded in 1961 by Olle Larsson and headquartered in Switzerland, Email: info@monivent.se
Medela today is led by his son Michael Larsson. Medela concentrates Telephone number: +46 73 800 43 55
on two business units: Human Milk, which is leading in the develop- Booth N. : 18
ment and production of breastfeeding products and solutions, and
Healthcare, which engineers and manufactures highly innovative Monivent is dedicated to improving the care of newborn babies
medical vacuum technology solutions. Medela conducts basic rese- in need of respiratory support at birth. About 3-6 % of all newborns
arch in partnership with leading scientists, medical professionals and end up in this situation, and the caregiver needs to provide ma-
universities, and uses the research results in the development of its nual ventilation to the baby. Insufficient or excessive volumes of air
breastfeeding products and solutions. Medela has 19 subsidiaries in given may contribute to severe injury to the lungs and other or-
Europe, North America and Asia, and together with independent gans. Healthcare personnel are lacking good tools to determine
partners distributes its products in more than 100 countries. The com- how effective the treatment really is. Monivent Neo is a user-friendly
pany employs over 1,600 staff worldwide, 400 of whom are located in tool, measuring the airflow to the baby and providing continuous
the Canton of Zug, Switzerland. feedback on several parameters, helping the caregiver achieve a
gentle and effective treatment.
140
140 141
141
Natus Medical Nestl
Website: www.natus.com Address: Avenue Nestl 55, 1800 Vevey, Switzerland

Booth N. : 6 Website: www.nestle.com
Telephone number: +41 219241111
Natus Newborn Care products address the critical areas of asses- Booth N. : 3/5
sment and treatment of newborns, and are designed for use by
clinicians as they provide care in the critical minutes & hours after Nestl Nutrition helps the next generation of children to develop
delivery and prior to discharge from the hospital. By allowing for ear- their full potential and live healthier lives by providing high quality,
ly detection and treatment, we believe our products can improve innovative, science-proven nutrition solutions and education for
clinical outcomes, help reduce costs, and minimize the duration of mothers and infants in the crucial first 1000 Days of life. Together,
treatment, unnecessary retesting, or hospital readmission. The Natus nurturing a healthier generation.
Newborn Care product portfolio is offering a wide range of devices The Nestl Nutrition Institute (NNI), shares leading science based
dedicated to Hearing Screening, Thermoregulation, Newborn Brain information and education with health professionals, scientists, nu-
Injury and Jaundice Management just to name the major applica- trition communities and stakeholders in an interactive way. NNI is
tions. the worlds largest private publisher of nutritional information with
more than 3000 publications. All our nutrition resources are avai-
lable on the NNI website for free to registered members at http://
www.nestlenutrition-institute.org
Neotech Products Peak Medical Ltd
Address: 28430 Witherspoon Pkwy, Valencia, Address: Giborey Israel !0, Netanya, Israel
CA 91355 USA Website: www.peakmedic.com
Website: www.neotechproducts.com Email: info@peakmedic.com
Email: international@neotechproducts.com Telephone number: +972 522946755
Telephone number: +1 661-775-7466 Booth N.: 11
Booth N. : 14
Peak Medical Ltd is a provider of unique airway management,
Neotech Products, based in the USA, have been leaders in the field of emergency and critical care devices that do beyond what tradi-
neonatal care for 30 years. We create products that are developed tional devices would normally supply.
by clinicians for clinicians. Our focus is on disposable, skin care frien- Our mission is to develop a steady stream of novel, patentable me-
dly products that are gentle for neonatal and pediatric patients, and dical devices for Global Market.
now home care. Some of our most popular products are the Neotech Among the products that Peak Medical has developed and is
RAM Cannula, NeoShades Phototherapy Eye Shields, NeoBar ET Tube manufacturing are: - Video Laryngoscope for neonates, especial-
Holder, NeoPulse Pulse Oximeter Wrap and the EZ-Hold Tubing and ly for very low weight preemies, with range of disposable blades
Cannula Holder. and special attachments for surfactant application and oxygen
insufflation. - Range of disposable and reusable laryngoscope for
neonates, especially for very low weight preemies, with range of
disposable blades and special attachments for surfactant applica-
tion and oxygen insufflation. -Disposable Neonatal Transilluminator
-Portable Neonatal Resuscitator -Ventilator - Portable Mobile Moni-
tor of resuscitation process (under development) All the products
based on 7 companys patents and patents applications
142
142 143
143
PeerVoice SenTec AG

Address: 3rd Floor, 75 Davies Street, London W1K 5JN Address: Ringstrasse 39, 4106 Therwil, Switzerland
Website: www.peervoice.com Website: www.sentec.com
Email: info@peervoice.com Email: info@sentec.com
Telephone number: +44 (0)20 7665 9200 Telephone number: +41 61 726 97 60
Booth N. : 17
PeerVoice understands that todays healthcare professionals are
expected to stay up to date with the latest medical information and SenTec is leading the way to a new standard of care for nonin-
to demonstrate continual improvements in patient care, but are vasive, continuous monitoring of neonates ventilation and oxyge-
often challenged to find the time. We facilitate excellence in clinical nation. Doctors and nurses receive the information they need to
practice through live and online education designed to positively im- safely adjust neonates respiration therapies and to reduce com-
pact patient care. You can trust us to provide: plications in neonatal care. SenTec OxiVenT Sensors feature inno-
Education designed to eliminate specific knowledge and/or practi- vative technologies overcoming the limitations of current sensors,
ce gaps such as drift of tcPO2 and risk of burns. The SenTec Digital Monito-
Objective discussion of the best-available evidence and treatment ring System is safe, accurate and easy to use. SenTec is already the
guidelines standard of care in many leading Children Hospitals world-wide.
Practical clinical perspectives from internationally-renowned facul-
ty
An easy-to-use online educational platform that allows you to con-
trol how, when and where you learn
Prolacta Bioscience Inc. SIMCharacters GmbH

Address: 1800 Highland Avenue Duarte, CA 91010, USA Address: Rdigergasse 10, 1050 Vienna, Austria
Website: www.prolacta.com Website: www.simcharacters.com
Email: info@prolacta.com Email: info@simcharacters.com
Telephone number: +1 626-599-9260 Telephone number: +43 1-5812094
Prolacta Bioscience, Inc. is a privately-held life sciences company SIMCharacters develops paediatric simulators to improve the me-
dedicated to Advancing the Science of Human Milk. The com- dical care of critically ill children. His work as a NICU specialist has
pany pioneered the development of human milk-based nutritional taught founder Jens Schwindt that a highly professional interdisci-
products to meet the needs of critically ill, premature infants in the plinary team is an indispensable prerequisite for effective medical
NICU and leads the industry in the quality and safety of nutritional care. SIMCharacters High Emotion Preterm Simulator Paul enables
products made from breast milk. Prolacta operates the first and only medical teams to train how to handle critical neonatal emergen-
pharmaceutical-grade manufacturing facility for the processing of cies under highly realistic conditions.
human breast milk.
144
144 145
145
SLE Ltd. Wisepress Medical Bookshop

Address: Twin Bridges Business Park, 232 Selsdon Road, Address: 25 High Path, Merton Abbey, London SW19 2JL, UK
Croydon, CR2 6PL, UK Website: www.wisepress.com
Website: www.sle.co.uk Email: marketing@wisepress.com
Email: cworrell@sle.co.uk Telephone number: +44 20 8715 1812
cc: swestlake@sle.co.uk Booth N. : 4
Telephone number: +44 (0)208 681 1414
Booth N : 19 Wisepress.com, Europes leading conference bookseller, has a ran-
ge of books and journals relevant to the themes of the meeting. In
SLE Ltd is a leading developer and manufacturer of infant life support addition to attending 200 conferences per year, Wisepress has a
devices based in the UK. Our products provide respiratory support to comprehensive medical and scientific bookshop online with great
infants in Neonatal Intensive Care Units globally, providing a range of offers. Follow us on Twitter for the latest news @WisepressBooks.
invasive and noninvasive respiratory support modes.
At this meeting we will be showing our new SLE6000 ventilator with
its easy-to-use Lunar interface and additional non-invasive modes
(Including nHFOV).
The new SLE6000 uses SLEs well-known technologies such as valveless
ventilation and High Frequency Oscillation to give more controllable,
responsive and powerful ventilation, and its compact design makes it
ideal for the busy neonatal unit.
Vygon
Website: www.vygon.com
Booth N. : 24
Vygon is a world leader in the creation of high technology single-use

medical devices, distributed throughout the world by our dedicated
network of 27 subsidiaries and 331 integrated distribution partners.
Vygon offers an extensive range of products suitable for use in the
following clinical departments:
Neonatology, nutrition & obstetrics
Intensive care
Anaesthesia & Emergency
Intravascular Therapies
Cardiovascular & Surgery
146
146 Supporters Supporters 147
147
GENERAL INFORMATION
CONGRESS SITE
VENICE CONVENTION CENTER - veniceconvention.com
Address: Lungomare Guglielmo Marconi - Lido di Venezia, VE, Italy
Plenary room (Darsena) is located in Palazzo del Cinema

Parallel sessions and Exhibition/F&B area are located in Palazzo del Casin
CONGRESS DATE
31st October - 4th November 2017
PRE CONGRESS COURSES DATE
30th October 2017

ESN
COURSE
1
ESN COURSE 1 - Neonatal Infections
31st October 2017
ESN ESN COURSE 2 - Neonatal PCC 3 - Unmet needs: improving the

COURSE PCC 3
2 Haemodynamics quality of neonatal care - approaches
and strategies
PCC 1 - Ventilatory support- PCC 4 - Controversity in

PCC 1 PCC 4
matching physiology? pharmacology
PCC 2 - Multimodal neuro-imaging PCC 5 - Neonatal gastroenterology,

PCC 2 PCC 5
and neuro-monitoring in neonates surgery and nutrition
2nd November 2017
Neonatologist performed echocar-

NPE
diography (NPE)
Abstract Book
All abstracts submitted within the deadline are published on Journal of Pediatrics and
Neonatal Individualized Medicine (JPNIM). Late breaker abstracts (the ones submit-
ted after the deadline) will only be published in the abstract book. Both documents
will be available on the congress website www.jens2017.eu
148
148 149
149
INTERNATIONAL ACCREDITATION (UEMS) Certificate of Attendance
The Certificate of Attendance will be available for download at the end of the
The 2nd Congress of Joint European Neonatal Societies has been accredited by the congress from the congress website. Participants will be notified by email.
European Accreditation Council for Continuing Medical Education (EACCME) as
following: ORGANISING SECRETARIAT
n. LEE17-00673 with 31 European CME credits (ECMEC) for the entire Congress. All attendees have to finalise their registration at the registration desk starting from
EACCME credits are recognized Europe-wide and in North America. 31st October from 07:30.
They can be converted into their national equivalent by contacting your National FROM TO
CME authority. EACCME credits are recognized by the American Medical Associa-
tion (AMA) by the Physicians Recognition Award (PRA). 31st OCTOBER 07:30 19:30
1st NOVEMBER 07:30 19:30
2nd NOVEMBER 07:30 19:30
ITALIAN ACCEDITATION (ECM - EDUCAZIONE CONTINUA IN MEDICINA)
3rd NOVEMBER 07:30 19:30
Congresso - 2nd Congress of joint European Neonatal Societies 4th NOVEMBER 07:30 13:00
N evento: 202261
Crediti assegnati: 6 crediti
OFFICIAL LANGUAGE
CORSO ESN COURSE - Infectious Diseases English is the official language of the Congress. No simultaneous translation will be
N evento: 202050 provided.
Crediti assegnati: 7 crediti
COMMERCIAL EXHIBITS
CORSO ESN - Circulation Course The Trade Show Exhibition, located on the third floor of Palazzo del Casino will be
N evento: 202072 held from 1st to 4th November 2017. It will feature pharmaceutical and biotech-
Crediti assegnati: 5 crediti nology companies, medical publishers and scientific societies. Please refer to the
exhibition area map in order to check all the companies that are present in the
CORSO - Neonatologist performed echocardiography (NPE) exhibition area.
N evento: 202232
Crediti assegnati: 2 crediti SOCIAL EVENTS
Il congresso e i corsi sono stati accreditati per le seguenti Welcome cocktail
categorie: The welcome cocktail will be held in the Exhibition area anex (located on the 3rd
floor of Palazzo del Casin) Tuesday, 31st October at 18:30.
MEDICO CHIRURGO - discipline di: FARMACISTA
Neonatologia (farmacia ospedaliera/farmacia ospedaliera) Networking dinner
Pediatria Infermiere Pediatrico The Networking dinner will be held on Friday, 3rd November 2017 close to the con-
Pediatria (pediatri di libera scelta) Infermiere gress venue at Palazzo del Cinema Foyer.
Ticket cost: 50,00* (per person)

Per acquisire i crediti ECM, i partecipanti dovranno: Available for purchase at the new registrations desk.
aver partecipato al 90% dellevento
aver compilato on line la scheda di partecipazione, la scheda di valutazione per *The price includes light dinner and welcome drinks.
il congresso e il questionario per i corsi.
This version of the programme has been printed on 20th October, 2017
aver risposto correttamente ad almeno l80% delle domande incluse nel questio-
All the modifications sent after this date have not been taken into consideration
nario ECM del congresso
150
150 151
151
152
152 153
153
Amadei F. 36
A Ambjrnsson T. 66
Ameliana E. 85
Abduvalieva S. 85 Amess P. 22
Abed Y.E.L. 112 Amirouche A. 88
Abogunrin S. 102 Amodeo I. 28, 49, 63
Abraham V. 37 Amoedo Blanco R. 116
Abroug S. 77 Amunts L. 47
Abrudan G. 115 Anastasovska V. 24
Achille C. 94 Anblagan D. 86
Achiron A. 76 Andelius T.C. 78
Achiron R. 76 Andersen G. 103
Acosta L. 17 Anderson C. 39
Adamczak A. 37 Anderson P. 103
Adam-Darque A. 118 Andersson M.X. 32, 45
Adams M. 58, 79, 93, 95, 103 Andersson O. 29, 33, 94
Adamsson M. 56, 86, 94, 103 Andersson S. 118
Aden U. 68, 77, 103, 104 Andorka C.S. 63
den U. 67, 103, 109 Andrada M.G. 94
Afset J. 103 Andraka B. 65
Agbeko R. 68 Andreicu D. 25
gren J. 111 Andresen J. 69
Ahearne C. 53 Andreu A. 114
Ahlqvist-Bjrkroth S. 90 Andriessen P. 31, 49, 88
Ahlsson F. 111 Angelico R. 75
Ahmad S. 50 Angelini F. 116
AI Evensen K. 78, 118 Annink K. 72
Aikey C. 97 Antari V. 44
Ai-Rhan Kim E. 62 Anthony M. 115
Aita M. 39, 82, 83 Antognoli L. 61
Aiton N. 22 Apsey C. 111
Ajmi H. 42, 77 Aquilano G. 117
Akanbi S. 40 Aquino G. 36
Akira O. 76 Aragon D.C. 61, 110, 20, 22, 25
Akuma A. 85 Arca G. 76
Al Masri D.A. 90 Arifoglu I. 83
Al Samnan M. 96 Arsoy A.E. 98
Aladangady N. 42, 43, 64 Arjona D. 78
Alarcon A. 101 Arlettaz R. 76, 26
Albachiara R. 21 Arman D. 113
Aldecoa-Bilbao V. 83 Armengaud J.B. 116, 121
Alfani R. 66 Arnold C. 37
Algra S.O. 53 Arques L. 83
Al-Hosni M. 99 Arriada Redondo M. 41
Ali A. 50, 53, 112 Arruza L. 36
Ali Mamuri G. 20 Arslanoglu S. 108, 24
Aliefendioglu D. 43 Arun Ozer E. 66, 78
Alisik M. 83 Arunoday 81
Alkan Ozdemir S. 79 Asaro J. 97
Alkhoraidly A. 32, 112 Asay G. 99
Allegaert K. 9, 15, 41 Ashina M. 110, 21
Allendorf A. 76 Ashton J. 43
Almeida A. 19, 116 Asner S. 101
Alonso-Clemente S. 112 Aspevall O. 66
Alonso-Moya M. 112 Assaf Z. 97
Alsina M. 20, 76 Ate Beirik S. 81
Alsweiler J.M. 61 Atikah S. 30
Altman M. 92, 95 Augurio M.R. 66
Alvarelho J.J. 94 Aunal R. 115
Alves S de Almeida 68 Austin T. 48, 91
Alyamac E.D. 53 Avdic-Belltheus A. 54, 119
Alyamac Dizdar E. 23, 85, 98 Avenarius S. 120
154
154 155
155
Avian A. 64 Baydemir C. 98 Bidho M. 121 Branco M. 116, 115, 19
Axelin A. 30, 39, 90, 122 Bearer C.F. 43, 44 Binder C. 43, 44, 61, 87 Brandstetter S. 36
Ayache H. 108, 116, 25 Beaulieu J-F. 70 Binder J. 61, 62 Branvik-Ingelsson C. 83
Ayachi E. 81 Beauport L. 45 Binder-Heschl C. 61 Brasseler M. 49
Aydemir O. 39 Bech B.H. 58 Bjellmo S. 103 Bravo M.C. 19, 48, 64
Ayech H. 108, 109 Bech Jensen J.-E. 121 Bjrklund L.J. 97 Breatnach C. 14, 33, 64, 89
Ayyagari R. 31, 55 Beck I. 29 Bjuland K.J. 78 Breatnach C.R. 33, 41, 65, 89
Behrsin J. 85 Blackwell S.J. 47 Brgre C. 93
Beke A. 17 Blackwood B. 99 Breindahl M. 16, 62
B Belfort M. 82 Blaga L. 62, 115 Brenda E. 84
Belik J. 19, 42 Blake K. 71 Brennan C. 89
Babakissa C. 70 Bellalah M. 25, 108, 116 Blake R. 18, 116 Bresesti I. 27
Bach C.C. 29, 94, 103 Bellaleh M. 108, 109 Blanco C. 87 Breur J.H.M.P.J. 80
Bckman M. 56, 94 Bellallah M. 77, 107 Blanco D. 72, 93 Breur J.M.P. 29, 109
Backman Johansson C. 44 Beller E. 79 Blaz W. 65, 83 Brightman L. 48
Bae J.G. 111 Bellini C. 79, 80 Blennow M. 36, 62, 120 Brignole D. 72
Baerts W. 47 Bellis S. 41, 107 Blibech S. 18, 19, 117 Brini I. 115
Bagc O. 44, 66 Belteki G. 48 Blom H. 100 Brisigotti M.P. 72
Bahonjic A. 50 Beltempo M. 95 Bloor I. 119 Brodin P. 59
Baibarina E. 48 Belzer C. 43 Bluhme E. 57 Brohet R.M. 84
Baik-Schneditz N. 61, 62, 64 Bemgard C. 44 Boant O. 25, 85 Brom M.K. 24
Bakalli I. 20 Ben Ahmed A. 112 Boardman J. 86 Brookle M.E.L. 79
Bakar F. 75 Ben Ameur K. 24, 25, 42, 77, 112 Bocu E. 24 Brring T. 78
Balaam M-C. 123 Ben Ammou S. 77 Bodeau-Livinec F. 53 Brostrm L. 109
Balasch M. 114 Ben Amor S. 77 Boeri L. 68, 80 Brown A. 62
Balashova E. 75 Ben Hamida H. 24, 25, 42, 112 Bgh N. 78 Brown S. 30
Balcells C. 45, 83, 113 Ben Salah N. 77, 112 Bogossian F. 79 Brubakk A. 78
Balestriere L. 38 Ben Salem A. 24, 25, 42 Bohlin K. 20, 51, 59, 82, 97, 120, 122 Brubakk A.M. 78
Balink S.J.A. 61 Ben Salem H. 18, 19, 117 Bohnhorst B. 120 Brugman A. 78
Ballantyne M. 81 Ben Singor C. 112 Boix H. 36, 72, 93 Brunet S. 81
Ballard P. 51 Ben Slamia L. 77 Bol B. 99 Bruno L. 109
Ballard R. 120 Benavente-Fernndez I. 72, 93 Boldrini R. 75 Brunton A. 27
Baltane Z. 17 Benders M.J.N.L. 12, 29, 39, 47, 53, 68, 72 Bolger T. 18 Bruschettini M. 30, 77
Banerjee J. 42, 43, 64, 71 73, 80, 87, 118 Bolk J. 77 Bruss I.A. 57
Bansal S.C. 23 Bendix I. 87, 119 Blte S. 67,104 Bruzzese D. 66
Baquedano I. 36 Bendor-Samuel O.M. 96 Bomont R. 22 Bucci L. 66
Baraldi E. 120 Bennedsgaard K. 64 Bonafiglia E. 110 Buchan S. 115
Barbaria W. 18 Berber M. 75 Bonefeld-Jrgensen E.C. 58 Bucher H. 57
Barbouch H. 109 Bercovitz R. 76 Bonsante F. 110 Bucher H.U. 42
Barbouche H. 25, 108, 116 Berger A. 36, 43, 44, 80, 81, 87, 103 Borena W. 115 Buffat C. 64
Barczyk-Kahlert K. 66 Berglund S.K. 93 Borges A. 25 Buhrer C. 9, 59, 65
Bariamis S.E. 113 Bergonzelli Degonda G. 118 Boria A. 62 Bujari D. 37
Baritussio A. 65 Bernet V. 29 Brjesson L. 39 Bujorescu D. 85
Barone C. 38 Bernhard J. 19 Borradori C. 67 Bullimore G. 39, 70
Baros A. 117 Berretim-Felix G. 113 Borradori Tolsa C. 79, 93, 103 Buonocore G. 79, 92
Barrett M. 18 Bertoldi M. 20, 22, 25 Borrego R. 78 Burger D. 41, 49, 88
Barrington K. 58 Bettolli M. 70 Borrelli A.C. 21 Burgess L. 45, 111
Barro C. 92 Betzelos N. 82 Borysiuk O. 37, 44 Burghardt K.M. 69
Barry J. 99 Bezirganoglu H. 53, 85, 96, 98 Bttger R. 120 Burgmann J. 66
Barta H. 67 Bezrukov L. 117 Bouaicha E.D. 19 Burkhardt T. 26
Bartnicka A. 113 Bhat N. 22 Boubred F. 64 Bussmann N. 19
Bartocci M. 42 Bhat P. 39, 70 Boukadida J. 115 Buttic S. 84
Barton N. 84 Bhatia A. 33, 50 Bourika V. 115 Buxmann H. 120
Bassi E. 120 Bhatt J. 27 Bouwmeester R. 27 Buyukkayhan D. 24
Bassler D. 19, 42, 58, 76, 85, 95, 103 Bhayat S. 26, 61 Bouza H. 59 Buyuktiryaki M. 23, 41, 53, 59, 82, 85
Basso O. 58 Bhisikar S. 30 Bowden A. 81 96, 98
Bastanie M. 100 Bialas A. 83 Boylan G. 12 Byrne J. 53
Bastin M. 86 Bianco F. 36 Boylan G.B. 72, 80 Byrne M. 81
Batra D. 24, 98, 109 Bianconi T. 98 Boyle E.M. 53, 86 Bystrykh O. 75
Battersby C. 95 97 Biban P. 110 Boyle M. 31, 65
Baud O. 75, 76, 101 Bickes M.S. 67 Bragatti J.A. 47
Baumann-Holzle R. 57 Bickle-Graz M. 79, 93, 103 Branagan A. 108
156
156 157
157
Cavallaro G. 28, 49, 63 Cirulli F. 86
C Cavanagh P. 69 Civelli M. 36 D
Cebeci B. 22 Claessens N. 29
Caballero S. 122 Celaj E. 20 Claessens N.H.P. 29, 53, 118 DAl F. 36
Caballero-Villarraso J. 110 Cenni S. 66 Clark R. 99 DAronco S. 33
Cabaas F. 72, 93, 101 Cernada M. 72, 93 Clarke G. 72 DHaens E. 43
Cacchioli A. 36 Ceroni F. 77, 123 Clarke P. 20 DHaens E.J. 31
Cadete A. 94 Cerritelli F. 27 Claure N. 68 Dbritz J. 96
Caiazzo M.A. 21 Cspedes M.C. 114 Clayton A. 54 Daley A.J. 66
Cainelli E. 48 Cetinkaya M. 22 Clayton S. 56 Damhuis G. 122
Cakr U. 59 Ceyte H. 78 Cloet E. 53 Dammann O. 118
Calado E. 94 Chaaya S.B. 114 Cnattingius S. 102 Danhaive O. 80
Calderisi M. 79 Chae S.A. 78 Cobas J. 24 Dani C. 98
Calevo M.G. 30, 47, 72, 77, 80 Chaffanel M. 72, 93 Cobas Pazos M.J. 115 Dargaville P. 46, 68, 73
Calik Saglik A. 39 Chakhunashvili A. 83 Cobo T. 116 Darlow B. 58
Calixto C. 20, 22, 25, 61, 107 Chakravarty M. 45 Codru M. 85 Darlow B.A. 95
Callaghan F. 111 Chang J. 65 Coffey D. 97 Darque A. 68, 118
Callea F. 75 Chang M. 65 Coffrey Z. 97 DAscenzo R. 67
Calthorpe R. 84 Chang Y.S. 28, 95 Cogo P. 33, 48, 65, 120 Dassios T. 55
Cama A. 26, 79, 82 Chang Y-S. 28 Colby C. 99 Datta A.N. 118
Camblos A. 99 Chao K.Y. 23, 37, 107 Collins J. 33 Davies A. 27, 109
Campbell-Yeo M. 13, 30 Chappell F. 86 Colnaghi M. 63 Davis J. 22
Camporeale A. 66 Charlton M. 85 Comito V. 109 Davis J.W. 95
Campos A.C. 19, 76 Chartrand C. 81 Concheiro-Guisan A. 112 Davis P. 29, 37, 38, 46
Canabarro N.T. 96 Chasapi S.A. 113 Conti G. 38 Davis P.G. 30, 68, 84
Candace R. 79 Chatzidimitriou K. 79 Conti R. 44 De Angelis L. 65
Candotti F. 116 Chatzitoliou E. 44 Conway J. 80 De Bisschop B. 97
Caner I. 40 Chaudhry S. 107 Cools F. 97 De Boer J. 40, 57
Caete M.D. 110 Chebsey A. 79 Cooper E. 86 de Boode W. 40, 48, 54, 89, 14
Canizci P. 108 Chen C.Y. 98 Corcoran D. 19 De Boode W.P. 48, 108
Caizo D. 113 Chen H.K. 120 Cordero-Llana O. 54 De Booij E. 57
Canpolat F.E. 23, 41, 53, 85, 96, 98 Chen M. 121 Cornacchione S. 79 De Cssia Pinheiro Da Motta G. 83
Cao B. 96 Chen W.M. 108 Cornet M.-C. 32, 80 De Clifford-Faugre G. 39, 82
Cao Y. 40 Chen Y.L. 23, 37, 107 Correani A. 33, 50, 120 De Coppi P. 34
Caoci S. 23 Chen Y-T. 98 Corrias M. 82 De Dassel T. 79
Capasso L. 21, 66, 98, 120 Cheong J.L.Y. 47 Corsi C. 76 De Graaff J.C. 118
Capdevila E. 123 Chernausek S.D. 121 Corsini I. 98 De Grandis E. 68, 80
Capone E. 66 Chessell L. 50 Corso A.L. 65 De Groot R. 49, 88
Caram-Deelder C. 31 Chetcuti Ganado C. 115 Cortes D. 121 De Haan M. 53
Cardoso W.V. 120 Chiang C.E. 23, 37, 107 Coscia T. 32 de Halleux V. 96
Carey W.A. 99 Chien Y.H. 23, 37, 107 Cosmi E. 33 De Jonge R.C.J. 23, 61
Carfagna M. 50 Chimenti-Camacho P. 26, 82 Costeloe K. 95 De Jongh F.H.C. 36
Carlsson S. 43 Chiofalo B. 84 Coutts J. 115 De Klerk J. 41
Carmona F. 107 Chioukh F. 77 Coviello C. 98 De Kort E. 100
Carnielli V.P. 33, 48, 50, 51, 55, 61, 62 65, Chioukh F.Z. 24, 25, 42, 77, 112 Cowan F.M. 47 De la Torre M.J. 110
70, 102, 104, 120 Chisholm C. 99 Cozinov A. 67 De Luca D. 11, 20, 38, 55, 63, 69, 70
Carolan S. 53 Chisholm P. 64 Cragg L. 56 98, 101, 102
Carpenter J. 61 Chitty H. 68 Crasmller M. 87 De Martino D. 66
Carpenter M. 114 Chmielarz B. 65 Croon A. 57 De Martino L. 102
Carr P. 30 Chmielewska A. 32 Crossley K.J. 84 De Meulemeester J. 97
Carter B. 22 Choi B.M. 42 Crothers E. 108 De Mol A.C. 100
Carvalho C. 19, 116 Choi Y.J. 62 Crott G.C. 19 De Rooy L. 111
Casale M. 44 Chojnacka K. 109 Cseko A. 64 De Tersant M. 38
Casale Aragon D. 22 Chollopetz Da Cunha M.L. 83 Cucerea M. 17, 107 De Villepin B. 88
Cassidy M. 81 Chou H-C. 98 Cucerea M.C. 108 De Vries L. 67, 87, 101
Castoldi F. 27 Christopoulou I. 113 Culliney L. 97 De Vries L.S. 29, 53
Castro Conde J.R. 47 Chu S.H. 21 Cuttini M. 53 De Vries W.B. 109
Catinella S. 36 Chu S.M. 59 Cuzino I. 67 De Waal C.G. 36
Catozzi C. 36 Chuang C.Y. 77 Cuzzilla R. 24, 47, 66 Dean F. 17
Catroon K. 90 Chung S.H. 110 Cyr P. 47 Dear P. 38
Caudron S. 78 Cilio M.-R. 32, 80 Cyranowicz B. 64 Degraeuwe P. 49
Caulfield F. 97 Ciralli F. 63 Degtyarev D. 48, 75
158
158 159
159
Degtyareva M. 98 Dudink J. 72 Escribano E. 114 Fitting C. 55, 102
Del Campo R. 114 Duerden E. 45 Eskola V. 81 Fitzgerald E. 65
Del Pozo S. 114 Dumitra R. 25, 85 Espinosa M.G. 24, 111 Fitzgerald M.P. 76
Del Rey Hurtado De Mendoza B. 26, 45, 113 Dunlop A. 40 Essers J. 38 Fitzpatrick C. 26
DellOrto V. 38, 55, 69, 102 Durmush R. 114 Evans D. 58 Fitzsimons J.J. 81, 82
Demeulemeester V. 100 Dzietko M. 119 Evans N. 54, 89 Fjalstad J. 114
Demirel N. 83, 113 Evensen K.A.I. 78, 118 Flacking R. 39
Dempsey E. 15, 49, 88 Evers K.S. 92 Fleiss B. 54, 71, 119
Dempsey E.M. 23 E Ewald U. 29, 122 Flemmer A.W. 19, 21, 111
Deneva S. 20 Ewer A. 35 Flint R. 34, 41, 49
Deoni S. 33 Ebbesen F. 46 Flint R.B. 88
Depoorter A. 92, 118 Ebela I. 17 F Flood E. 84
Derhaschnig U. 43 Edqvist I. 83 Florez I.D. 40
Dermitzakis M. 93 Edstedt Bonamy A-K. 53, 109, 111, 121 Faas D. 120 Flunt A. 36
Derriks F. 97 Edwards D.M. 78 Faiella A. 38 Folha T. 94
Descloux C. 119 Efstathiou A. 59 Fairchild K. 99 Folkmanis V. 17
Deshpande G. 42 Efstathiou P. 59 Falasco G. 48, 65 Fonoll Joya J. 116
Dewhurst C. 66, 92 Eggink A. 57 Falco I. 19, 116 Foong J. 45
Dewitt K. 18 Egyepong J. 23, 82, 95 Fang A. 32 Frster K.M. 21
Dewitz R. 76 Ehman G.L. 41 Fang J. 99 Fowler S. 99
Di Costanzo P. 66 Eijsermans M.J.C. 39, 53 Fang L.C. 21 Fox C. 115
Di Cunto F. 100 Ejder Apay S. 114 Fantinato M. 120 Frame A. 70, 39
Di Fabio S. 109 Ejder Tekgndz S. 114 Farombi I. 81 Francalanci P. 75
Di Guardo V. 98 Eklf E. 67, 104 Farooqi A. 32, 56, 58, 77, 86, 94, 103 Frange P. 114
Di Lallo V. 36 El Doory S. 75 Farr J.M. 123 Franklin O. 33, 41, 65, 89
Daz R. 78 El Halik M. 75 Farr-Sender B. 123 Franta J. 81
Daz-Castro J. 66 El Helou S. 50 Fasth A. 33 Franz A.R. 109
Diaz-Redondo A. 82 Eldaw S.M. 82 Fauchre J. 57 Frauenfelder O. 122
Dima M. 117 El-Dib M. 47 Fedorova N. 75 Fredriksson Kaul Y. 78
Dinerstein A. 44 Eleanor M. 116 Fedorova T. 75 Freitas A. 116
Dinsdale S. 30 Eleuteri A. 48 Feeley N. 82, 83 Freitas L. 118
Dionne K. 30 Elfvin A. 43 Fehlhaber B. 65, 66 Frick M.A. 114
Doagi M. 19, 117 El-Khuffash A. 14, 19, 33, 40, 41, 48, 54 Felderhoff-Mser U. 87, 119 Friesenhagen J. 66
Doberschuetz N. 76 65, 89 Fellman V. 39, 88, 118 Frisland D. 46
Dobryanskyy D. 21, 37, 44 Elliott M. 16 Feng W.W. 96 Fromonot J. 64
Dobush O. 44 Ellis E. 41, 57, 107 Fenton T.R. 53 Frusca T. 104
Doerr A. 39, 94 Ellsworth K. 99 Ferkol T. 41 Fuchs H. 29, 37, 97, 120
Dogan P. 44, 66 Ellsworth M. 99 Fernandes G.M. 113 Fuentes T. 75
Doglioni N. 120 El-Naggar W. 63 Fernandez P. 36 Fuiko R. 36
Doherty A. 41 Elorza M.D. 26, 33 Fernandez R. 22, 80 Fujioka K. 21, 67, 110
Doherty D. 80, 55 Elsaadany L. 109 Fernndez C. 36 Fukushima S. 21
Doherty R. 75 Emery F. 39, 68 Fernandez Oviedo A.N. 82 Fulcheri E. 72
Doll H. 84 Emond A. 58 Fernndez-Colomer B. 93 Fullarton J. 115
Domellf M. 32, 43, 45, 93, 111, 121 Enes C. 19 Fernandez-Lorenzo J.R. 93, 112 Furness J. 18
Donaldson B. 114 Engstrm E. 32, 45 Fernando I. 24 Fusch C. 32, 50, 53, 82, 112
Donnikov A. 48 Er I. 98 Ferradal S.L. 47 Fusch G. 50, 53, 82, 112
Doolan A. 97 Erin S. 112 Ferrara T. 66 Fustolo-Gunnink S.F. 31
Dor-Bergeron M.-J. 81 Ercoli G. 49 Ferreira C.H. 19, 42
Dorling J. 15, 18, 42, 69 Erdem Dursun Z.E. 43 Ferreira E. 36
Doros G. 108 Erdil A. 113 Ferretti E. 69
G
Dorsi M. 114 Erel O. 83, 113 Festival J. 82
Douagi M. 18 Ereno I. 76 Ficial B. 110 Gadzinowski J. 17, 37, 53, 92
Downe L. 42 Erickson-Owens D. 33 Field D. 86 Gafencu M. 108
Doyle L. 46, 101 Eriksson J.G. 118 Fields D.A. 121 Gaia T. 94
Dozier M. 80 Eriksson M. 30 Fijnvandraat K. 31 Gale C. 90
Draper E.S. 86 Erokhina A. 98 Filip V. 75 Gacka M. 113
Drenchev N. 22 Erol S. 83, 113 Finer N. 30 Gll Z.S. 108, 17
Drevin G. 61 Eros F.R. 17 Firmino I.C.L. 113 Gamulescu D. 13
Drews K. 92 Ertekin O. 23, 53 Fisch U. 92, 93 Gancheva S. 83
Dreyhaupt J. 120 Esaiassen E. 69, 114 Fischer Fumeaux C. 45 Gangaram-Panday N.H. 23
Drugan T. 190 Escobar A. 24, 78 Fischer-Riepe L. 66 Gantseva-Patsoura S. 101
Dubois J. 12 EscobarIzquierdo A.B. 115 Fischler B. 57 Gao F. 55
160
160 161
161
Gao W. 31, 55 Gonzlez Pacheco N. 25, 26, 38, 41, 94, 112 Guzman R. 93 Hazbahta G. 23
Gao X. 90 Gonzlez Gonzlez N.L. 47 Guzoglu N. 43 He M. 43, 44
Garca-Alix A. 76, 101 Gonzlez-Valcrcel M. 24, 75 Heathcote A. 20
Garca-Fragoso L. 113, 116 Goos T.G. 23, 61 H Heckmann M. 120
Garca-Garca I. 113, 116 Gpel W. 32, 73, 90 Hedin M. 100
Garcia-Rodenas C.L. 118 Gorbunov A. 98 Heep A. 79, 54
Garca-Snchez A. 63, 102 Gordon E. 115 Hmida D. 77, 107 Heijnen C. 87
Garg S. 77, 84 Gorman T. 99 Hmida-Ben Brahim D. 77, 112 Heinemann A.S. 66
Garland C. 22, 39, 70 Goudoever J.B.V. 50 Ha C.G. 47 Heinonen K. 118
Gatti M.G. 92 Gounaris A. 101 Hachem T. 114 Heiring C. 120
Gatti S. 49 Gouvea A.B. 61 Haddaji Mastouri M. 77 Helder O.K. 99
Gavare I. 17 Gouveia R. 94 Hadj-Abdallah H. 107 Helenius K. 95
Gebauer C. 97 Gouyon J.B. 110 Haeberlin A. 99 Hellgren G. 32, 45, 87, 112
General F. 44 Govaert P. 92 Hafstrm M. 77, 103 Helliwell E. 68
Gennissen L. 57 Gowda H. 22, 25, 26, 61 Hagberg H. 54, 119 Hellstrm A. 32, 45, 60, 62, 87, 112
Gentilino V. 28 Gozen D. 112 Hgglf B. 56, 86, 94 Hellstrm W. 112
Genzel-Boroviczeny O. 120 Gzen D. 81 Hagman C. 97 Hellstrm-Westas L. 78, 118
Georgakopoulou I. 113 Gozzini E. 98 Hagmann P. 45 Hemels M. 43
Georgieva R. 20 Gragnaniello D. 120 Haiden N. 36, 43, 44, 81, 87 Hemmatpour S. 81
Geraci D.M. 94 Gramignoli R. 57 Haiek L. 83 Hemse Nojd K. 44
Gerbaulet L. 117 Grandvuillemin I. 64 Hair A. 82 Henckel E. 57, 59
Geurtzen R. 27 Grant P.E. 47 Hakannson S. 95 Hending M. 57
Ghazal K. 77 Grathwohl D. 121 Hakeem M.A. 62 Hendriks M. 47, 57
Ghith A. 25, 108, 116 Gratopp A. 40 Halamek L. 27 Hendriksen A. 47
Giacalone M. 98 Gray J. 117 Halil H. 59 Henriksen T.B. 29, 31, 46, 58, 64,
Giampietri M. 98 Gray P.H. 78 Hallab Y. 112 71, 78, 86 102, 103
Giampietro S. 94 Grayson N. 30 Hallak A.C. 22, 25 Henry C. 61, 95
Giannakopoulos I. 113 Green G. 118 Hallberg B. 34, 45, 57, 72, 83, 87, 88 Hentschel R. 34, 61, 96, 120
Giannattasio A. 66 Greenough A. 55 90, 94, 111 Hon M. 82, 83
Giann M.L. 110 Gregersen N. 64 Halleb Y. 77, 107 Herber-Jonat S. 19, 21
Gibbins S. 30 Gregorio-Hernndez R. 26, 82 Halonen S. 81 Herdt A. 97
Gibbons D. 53 Greisen G. 48, 50, 100, 103 Hamazaki T. 76 Herlenius E. 61, 117
Gil Fenoy A.M. 24 Gressens P. 34, 54, 72, 100, 119, 123 Hamdi S. 42 Hernandez-Chirlaque C. 19
Gil-Campos M. 19 Gribaa M. 77 Hamilton R. 86 Herranz Barbero A. 116
Gill A.W. 55 Griesmaier E. 92 Hammami S. 77 Herz J. 87, 119
Gilmore C. 56 Griffin I. 97 Hamolko K. 36 Hetzer B. 115
Ginet V. 119 Griggio A. 49 Hamvas A. 41, 89 Hiatt C. 18
Giordano V. 80, 87 Grill A. 36 Hannachi N. 115 Hidar S. 77
Giretti I. 120 Grimaldi C. 75 Hansen B.M. 103 Higginson J. 84
Giske C.G. 66 Grinfelde I. 17 Hansen G. 120 Higman W. 71
Giuseppi A. 81, 110 Grira M. 77 Hansen Pupp I. 45, 84, 97, 112 Hitendu D. 29
Gizzi C. 11 Groenendaal F. 29, 47, 53, 67, 72, 80, 87, Hansson V. 100 Hjerde E. 69
Gjeta I. 20 118 Hantzi E. 115 Hjortdal V. 29, 103
Gladstone M. 92 Gromann J. 26 32 Hrd AL. 45, 93 Hjortdal V.E. 31, 78
Glander S. 66 Grnqvist H. 78 Harding J.E. 28, 114 Hck M. 77
Glass H.C. 32 Grouiller F. 118 Harris D.L. 28, 114 Hoehn T. 17, 49
Gliga C. 17, 107, 108 Grunt S. 79, 93, 103 Harris L. 67, 80 Hofer M. 116
Glover A. 39 Grynspan D. 69 Hrtel C. 65 Hoffmann C. 76
Goel S. 30 Gudmundsdottir A. 83, 109 Hartley C. 118 Hogeveen M. 27
Goeral K. 80 Guedich N. 77 Haschke F. 121 Hgstrm J. 82
Gojnovci X. 114 Guerrero A. 115 Hascoet J-M. 78, 82 Hokuto I. 75
Gkalp A.S. 98 Gui L. 67 Hsmsanu M. 62, 109, 115 Holland M. 89
Golosovsky E. 83 Guimares H. 26, 85, 116 Haumont D. 31 Holland M.R. 41
Golovchenko O. 83 Gulati N. 85 Ha-Vinh Leuchter R. 118 Hller N. 64
Gomez-Solaetxe M. 36 Gulczyska E. 64 Hawksley J. 68 Hollis C. 104
Gonalves A.B. 22, 25 Gulden S. 28, 49, 63 Hayakawa M. 76 Holsti A. 86
Gonalves-Ferri W.A. 20, 22, 25, 61, 107, 110 Gnlemez A. 98 Hayde M. 36 Holsti L. 31
Gonzalez J.J. 114 Guo T. 45 Haydon H. 79 Holt A. 23
Gonzalez R. 36 Grol A. 114 Hayes B. 76 Hongjie G. 41
Gonzalez S. 114 Gursoy T. 112 Hayes-Gill B. 61 Honore A. 117
Gonzlez Barrios D. 47 Gustafsson A. 59 Haynes M. 99 Hooper S. 29
Gonzlez Campo C. 47 Gutierrez E. 63, 102 Hays N.P. 121 Hooper S.B. 84
162
162 163
163
Horgan E. 30 Isayama T. 95 Jost K. 55, 97, 99 Kendall G. 27, 59
Horoshkeeva O. 75 Igum I. 53 Jourdain G. 38 Kennedy G. 70
Hosang N. 84 Isidoro-Garca M. 63, 102 Juhl S.M. 50 Kennedy S. 120
Hovhannisyan C. 114 Isik S. 82 Jung E. 79, 112 Kenner C. 105, 122
Hovi P. 56, 96, 118, 121 Iskander R. 112 Juul S. 87 Kent E. 41, 65
Howarth C. 42 Isler H. 19, 42 Juvet L. 114 Keogh C. 30
Hristova E. 63 Ismaili H. 23 Jynge . 57 Kerinova E. 20
Hristova M. 54, 119 Israelsson C. 82 Kermorvant E. 32, 50, 75
Hsieh W.S. 98 Ivanova J. 20 Kernan R. 108
Hsieh W-S. 98 Ivanova V. 20
K Kerrn-Jespersen S. 64
Hsin A. 77 Iversen A. 66 Keshavjee B. 121
Hsu J.F. 59 Ives K. 37 Kacem I. 25, 107, 109, 116 Keskin H. 40
Hsu S. 108 Iyore E.O. 50 Kadioglu Simsek G. 23, 41, 82, 96 Kettle R. 99
Hu X.J. 40 Izquierdo M. 113 Kaila K. 63 Khammari Nystroem F. 95
Huang C.C. 95 Izquierdo-Renau M. 45, 113, 116 Kairamkonda V. 32 Khan R.A. 115
Huang E. 80 Kajantie E. 118 Khemis T. 24, 25, 46, 112
Huang R. 90 Kajtazi F. 23 Khoo P.C. 23
Huber E. 44, 92
J Kalaydzhieva M. 20 Kidszun A. 37
Huescar M. 24, 111 Kallel F. 77 Kiechl-Kohlendorfer U. 92
Huescar M. 24, 111 Jackson A. 27 Klln K. 58, 109 Kiely M. 45
Huh J. 96 Jacobs S.E. 24, 66 Kaltsogianni O. 55 Kierkegaard H. 64
Huhn E.A. 118 Jaekel J. 56, 58, 94 Kamath-Rayne B. 99 Kilchevski A. 36
Huhtala M. 90 James A.T. 33, 89 Kampmann B. 114 Kilic D. 22
Hulzebos C.V. 31 James E. 76 Kan Onturk Z. 112 Killalea A. 112
Humaun Kabir M. 66 Jansen N.J.G. 29, 53, 80 Kang S.J. 111 Kim A.R. 62, 79, 112
Hummler H. 38, 120 Jansen S. 97 KanijoMller B. 121 Kim C.S. 111
Hundscheid T. 40 Jaraba M.P. 107 Kanmaz H.G. 23, 41, 96 Kim C.Y. 62
Hung C.C. 77 Jarosz-Lesz A. 19 Kanmaz Kutman H.G. 85 Kim E.J. 110
Hunt T. 22 Jrvelin M.-R. 118 Kao Y.H. 21 Kim E.K. 77
Huotilainen M. 39 Jarvis H. 17 Kapadia V. 30 Kim H. 62
Hppi P. 12, 34, 68, 86, 104 Jashari H. 114 Kapfhammer J. 79, 93 Kim H.R. 96
Hppi P.S. 67 Jayasinghe D. 84 Kappeler J. 21 Kim H.S. 77
Hurley M. 27 JazexhiuPostoli E. 37 Kara M. 40 Kim K.S. 62, 112
Hurley T. 26 Jebali S. 81 Karadag A. 78 Kim K.-S. 79
Hurtado Suazo J.A. 24, 66, 112, 116 Jenken F. 39 Karadagi A. 57 Kim S. 62, 111
Hussain J. 84 Jenkinson A. 31 Karageorgou K. 23 Kim W.H. 18, 62
Hutten G.J. 36 Jensen C.F. 46 Karagianni P. 44 King M. 76
Huttner W. 91 Jensen E. 121 Karam M. 100 Kioumi A. 44
Hwang J.H. 24, 62, 79, 11 Jermendy A. 6, 64, 67 Karen T. 19, 42 Kirkham J.J. 49
Jesacher B. 99 Karetnikova N. 75 Kirpalani H. 46
Jeter J.M. 121 Kari J. 81 Kirtbaya A. 75
I Jiang M. 96 Karkani A. 83 Kirupakaran K. 27
Jiang P. 50 Karpinski L. 37 Kistler K. 94
Iacob D. 117 Jiang S.Y. 40 Kasdallah N. 18, 19, 117 Kjeldsen M. 64
Iacob E.R. 117 Jilma B. 43 Kasprian G. 80 Kjellin T. 57
Iacobelli S. 44, 69, 110 Jimenez-Espinoza C. 68 Kasraoui I. 18, 19, 117 Kjellson K. 44
Ibrahim C.P.H. 114 Jin X. 96 Kasser S. 32, 118 Klarer N. 118
Ibrahim H. 90 Joels M. 86 Kassirer M.Y. 57 Klebermass-Schrehof K. 36, 80, 87
Ichiba H. 76 Johansson E. 59 Katayama Y. 67 Klein N. 54, 119
Iglesias I. 113 Johansson S. 86, 95, 104 Kattwinkel J. 99 Klein S. 57
Iglesias-Platas I. 45, 83, 113 Johnson K. 111 Kavalloor N. 23 Kleinlein B. 120
Iijima K. 21, 110 Johnson M. 15, 69, 110 Kawase A. 107 Kleiser S. 19, 42
Ikuta T. 21, 67 Johnson S. 56 Kayyali R. 65 Klemme M. 21
Ilieva I. 20 Johnston C. 30 Kazeem O. 116 Kleshchenko E. 102
Imbulana D. 38 Johnston L. 79 Kbaier H. 18 Klevebro S. 45, 87, 111
Inarejos E. 83 Jones J. 20 KC A. 29 Klingenberg C. 29, 68, 84, 114
Indredavik M.S. 78 Jones J.G. 55 Keenan W. 99 Klishch O. 38
Ingman A-S. 83 Jones R. 111 Kelly J. 112 Klotz D. 37, 62, 97
Inomata K. 107 Jongmans M.J. 39 Kelly L. 80, 101 Kneyber M.K. 70
Inoue T. 76, 107 Jonsson B. 66 Kelly L.A. 101 Knibbe C. 15, 41, 49, 88
Ionov O. 48, 75 Jordanova A. 63 Kemp J. 41 Knibbe C.A.J. 88
Ioroi T. 67 Jorns C. 57 Kempley S. 64 Knirsch W. 29
164
164 165
165
Knol J. 43 Leon M. 76 Lundgren P. 43, 87, 93
Kobas M. 101 L Leonardi V. 98 Luu T.M. 81
Koch B. 114 Leong V. 47 Lydersen S. 78, 103
Kocova M. 24 Laarman A.R.C. 45 Lequin M. 72 Lynne K. 116
Koehne P. 40 Lager M. 92 Leucuta D. 62
Kokkori F. 101 Lrum A.M.W. 78 Leung T. 42, 43
Koksal N. 44, 66 Lafeber H. 78 Leva E. 63 M
Kola E. 20 Lafeber H.N. 45 Levasseur K. 83
Kolossvary M. 67 Laforgia N. 37 Levy E. 69 Macchini F. 28
Koltunov I. 98 Lagan A.S. 84 Levy P. 89 Machidani N. 36
Komoriyama A. 92 Lagercrantz H. 67, 81, 88, 103, 104 Levy P.T. 41, 65 Mactier H. 86
Kondo Y. 107 Lahiff M. 84 Lewis J. 94 Mader S. 16, 51, 70, 90, 105, 122
Knig K. 122 Lakatos A. 67 Ley D. 45, 93, 112 Madero R. 26
Knigs M. 78 Lakshminrusimha S. 71 Li C. 55 Maderuelo-Rodriguez E. 26
Konstantinova V. 20 Lalchev Z. 63 Li N. 121 Maeyama K. 67
Kontilska S. 20 Lamouchi M.T. 18, 19, 117 Li Y. 50, 98, 120 Magalhaes L.V. 47
Koopman-Esseboom C. 53 Lamur K.D. 80 Liamlahi R. 29 Magerl W. 118
Korja R. 90 Lamy E. 64 Lieftchter V. 19 Magny J.F. 97, 114
Kornelisse R. 9 Landau-Crangle E. 32, 53 Liegl R. 87 Maguire F. 53
Kornsteiner-Krenn M. 43 Lange S. 59, 105 Liem D. 49, 88 Mahdhaoui N. 25, 77, 107, 108, 109, 116
Korstanje J.P. 100 Lano A. 118 Lien R. 106 Mahieu L. 100
Kortsalioudaki C. 27, 59 Lapaire O. 32, 92 Liew Z. 58 Mahoney L. 22
Kositamongkol S. 96 Lapillonne A. 15, 45, 50, 69, 97, 114 Likeman M. 79 Mai V. 65
Kosova R. 120 Laroche S. 100 Lillieskld S. 82 Maida C.M. 94
Kster C. 87, 119 LaroneJuneau A. 83 Lima B.B. 25, 110 Maier R.F. 53
Kostilainen K. 39 Larsen S.H. 29 Lin C-H. 28, 95 Maingay-de Groof F. 100
Kostovski A. 24 Lasheras G. 123 Lin Y.C. 95 Majcherczyk M. 19
Kostukov K. 75 Latal B. 29, 76 Lin Y.J. 95 Malavolti A.M. 76
Kotidis C. 48 Latour J. 13, 36, 57, 90 Linde M.A. 114 Malchau Carlsen E. 121
Kousholt B.S. 64 Lattuada D. 49 Ling T.Y. 120 Maldonado J. 112
Kouskouni E. 59 Lauenborg J. 121 Lingam I. 54, 119 Malic N. 113
Kovacs K. 63, 64 Lauridsen M.H. 31 Linklater A.K. 24 Mallardi D. 110
Kovacs S. 25 Lavalle A. 39, 82, 89 Linnr A. 38 Mallya P. 84
Kozak L.R. 67 Lavizzari A. 11, 36, 46 Linsell L. 56 Malniece I. 17
Kramer B. 54, 119 Law S. 71 Liotto N. 110 Malone F. 33, 41
Krasinski Z. 109 Lawn C. 22, 39 Lista G. 20, 27, 120 Malone F.D. 41
Krasniqi F. 23, 114 Lawrenson J. 48 Lithoxopoulou M. 44 Malova M. 47, 68, 72, 79, 80, 92
Krasniqi I. 114 Lazar C. 75 Little G. 99 Mlqvist M. 29
Kreissl A. 44, 87 Lazeyras F. 67, 68, 118 Little R. 39 Mancino I. 32
Kristiansen M. 81 Leach C. 39, 70 Liu K. 53 Mand C. 104
Kronstrm K. 81 Lebouedec A. 96 Liu S-Y. 98 Manerkar S. 30
Kroon A.A. 31 Lee B.S. 62, 79, 112 Liu Z-J. 87 Mangili A. 31, 55, 84, 95
Kryuchko D. 48, 102, 107 Lee E.H. 42, 96 Lfqvist C. 32, 45, 87, 93, 112 Manktelow B.N. 86
Ksia A. 25 Lee H.J. 78 Loftus E. 53 Manley B. 37, 38, 46
Kuehn T. 82 Lee K.H. 96 Logothetis M. 59 Mannheimer C. 87
Kuhle J. 92 Lee K.J. 47 Lombaard C.J. 48 Manolidou Z. 59
Kuhn P. 51, 84 Lee L.H. 96, 111 Longford N. 87, 97 Manou A. 81
Kujawa M. 19 Lee M. 96 Longini M. 79 Mansvelt P. 99
Kuligowski J. 72, 93 Lee N.H. 18 Loof T.G. 66 Marchini G. 44
Kumar A. 65 Lee N.M. 78 Looney A.M. 72 Marchionni P. 50, 61, 62
Kumar Bikkarolla S. 66 Lee S. 51, 58, 95 Lopes T. 19, 116 Marciano Alves Mousinho R. 97
Kunz N. 68 Lee S.J. 40 Lopez Lozano Y. 115 Mardare R. 82
Kurinczuk J. 56 Lee S.K. 40 Lpez-de-Heredia J. 36 Margeli A. 115
Kuroda J. 21 Lee S.L. 18, 84, 111 Lopriore E. 31 Marginean O. 108
Kurzawiska G. 92 Lee W.M. 18 Lordier L. 68 Marian R. 17, 107, 108
Kusuda S. 58, 76, 98 Lee Y.M. 18 Loureiro B. 36, 93 Mario M. 94
Kvanta H. 68 Lefebvre F. 81 Loureno M.M. 25, 107 Markasz L. 21
Kwan C. 82 Lehtonen L. 13, 31, 58, 90, 95, 122 Lozar Krivec J. 19 Marlow N. 53, 56, 86, 103, 104, 105
Kwinta P. 45, 110 Lei W.T. 21 Lu K. 30, 95 Marrin M.L. 53
Kwon J.Y. 96 Lemmers P. 29, 47 Ludea D. 63, 102 Marroun H.E.L. 118
Kyng K.J. 64, 71, 78, 86 Lemmers P.M.A. 109 Lui K. 30, 58, 95 Marl K. 58, 93
Lenderking W. 95 Luka R.L. 20 Marshall A. 115
166
166 167
167
Marsinyach-Ross I. 26, 38 Meder U. 63 Monk D. 20 Nadeem N. 17
Marsubrin P.M.T. 85 Meehan C. 54, 119 Monnelly V. 86 Nader P.J.H. 17, 96
Mrtensson G. 67 Meesters N. 31 Monteagudo-Snchez A. 20 Nader S.S. 17, 96
Martin A. 26 Meeus M. 100 Monteith C. 41 Naef N. 29
Martin D. 16 Megaw K. 113 Montesano G. 38 Nagamura-Inoue T. 76
Martin T. 65 Mellinger L. 66 Montirosso R. 122 Naghib S. 57
Martn C.M. 24 Melorz A. 116 Moore C.M. 81, 82 Nagy Z. 12
Martin-Alvarez E. 24, 66, 112, 116 Mendoza N. 114 Morales A. 24, 84 Naicker K. 65
Martin-Ancel A. 76 Menis C. 110 Morales De Mata P. 84 Nair H. 76
Martin-Celini F. 107 Menshykova A. 21 Moral-Pumarega M.T. 72, 93 Najm S. 32, 45, 112
Martinello K. 54, 119 Mercer J. 33 Morana G. 47, 68, 72, 80, 92 Nakato A.M. 20
Martinez A. 19, 24, 75 Merchant N. 77, 100, 123 Morcelli-Tovar C. 22 111 Nakstad B. 69, 116
Martinez F.E. 19 Merglen A. 118 Moreno A. 116 Nallagonda S. 82
Martinez V. 36 Mritet J.F. 88, 114 Moreno Hernando J. 20, 26 Napolitano 38
Martinez Gimeno A. 115 Mestiri K. 77 Moretti C. 68, 123 Narayanan S. 77, 100, 123
Martinez-Biarge M. 101 Methlouthi J. 25, 108, 116 Morgan C. 32, 45, 50, 110, 111 Nardi V. 109
Martini S. 47 Michalec M. 19 Mori R. 76 Nardou K. 116
Martn-Peregrina F. 66 Miechowicz I. 37 Mori T. 75 Nassel D. 81
Martins C. 101 Mielgo V. 36 Morioka I. 21, 67, 110 Nasseri N. 42
Martins-Celini F.P. 20, 22, 107, 110 Mielnik K. 17, 113 Morisaki N. 95 Natalucci G. 76, 79, 85, 93, 103
Maruniak-Chudek I. 19 Migliaro F. 98, 120 Morisawa T. 67 Nath P. 18, 23, 39, 100, 114
Masaki H. 113 Mikhalenka E. 36 Morley C.J. 30, 68 Navarro N. 85
Masilungan C. 115 Mikkola K. 39 Morris C. 115 Navarro Patio N. 25, 41, 85
Maslarska R. 20 Mildenberger E. 37 Morris J. 42, 56, 64 Navr L. 66
Mastouri Haddeji M. 112 Mileder L.P. 61, 62, 64 Morsing E. 93 Negro S. 92
Mateos M. 63, 102 Miletin J. 26, 42, 108, 109, 112 Mosca F. 28, 49, 63, 110 Negrn J. 113
Mathlouthi J. 112, 107, 109 Miller P. 108 Moshous D. 114 Nelle M. 82
Matic A. 77 Miller S. 29, 45, 100 Mosig D. 121 Nelson S.E. 121
Matinolli H-M. 118 Mills M. 67, 80 Mougou S. 77, 108 Nemeth A. 57
Matterberger C.H. 62 Milov V. 63 Moungsuwan K. 96 Neovius M. 102
Matthew A. 64 Minoo P. 55 Mowitz M. 31, 55 Neelioglu S. 83, 113
Matthiesen N.B. 29, 31, 58, 103 Mirada Vives A. 84 Msalbi K. 112 Nestaas E. 14, 33, 40, 54
Matusiak G. 17 Mirahamdi S. 61 Mu S.C. 23, 37, 107 Neumann R. 92
Matyas M. 62, 109, 115 Miranda A.M. 113 Muche R. 120 New K. 105, 122
Maurina A. 17 Miranda L. 94 Mukai T. 76 Newell S. 38
Mayer B. 37, 38 Miranda Romera P. 24 Mukherjee A. 117 Nguyen A. 50
Mazaev A. 98 Mitra S. 40, 63 Mukherjee D. 117 Nguyen T.D. 85
Mazela J. 37, 109, 113 Mitsiakos G. 44 Mulder A. 100 Nichols T. 58
Mazur-Magoa M. 83 Mittal S. 85, 107 Mulder E.E.M. 84 Nicloux M. 114
Mbuagbaw L. 40 Miyazawa T. 110 Mller V. 66 Nicolau Manzano M. 84
Mc Coy R. 32 Mizobuchi M. 67 Mungan Akin I 24, 108 Niedbalski P. 37
McCallion N. 33, 41, 68 Moczko J. 37 Mupanemunda R.H. 27 Niederhauser T. 99
McCarthy E. 45 Modi N. 31, 58, 90, 95, 97, 121 Muppidi P. 32 Niermeyer S. 99
McCarthy L. 65 Moeskops P. 53 Muraca M.C. 92 Nieto R. 44
McCartney D. 61 Mohammadzadeh A. 20 Muresan D. 109 Nijboer C. 87
McCormack M. 82 Mohammed L. 82 Murillo C. 116 Nikitina I. 48
McCurmin D. 87 Mohanraj N. 81 Mrner-Lavanchy I. 79 Niklas V. 91, 96
McDermott H. 24, 39 Mohlkert L.A. 121 Murphy M. 65, 120 Nilas L. 121
McDonald K. 22 Moiron M. 44 Murphy R. 53 Nilsson A.K. 32, 45
Mc Eneaney V. 80, 101 Moja L. 30 Murray D.M. 53, 71, 72, 80 Nilsson J. 82
McFadden V. 18 Mok D. 108 Mussi M.M. 110 Nishimura N. 67
Mc Garvey C. 76 Ml N. 45, 110 Mustafa S. 23, 87 Nixon P. 121
McGillick E.V. 84 Moldovan E. 107 Mustafa Kamal A.M. 84 Nobile S. 50, 61, 62
McGregor C. 72 Moles L. 114 Muster M. 83 Noguchi A. 95
McGuire J. 80 Moll J. 64 Mynarek M. 103 Nogueira M. 85, 116
McMillan D. 63 Mollamahmutoglu L. 83 Nohr E.A. 58
McNair C. 30 Molloy E.J. 18, 30, 43, 53, 80, 101 Nolan O. 108
McNamara D. 61 Moloney G. 72 N Nolbrant S. 94
McNamara P. 14, 54, 89 Moltu S. 32, 44, 50, 69, 110 Noori S. 14, 54
McNulty A. 70 Monastiri K. 24, 25, 42, 77, 112 Naberezhnev Y. 83 Noorizadeh S. 20
McPherson B. 54 Mondello I. 109 Nabetani M. 76 Noorlag L. 29
McSweeney L. 41 Mondkar J. 30 Nabialek T. 97 Nordberg V. 66
168
168 169
169
Nrgaard K. 121 Oosterlaan J. 78 Pavlyshyn H. 38 Polat S. 114
Norman E. 88, 122 Oostrom K. 78 Pavon A. 72, 93 Polentarutti S. 29
Norman G. 76 Oral B. 66 Pavord S. 81 Polglase G.R. 84
Norman M. 58, 66, 82, 93, 109, 111 Ordoez M.D. 107 Paynter J. 79 Pollien P. 118
121 ORegan S. 30 Pedersen L.H. 71, 86 Polonara G. 67
Nosarti C. 56 OReilly H. 56 Pedersen M. 78 Polycarpou E. 40
Noureldein M. 23, 82, 95 Orlikowsky T. 35 Pedersen M.V. 78 Ponce J. 116
Nouri A. 77 rtenstrand A. 100 Pedersen T. 69 Ponchia E. 33
Nouri S. 77, 107, 109, 112 Osborne L. 23, 40 Peinado H. 26 Ponnusamy V. 75
Nouri Merchaoui S. 25, 108, 115, 116 Orsini B. 38 Pejovic N.J. 61 Popoiu A. 108
Noventa M. 84 Oshalim M. 59 Pelligra G. 82 Poppe J. 88
Nowak G. 57 stergaard J.R. 29, 31, 103 Pelling V. 67, 80 Porcarelli F. 62
Nez-Ramiro A. 72, 93 sterholt H.C.D. 116 Pea-Caballero M. 66, 112 Porta R. 123
Ostojic D. 19, 42 Peng X. 90 Porter R. 85
O Ouwehand T.L.
Ovali F.
53
24
Peralta J.
Pereira Martins-Celini F.
115
22
Posod A.
Prager S.
77, 92
119
Owen L. 37, 38, 46 Peretti A. 67 Prasad R. 75, 108
Cathin N. 112 Owsiaska Z. 17 Perez E. 76 Prayle A. 27
OConnor D. 82 zcan B. 83 Prez I. 24 Pre-Curto F. 116
OConnor N. 53 Ozdemir N. 78 Perez-Navero J.L. 110 Preusche A. 109
ODea M. 101, 116 Ozer Bekmez B. 85 Perez-Perez A. 26 Pritchard M. 78, 79, 105, 122
ODowd M. 39 Ozkan H. 44, 66 Perk Y. 81 Procianoy R.S. 47, 65
OLeary J.J. 101 Perrone M. 110 Proena E. 19, 116
ORiordan M.
OSullivan M.P.
97
72
P Perrone S.
Perrotta I.
79, 92
38
Proietti F.
Provitera L.
79
28, 49
OBrien O. 53 Pertile M. 36 Pryds O. 121
Ochoa J.J. 66, 112 Padalino M. 48, 65 Pescador Chamorro I. 25, 38, 94, 95 Psyllidou S. 117
OConnor N. 53 Padbury J. 33 Peters J. 120 Puccini P. 36
Odd D. 58, 79, 94 Padilla N. 67, 68 Petersen O.B. 31 Pugni L. 63
Oddie S. 59, 65 Pagel J. 65 Peterson M. 102 Puigarnau Vallhonrat R. 84
ODea M. 101, 116 Paiva P. 22, 25 Petersson G. 92, 102 Pulzer F. 120
ODonnell C. 65, 120 Paiva P.P. 61 Petrela E. 37 Pupp Hansen I. 112
ODonnell C.P.F. 30 Paize F. 92 Petroni G. 99 Putter H. 31
Oei J. 30 Pakarinen S. 39 Petropoulou C.H. 59 Puyal J. 119
Ofoegbu B. 82, 90 Pal R. 22 Petrova D. 63
Ognean M.L. 25, 85 Palmkvist Kaijser K. 44 Petrukhina N. 102
Oguz S.S. 23, 41, 53, 59, 82, 85 Panickar A. 77 Petty J. 105 Q
96, 98 Panjwani D. 107 Peyter A.C. 64
Ohlund I. 32 Pansy J. 64 Pfeifer S. 66 Quero J. 101
Ohyama S. 21 Pantoja A. 24 Pfeiffer H. 32 Quigley A. 86
Okafor I. 18 Panza R. 37 Pfister M. 32 Quigley J. 44
OKelly R. 112 Papadopoulou M. 83, 101 Pfister R.E. 79 Quintana Rio E. 84
Okubo S. 21 Papamichael E. 40 Philpott A. 18 Quintero Fuentes I. 47
Okur N. 23, 41, 53 59, 82, 85, Papassotiriou I. 115 Pianesi A. 67
96, 98 Park J.H. 18, 111 Pichler G. 61, 62, 64
Olariu A. 23, 82, 95 Park S.H. 18 Pieltain C. 96 R
Olariu E. 25 Park W.S. 34 Piemontese P. 110
Olariu G. 20, 27, 85 Parker A. 33 Pietrobelli A. 110 Raaymakers M.J.A. 108
Olariu L. 20 Parmar M. 77, 123 Pillow J.J. 55, 62 Raba G. 83
Olariu S. 20, 27 Parodi A. 47, 68, 72, 79, 80, 92 Pieiro-Ramos J.D. 72 Rabe H. 22, 27, 33, 48, 49, 67, 80,
Olbertz D. 96 Paro-Panjan D. 19, 79 Pinho L. 19 91, 109
Olin A. 59 Parra A. 72, 93 Pioselli B. 36 Rabi Y. 30
Olischar M. 80 Parraga M.J. 107 Pirr S. 65, 66 Raffa S. 47
Olsen J. 58 Parrella C. 21 Pissarra S. 26 Raffaeli G. 28, 49, 63
Olsen R.K. 64 Parri N. 98 Pittet M.P. 79 Ragab S. 54, 119
Olsson K.W. 43 Partanen E. 39 Poets C.F. 68, 101, 109 Rahim R. 114
Olsson Mgi C-A. 81 Parthasarathy P. 100 Poggi C. 98 Rai D. 86
Olteanu R.G. 67 Patel B. 27 Poggi G. 120 Rikknen K. 118
Omann C. 78 Patel M. 89 Pogka M.M. 113 Raimondi F. 21, 66, 98, 120
Omer M. 116 Patel M.D. 41 Poindexter B. 82 Raiskila S. 122
Oncel M.Y. 59, 82 Pavel A.M. 97 Pokrzywinski R. 95 Rajadurai V. 23
Onland W. 31, 98 Paviglianiti E. 109 Polat I. 40 Ramanathan R. 55, 90
170
170 171
171
Ramaswamy R.C. 24 Rocha N.A.C.F. 76 Sadeghirad B. 40 Sauser J. 118
Ramenghi L.A. 12, 27, 47, 67, 68, 72, 79 Rochow N. 32, 50, 53, 82, 96, 112 Saeidi R. 20 Savani R.C. 21
80, 92, 104 Rodgers-Gray B. 115 Saenz De Pipaon M. 114 Svman K. 32, 45, 112, 118
Ramos N. 24 Rodrigues M. 116 Saffioti M.C. 75 Saysanasongkham B. 17
Ramos-Navarro C. 18, 25, 26, 38, 41, 85 Rodriguez A. 95 Saghrouni F. 116 Sboui H. 77, 107, 115
Rana N. 29 Rodriguez M.V. 107 Saglam O. 22 Scacioli L. 22, 25
Rapisarda A.M.C. 84 Rodrguez J.M. 114 Sala D. 20 Scalise L. 61
Rapushi E. 37 Rodrguez J.R. 114 Salabay Z. 37, 44 Schaefer C. 29
Rascher W. 120 Rodriguez Fanjul J. 26, 98 Salas S. 113 Schappin R. 53
Raschetti R. 55 Rodriguez Guerineau L. 20 Saleh M.T. 75 Schelonka R. 99
Rasiah S. 24 Rodriguez Snchez De la 18, 25, 38, 41, 82, 94, 95 Saleh S. 75 Schenk D. 19
Rasiah S.V. 18, 24, 75, 108 Blanca A. Salguero E. 24, 111 Schenk W. 120
Rasiah V. 117 Rodriguez-Benitez M.V. 19 Saliba A. 90 Schiefele L. 38
Ratiu A. 85 Roehr C.C. 18, 20, 23, 31, 37, 46, 62, Sallabanda S. 20 Schimmel M.S. 57
Ravanetti F. 36 81 91, 96, 115, 123 Sallemi M. 18 Schloesser R. 76
Ravegnani M. 79 Roesch L.F. 65 Sallmon H. 18, 40 Schlsser R. 120
Ravn M.J. 81 Rogerson S. 47 Salomone F. 36 Schmid A. 77
Raynero R.C. 24 Roggero P. 110 Salvagno M. 48, 65 Schmid M. 38, 120
Razai A. 117 Rogido M. 97 Samuelsson M. 86 Schmidt L. 80
Re M. 72 Rohde O. 120 San Feliciano L. 63, 102 Schmidt S. 17
Rechtman D. 96 Rohsiswatmo R. 85 Sanches E.F. 87 Schmolzer G. 99
Ree I.M. 31 Roldn R. 24 Sanchez A. 36 Schmlzer G.M. 62
Regnicolo L. 67 Rolle U. 76 Sanchez A.A. 41, 89 Schneider H. 37, 97
Reicherzer T. 111 Romantsik O. 77 Sanchez T. 111 Schneider J. 45, 47, 101
Reichman B. 58 95 Rombo K. 13 Snchez-de-Toledo J. 26 Scholkmann F. 19, 42
Reinboth B.S. 119 Romero J. 87 Snchez-Gmez De Orgaz M. 26 Schning J. 66
Reis e Melo A. 26 85 Romeu Garb J. 84 Snchez-Illana 72, 93 Schreek S. 66
Reiss I.K.M. 9, 23, 31, 35, 49, 57, 88 Rook D. 30 Snchez-Luna M. 16, 18, 26, 38, 41, 60, 68 Schultze J.L. 66
100 Rosander K. 78 82, 85, 94, 95 Schulze A. 21, 111
Reister F. 38 Rosrio M. 26, 85 Snchez-Martnez M.B. 66, 112 Schulzke S.M. 99
Reitan S.K. 78 Rosario Filho N. 20 Snchez-Redondo M.D. 24, 78, 115 Schumann S. 37
Relton C.L. 71, 86 Rosenbaum J. 78 Sanchez-Torres A.M. 26 Schtze G. 111
Remesal A. 63, 102 Roseto B. 38 Sandegren L. 66 Schwaberger B. 61, 62, 64
Renes I. 43 Rossetti D. 84 Sangalli A. 17 Schwartz E. 84
Repa A. 43, 44, 81, 87 Rossi A. 47, 68, 72, 80, 92, 109 Sangaralingham L. 99 Schwarz C.E. 109
Resnick S. 95 Rossi R. 120 Sangild P.T. 50 Scopesi F. 27
Rettedal S. 69 Roth J. 65, 66 Sannia A. 47, 68, 72, 79, 80 Scott J.G. 79
Reulecke B. 22, 80 Rotta I. 38 Sanpietro G. 84 Scott M. 114
Reuner F. 66 Rousson V. 29 Sansone C. 120 Scrivens A. 37
Reyes Milln B. 47 Roviglione B. 27 Snta R. 17, 108 Sdobnikovs M. 17
Reynolds A. 76 Rovira Zurriaga C. 20 Santhalingam T. 95 Seboui H. 25, 77, 108, 116
Reynolds P. 37 Roy R. 21, 116 Santos A.L. 116 Sedin G. 21
Rey-Santano C. 36 Rudas G. 67 Santos M.M. 76 See L.C. 108
Rheinlnder C. 40 Rueda C. 116 Santos Silva J. 85 Segerer H. 120
Riccardi D. 38 Rueda R.L. 107 Sanz-Lopez E. 26, 82 Seidenberg J. 120
Ricci F. 36 Ruiz M.D. 107 Sapia F. 84 Sekarski T. 89
Rich W. 30 Ruiz-Gonzalez M.D. 19 Saporito L. 94 Sekarski T.J. 41
Richter A. 61 Rumba-Rozenfelde I. 17 Sapun O. 102 Sekili Z. 39
Richter M. 65 Rusconi F. 58 95 Sarapuk I. 38 Sekretar L. 37
Rickenbacher H. 118 Rusneac M. 17, 107, 108 Sarda S. 31, 55, 84, 94, 95, 102 Sellami M. 117
Rigby M. 65 Russo L. 101 Sari F.N. 85, 98 Sellwood M. 27, 59
Rigo J. 96 Russo S. 79 Sari R. 85 Semberova J. 26, 42, 108, 109, 112
Rigourd V. 81, 88, 97, 110, 114 Ryan E. 18 Sarmiento-Carrera N. 112 Semple S. 86
Rimensberger P. 70 Sarosa G. 114 Senterre T. 96
Rimol L.M. 78 Sarri G. 102 Senyuk T. 102
Rite S. 36 S Sartori S. 48 Seppnen A-V. 53
Rivera-Snchez S. 116 Sartz L. 94 Seraissol P. 88
Roberts C. 37, 46 Saad A. 77, 107, 112 Saso A. 114 Serdar M. 87
Roberts E. 49 Saccani F. 36 Sato Y. 76 Seremak-Mrozikiewicz A. 92
Robertson N.J. 54, 87, 119 Sacramento E. 20, 22, 25, 61, 107 Satodia P. 17, 18, 23, 40, 114 Serenius F. 58, 77, 86, 103
Roch G. 83 Sadarangani M. 115 Saugstad O.D. 30, 31, 61, 62, 71, 92, 118 Seribeli G.H. 20
Rocha G. 26 Sadasivam I. 81 Saunders M. 116 Seribelli G.H. 25, 107
172
172 173
173
Serkant U. 59 Singh Y. 41, 89, 107 Stewart M. 37 Taki A. 76
Serrano I. 36 Singhal N. 99 Stiles S. 111 Takyi A. 27
Serrano Lpez L. 24, 66, 112, 116 Sinha A. 64 Stjernqvist K. 103 Talar T. 64
Serreau R. 88 Sinha S. 68 Stocken D. 68 Talbot L. 83
Severino M. 47, 68, 72, 80, 92 Sipola-Leppnen M. 118 Stoecklin B. 55, 62 Talias M. 40
Sevuk Ozumut S. 24, 108 Sizonenko S. 51 Stoelhorst G.M.S.J. 100 Talman M. 121
Sgarbi E. 36 Sizonenko S.V. 87 Sten R. 69 Tamayo M.E. 40
Shah P. 58, 95 Sizun J. 51, 57 Stoiber H. 115 Tammela O. 81
Shah Farhat A. 20 Sjrs G. 95 Stoimenova E. 63 Tamura M. 76
Shanahan I. 65 Sjstrm A. 94 Stokes S. 66 Tan J. 22, 64
Shankar-Aguilera S. 55, 63, 102 Skenderi Mustafa B. 23 Stoltz Sjstrm E. 45, 111, 121 Tan K. 38
Shankle N. 18 Skild B. 38, 92, 109 Storring N. 75 Tandberg B. 122
Sharafutdinova D. 75 Skjaerven R. 102 Stoyanova V. 63 Tang N. 43, 44
Sharkey D. 61, 95, 119 Skranes J. 18 Stranak Z. 42, 109 Taniguchi S. 107
Sharp G. 71 Slater R. 118 Strand M. 99 Tann C. 54, 119
Sharp G.C. 86 Sminato M. 55 Strand Brodd K. 78 Tann C.J. 59
Sharp H. 27 Smith A. 39, 41, 65, 89 Streuli J. 57 Tarko A. 19
Shetty N. 59 Smith J. 48, 67 Stringer S. 95 Tarnow-Mordi W. 30, 88
Shibata A. 67 Smith L.E.H. 45, 87, 93 Stroescu R. 108 Tataranno M.L. 109, 118
Shimotake J. 80 Smyth J. 30 Strom S. 57 Tayman C. 59, 85
Shin J. 42 Snoek L. 98 Stucchi I. 120 Tchirikov M. 83
Shin J.S. 77 So H.Y. 53 Studzinski F. 96 Tedroff K. 102
Shin S.H. 77 Sodano A. 98 Su Y.N. 77 Teh W.Y. 76
Shin S.Y. 18, 111 Sderstrm M. 57 Suarez-Albo M. 112 Tei M. 92
Shing H. 25 Sol J. 57 Subhedar N. 14 Teig N. 120
Shintaku H. 76 Solana C. 44 Subhedar N.V. 99 Tekgndz K. 40, 114
Shipley L. 61, 119 Sola A. 35, 60 Suchojad A. 19 Tekgndz S.E. 114
Shires P. 109 Sola-Visner M.C. 87 Suciu L. 17, 107 Tekin N. 39
Shishkina O. 102 Soler P. 114 Suciu L.M. 108 Teles Silva C. 85, 116
Shishko G. 36 Solevg A.L. 116 Sukharava A. 36 ter Heine R. 41
Shoji H. 110 Soliz A. 21 Sun A. 96 Terki Hassaine R. 81
Shore H. 111 Soliz J. 21 Sun K.M. 22 Testoni D. 25
Shuttleworth B. 59 Soltirovska Salamon A. 79 Sun Y. 87 Tetruashvili N. 75
Shyur S.D. 21 Song I.G. 77 Sun Song W. 62 Thanhaeuser M. 43, 44, 81, 87
Siahanidou T. 115 Songstad N.T. 84 Sundberg B. 38 Theodoraki M. 83, 101
Siddiqui F. 85 Srensen A.S. 46 Suppiej A. 48 Thibault M-P. 69
Sierra A. 100 Soubasi V. 44 Sutcliffe M. 18 Thiele N. 57, 105
Siffel C. 55, 94, 102 Souza T.S. 22 Suter L. 99 Thielen M. 99
Siljehav V. 117 Spaans E. 41 Suzuki K. 43, 113 Thio Lluch M. 62
Silva A. 87 Spth C. 111 Svedenkrans J. 55 Tho A. 95
Silva G. 85, 116 Spaull R. 54 Svensson J. 103 Thomas S. 99
Silva R.P.G.V.C. 20 Spencer S. 27 Sweetman D. 31, 43, 44, 80 Thomson G. 39, 123
Silveira R.C. 47, 65 Spittle A.J. 47 Syrimi E. 23 Thomson L. 50
Silverman A. 27 Spong R. 56 Szabo M. 63, 64, 67 Thorolfson F. 82
Simard J.M. 43 Spyroulias G.A. 113 Szadkowska A. 65 Thwaites R. 115
Simeoni U. 53, 64, 96, 116, 121 Staffler A. 21 Szakmar E. 63, 64 Tibboel D. 48, 49, 57, 88, 118
Simmen P. 99 Stanescu A. 97 Szczapa T. 17, 37 Tidrenczel Z.S. 17
Simms V. 56 Stanulla M. 66 Szczapa-Krenz H. 37 Tikanmki M. 118
Simon M. 17, 107, 108 Stanzelova A. 112 Szepetowski P. 100 Timme K. 120
Simonato M. 33, 48, 65, 102, 120 Starnberg J. 93 Szpecht D. 92 Tin W. 68
Simons E.A. 100 Stas H.G. 100 Szymankiewicz M. 92 Tocoian A. 84
Simons S.H.P. 9, 15, 27, 31, 41, 49, 57, Staunstrup N.H. 86 Todorov T. 20
59 88, 100 Staves J. 81 Toet M. 29, 118
Sindelar R. 21, 43 Stefanovic S. 115
T Tofani L. 98
Singer B.B. 119 Stefanovic V. 115 Tof I. 19, 72, 93, 107, 110
Singh A. 24, 85 Stegeman R. 80 Tabasso C. 110 Toivonen M. 90
Singh B. 63 Steinhorn R. 11, 55, 71 Taber M. 42 Toma A.I. 67
Singh G. 89 Stellari F.F. 36 Tachtsidis I. 54, 119 Tomasik P. 45, 110
Singh G.K. 41 Stellin G. 48 Taddio A. 30 Tomasini E.P. 61
Singh K. 32 Stendahl T. 39 Taguchi A. 76 Toome L. 53, 122
Singh M. 108 Stephansson O. 92, 95 Taher N.A. 80, 116 Topf H-G. 120
Singh N. 85 Stevens B. 30 Takatera A. 67 Tormey P. 44
174
174 175
175
Toro F. 38 Veneselli E. 68, 80 Wagner M. 80
Torres Torres M. 95 V Vento Torres M. 30, 31, 35, 58, 60, 71, 72, Waheed G. 86
Tortora D. 47, 68, 72, 80, 92 73, 93, 95 Walker A. 109
Totsu S. 110 Vrsmki M. 118 Verdoliva L. 120 Walker K. 105, 122
Touati A. 77, 107, 112 Vaiman D. 81 Vereshchak S. 37 Walker S. 118
Touqui L. 55, 102 Valenti G. 84 Vergely C. 121 Wallace L. 71
Towers H.M. 57 Valentsiukevich I. 36 Verhage C. 67 Wallendorff M. 41
Trabelsi S. 77 Valstar M. 95 Verhage C.H. 39 Walsh B. 47
Traggiai C. 80 Valverde E. 72, 93 Verhagen E. 55 Walsh B.H. 80
Tran P-A. 99 Van Beek F. 49 Verlato G. 120 Wang D.H. 96
Trancassini M. 94 van Beek R.H.T. 61 Vermeulen R. 100 Wang H.S. 96
Tremblay E. 69 van Bel F. 47, 87 Verstyuft C. 88 Wang J. 31
Tremlett C. 116 Van De Heuvel M. 12 Vervenioti A. 51 Wang J.Y. 21
Treston B. 108, 112 Van De Ville D. 118 Vestergaard E.M. 31 Wang L.X. 96
Trevisanuto D. 23, 62, 120 van Den Akker C.H.P. 43 Viberg M. 83, 100 Wang M. 33
Triantafyllidou P. 101 van Den Anker J. 114 Vidra C. 115 Wang S.M. 96
Trickett J. 104 van Den Anker J.N. 32 Vieira A.A. 22, 111 Ward C. 61, 95
Troiano D.C. 22 van Den Bosch G.E. 110, 118 Viemann D. 65, 66 Ward R. 84
Truttmann A. 45, 119 van Den Hoogen A. 9, 16, 38, 39, 70, 80, 105 Vieten D. 18 Warner B. 41
Truttmann A.C. 101 van Der Aa N. 67 Vijlbrief D. 72 Warren J. 99
Tsai L.Y. 23, 37, 107 van Der Bom J.G. 31 Vijlbrief D.C. 31, 109 Warwick H. 23
Tsai M.H. 59 van der Horst B. 88 Vik T. 103 Washburn L. 121
Tsai Y-S. 28 van Der Lugt A. 118 Villamor E. 28, 49, 102 Watabe S. 76
Tsakalidis C. 44 van Der Net J. 39 Villar-Castro S. 25 Watchko J.F. 43, 44
Tsanova A. 63 van Dijk M. 31, 40, 57, 118 Villarino R. 75 Watkins R. 22
Tsao P.-N. 77, 98, 120 van Dijk-Lokkart E. 78 Villetti G. 36 Watts L. 39, 70
Tsilika S. 24, 98 van Drongelen J. 108 Vinaixa Vergs A-A. 84 Wauer R.R. 18
Tsou K.I. 95, 98 van Essen T. 23 Virella D. 94 Webbe J.W.H. 90
Tsou K-I. 98 van Eyck J. 84 Virupachi S.F. 115 Weber S.C. 40
Tsuji M. 76 van Gasselt B. 67 Visentin S. 33 Wechselberger K. 77
Tubman R. 39 van Gennip A. 84 Vishna Rasiah S. 85 Weeke L. 12, 29
Tufvesson E. 97 van Haastert I.C. 53, 109 Visick M. 99 Weider S. 78
Tully E.C. 41 van Heijst A. 27 Vitagliano A. 84 Weindling M. 48
Tunescu M. 27, 85 van Kaam A.H.L.C. 36, 70, 73, 98, 101 Vitale S.G. 84 Weiss M.D. 79
Turner A. 71 van Kampen F.S. 100 Vitsa L. 113 Wellmann S. 26, 32, 79, 92, 93, 118
Turner M. 9, 31, 45, 47, 84, 105 Van Laere D. 100 Viuff A-C. 58, 71, 86, 94 Wells J. 123
Turner M.A. 47 van Lingen R. 43 Vlasova O. 69, 117 Wen Y.H. 98
Twomey D.M. 53 van Lingen R.A. 84 Voeten M. 100 Wertheim D. 65
Tzialla C. 94 van Marter L. 99 Vogeser M. 111 Wesolowska A. 82
van Meurs-Asseler L. 100 Vogl T. 65, 66 Westerlund F. 66
van Rosmalen J. 31 Voigt M. 96 Westin V. 45, 111
U van Straaten I. 101 Vller S. 88 Weston P.J. 28, 114
van Tuyl M. 98 Vllger L. 66 Westrup B. 38, 93, 122
Uccella S. 68, 80 van Weissenbruch M. 100 Volpe J.J. 92 Wheeler K.I. 68
Ucls G. 24, 75, 78 van Weissenbruch M.M. 45 von Hofsten C. 78 White T. 118
Ucls Lpez G. 115 van Weteringen W. 23, 88 von Kaisenberg C.S. 66 Whybra-Trmpler C. 37
Ueda M. 67 Van Wyk L. 48, 107 von Kckritz-Blickwede M. 66 Wickstrm R. 92
Ulas T. 66 van Zanten H. 99 von Krusenstiern L. 31 Wielenga J. 99
Uldbjerg N. 31 van Zoeren-Grobben D. 43 Von Laer D. 115 Wigdel J.B. 81
Ulrich T.H. 120 vant Verlaat E.P.G. 100 Vora S. 23 Wiingreen R. 103
Ulubas Isik D. 83, 113 Vanniyasingam T. 40 Vormoor J. 68 Wilbaux M. 32
Umphrey L. 62 Vanpe M. 45, 117 Vu K.P.T. 45 Wilde 93
Unal S. 83, 113 Vanya M. 84 Vucinovic A. 80 Willassen N.P. 69
Uney J. 54 Varal I. 44, 66 Vucinovic M. 80 William J. 17
Ungureanu M. 107 Varvarigou A. 113 Vyas R. 47 Williams K. 111
Uras N. 23, 41, 82, 85, 96, 98 Varxalama E. 101 Williams L.Z.J. 61
Urbanek M. 77 92 Vecchio D. 94 W Williams M. 57
Urilli D. 92 Vedovelli L. 33, 48, 65, 102 Williams T. 17, 76, 102
Urlesberger B. 61, 62, 64, 80, 82 Vedovili L. 55 Wackernagel D. 62 Wilson E. 83
Uygun M. 24 Vejnoska B. 92 Wada K. 110 Wilson P. 59
Veldhuis M.S. 109 Wagenaar N. 67, 87 Winckler M.I. 47
Velilla-Aparicio M. 38 Wagh D. 22 Winderbank-Scott D. 39
176
176 177
177
jENS 2017 Industry Satellite Symposium
To register visit us online at www.peervoice.com/RSVLive
Winter J. 37, 99 Zareen Z. 80, 101

Witoslaw B.
Wittekindt B.
Wittwer-Backofen U.
37
76
96
Zasada M.
Zdraveska N.
Zea A.M.
45, 110
24
40
Respiratory Syncytial Virus:
Wolf M.
Wolfs T.
Wolke D.
19, 42, 109
54, 119
56, 58, 94, 103, 104, 118
Zeballos Sarrato G.
Zeballos-Sarrato S.
Zeitlin J.
26
25
53
Should We Identify Paediatric
Patients at Risk for Severe Disease?
Wood C. 76 Zenker S. 66
Wood H. 108 117 Zernickel M. 120
Woodgate L. 115 Zgrcea C. 25
Woods P. 62 Zhang L. 50
Wsten-van Asperen R.M. 98 Zhang R. 90
Wright B. 116 Zhang Y. 40, 96 Pre-registration
Wright I.
Wrigley C.
30
53
Zhao J.
Zhou P.
31, 55
50
Wednesday, 1 November 2017 is preferred, but
walk-ins welcome
Wrblewska-Seniuk K. 109 Zhou Q.
Zhu L.
40
90
13:30 15:00
Zhu X. 79, 93
X Ziegler E.E. 121 Venice Convention Centre
Zile I. 17
Xiao J. 42 Zimmermann A. 120 Room: Lecce
Zimmermann L. 16, 53, 62, 91
Zivanovic S. 20, 37, 96
Y Zoutkamp G.I. 43 Expert perspectives from:
Zuanetti G. 28, 49, 63 Chair Bosco A. Paes, MBBS, FRCPI, Maarten O. Blanken, MD, PhD(c)
Yacoubi M.T. 25 Zubkov V. 75 Paolo Manzoni, MD, PhD Utrecht University Medical Center
FRCPC, FAAP
Yagmur Bas A. 83, 113 Zwittink R. 43 SantAnna Hospital McMaster Childrens Hospital Utrecht, the Netherlands
Yahya L. 90 Zych B. 65, 83 Torino, Italy McMaster University
Yajamanyam P. 43 Hamilton, Ontario, Canada
Yalnzolu aka S. 81
Yamada J. 30
Yamada N. 27
Yamana K. 21
Yamane M. 67 AGENDA
Yan J. 79, 93
Yang H-I. 98 Severe RSV Disease: The Worldwide Burden
Yao L.M. 96 - Paolo Manzoni, MD, PhD
Yap T.L. 23
Yaprak Sul D. 113 Who Needs RSV Infection Prevention? A Closer Look at Children With Chronic Diseases
Yaremchuk S. 37
Yasin F. 115
- Bosco A. Paes, MBBS, FRCPI, FRCPC, FAAP
Ye X. 50
Yen T.A. 84, 98 Cases in Identifying Children at Risk of Severe RSV Disease
Yi F. 47 - Panel
Ylmaz Semerci S. 22
Yoon H.R. 77 The Acute and Long-Term Consequences of Severe RSV Disease
Yoon Y.M. 77
- Maarten O. Blanken, MD, PhD(c)
Yoshimoto S. 67
Yousef N. 63, 98
Yurdakul E. 113
Ask the Faculty and Concluding Remarks
Yzydorczyk C. 64, 116, 121
Z Learning Objectives
Describe the current clinical burden of severe RSV disease in early childhood
Zaharie G. 62, 115 Identify paediatric patients, particularly those with chronic diseases, at risk for severe RSV disease
Zaharie G.C. 109 Describe the potential clinical and societal consequences associated with severe RSV disease
Zamir I. 121
Zanetti B. 21
Zanin A. 75 This activity is supported by an educational grant from AbbVie.
Zappettini S. 30 This independent medical education activity is organised by PeerVoice. PeerVoice activities are designed to fill the unmet needs of the medical community by reporting
information pertaining to clinically relevant advances and developments in the science and practice of medicine. The preparation of PeerVoice activities is supported by
Zardi S. 77 written agreements that clearly stipulate and enforce the editorial independence of PeerVoice and the faculty presenters.
178
178 Copyright 2010-2017, PeerVoice
CCHD Screening with Masimo SET
Measure-through Motion and Low Perfusion Pulse Oximetry

Please visit
us at Masimo
Stand #2
Studies found that Masimo SET contributed to increased sensitivity and specificity
of critical congenital heart disease screening compared to physical exam alone1-5
> In the largest CCHD screening study to date, with over 122,738 subjects, screening sensitivity increased
from 77% using clinical assessment alone to 93% when clinical assessment was combined with
Masimo SET pulse oximetry.4
> Masimo SET pulse oximeters and sensors were exclusively used in the two studies (59,876 subjects)
that were the basis for the CCHD workgroup recommendation for CCHD screening protocols.1, 3, 6
Eve Newborn Screening Software Application*

> Automates each of the screening steps
with animated instruction, including sensor
application, measurement selection, and
screening result determination.
www.masimo.co.uk/eve
PLCO-001150/PLLT-10032C-0717
2017 Masimo. All rights reserved.

1
de-Wahl Granelli A et al. BMJ. 2009 Jan 8;338:a3037. 2 de-Wahl Granelli A et al. Acta Paediatr.2007 Oct;96(10):1455-9. 3 Ewer AK et al.
Lancet. 2011 Aug 27;378(9793):785-94. 4 Zhao QM et al. Lancet. 2014 Aug 30;384(9945):747-54. 5 Meberg A et al. Acta Paediatr.2009
Apt;98(4):682-6. 6 Kemper AR et al. Pediatrics. 2011 Nov;128(5):e1259-67. * Referred to as CCHD Mode in Radical-7 Operators Manual.
For professional use. See instructions for use for full prescribing information,
including indications, contraindications, warnings, and precautions. Masimo
devices with Eve has obtained CE Marking. Not available in the U.S.

jENS - 2017

Enviado por

Dados do documento

Direitos autorais

Formatos disponíveis

Compartilhar este documento

Compartilhar ou incorporar documento

Opções de compartilhamento

Você considera este documento útil?

Este conteúdo é inapropriado?

Direitos autorais:

Formatos disponíveis

jENS - 2017

Enviado por

Direitos autorais:

Formatos disponíveis

Share your experience by using the

hashtag #jenscongress on:

HOW TO DOWNLOAD THE CONGRESS APP

1. Connect to the Wi-Fi

2. Enter your store:

3. Search and download the MCA EVENTS app

Networking and interactivity between renowned experts participants, Key Opinion

SUPPORTED BY Doctor Morten Breindahl Silke Mader

MANON BENDERS VIRGILIO P. CARNIELLI PIERRE GRESSENS

AGNES PETRA HPPI NEIL MARLOW

SILKE MADER MORTEN BREINDAHL

european foundation for

09:15 - 10:15 Basics of infectious diseases in neonatology

10:15 - 11:00 Early onset sepsis NICE guideline

11:00 - 11:30 COFFEE BREAK

11:30 - 12:30 Adequate antibiotic dosing/TDM

12:30 - 13:00 Time for questions

13:00 - 14:00 LUNCH BREAK

14:00 - 15:00 Infection prevention

15:00 - 15:45 Emerging resistance patterns of microbial pathogens and

15:45 - 16:00 COFFEE BREAK

16:00 - 17:00 Heart rate variability and physiologic monitoring of

17:00 - 17:30 Discussion

30th October, 2017 99

MULTIMODAL UNMET NEEDS: CONTROVERSY IN NEONATAL VENTILATORY

Validation of novel combined

Visit SenTec booth No 17 and inform

11:00 - 11:30 COFFEE BREAK

16:00 - 17:00 How to detect seizures in the newborn

10:30 - 11:00 COFFEE BREAK 11:00 - 11:30 COFFEE BREAK

13:00 - 13:40 LUNCH

16:40 - 17:00 Plenary discussion, summary and close

ID 004 AN EVALUATION OF DOCTORS AND MEDICAL STUDENTS

PLENARY SESSION 1 | DARSENA ROOM

ID 369 THE EFFECTIVENESS OF PRENATAL ULTRASOUND DIAGNOSIS IN

ID 409 PREVALENCE OF LATE PRETERM INFANTS IN THE UNIVERSITY HOSPITAL

ID 434 THE INFLUENCE OF TWO DIFFERENT FAT EMULSIONS USED FOR

ID 675 NECROTIZING ENTEROCOLITIS IN A NEONATAL INTENSIVE CARE UNIT

10:10 10:25 Cognitive stability in children with congenital heart disease

10:25 10:40 Congenital heart defects and academic performance in a

10:40 10:55 Early postoperative amplitude-integrated electroence

09.00 11.00 PARALLEL SESSION 2 (RESUSCITATION) |VENEZIA ROOM

09:00 - 09:20 New techniques for optimising newborn resuscitation

09:20 - 09:40 Unravelling the physiology of haemodynamic transition

09:40 - 09:55 Delayed cord clamping during resuscitation -

09:00 - 09:25 The case for the term infant

10:25 - 10:40 Z-score differences based on cross-sectional

11:40 - 13:20 Hands on closed loop ventilation / HFOV in two groups

12:35 - 13:15 Early optimal nutrition in the NICU

13:15 - 13:25 Q&A

13:25 - 13:30 Concluding remarks

13:55 - 14:00 Kangaroo families - the meaning of sound environment for

13:45 - 13:50 Thermoregulation and physiological stabilization by

14:05 - 14:10 Association between size of patent ductus arteriosus and

15:50 - 16:05 MRI-diagnosed white matter lesions in the brain of VLBW

08:00 - 08:15 Individualized growth trajectories for preterm infants using a

08:15 - 08:30 Touchscreens for cognitive assessment of toddlers

08:30 - 08:45 Tracking childhood height of small for gestational age

08:45 - 09:00 Evaluation of effect of caffeine onset time on surfactant

2nd November, 2017 53

11:25 - 11:40 Identification of a regulatory alveogenesis gene cluster

10:00 10:30 COFFEE BREAK

10:30 11:00 Assessment of PPHN

11:00 11:30 Assessment of flow and contractility